Histone acetylase p300 inhibitors and their uses
Compounds targeting p300 histone acetyltransferase provide a solution to the lack of effective inhibitors, effectively inhibiting p300 activity and offering therapeutic potential for cancer and other diseases, with synergistic effects when combined with CDK4/6 inhibitors.
Patent Information
- Application Number
- JP2021529410
- Authority / Receiving Office
- JP · JP
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2018-11-27
- Filing Date
- 2019-11-27
- Publication Date
- 2024-11-07
- Estimated Expiration
- 2039-11-27
AI Technical Summary
Current research lacks effective histone acetyltransferase p300 inhibitors with high affinity and selectivity, which are crucial for balancing acetylation levels in the body and have potential therapeutic applications, particularly in cancer treatment.
Development of compounds with specific structures, including various substituents and stereochemical isomers, that act as potent histone acetylase p300 inhibitors, capable of inhibiting p300 activity and potentially treating cancer, metabolic diseases, and neurological disorders.
The compounds effectively inhibit p300 histone acetyltransferase activity, showing promise in cancer therapy, particularly for prostate cancer, leukemia, lymphoma, breast cancer, and multiple myeloma, and can synergize with CDK4/6 inhibitors for enhanced cancer cell proliferation inhibition.
Smart Images

Figure 0007579249000001 
Figure 0007579249000002 
Figure 0007579249000003
Abstract
Description
[Technical field]
[0001] The present invention belongs to the technical field of medicinal chemistry, specifically to histone acetylase p300 inhibitors, their preparation and use. [Background technology]
[0002] Post-translational modifications of histones, such as acetylation, phosphorylation, methylation, ADP-ribosylation, and ubiquitination, play important roles in the physiological and pathological processes of eukaryotic organisms. Among them, histone acetylation has attracted increasing attention in the field of life science research. Histone acetylation has important biological functions in gene transcription regulation, cell differentiation, cell proliferation, cell cycle control, cell apoptosis, and so on. Histone acetylation is carried out by histone acetyltransferases (HATs, also known as histone acetylases). Histone acetyltransferases catalyze the transfer of an acetyl group from acetyl-coenzyme A (Acetyl-CoA) to specific lysine epsilon-N. To date, the structures of several histone acetyltransferases have been determined and published. According to sequence conservation and distribution location, they can be divided into at least six major families, including the Gcn5 / PCAF family, the MYST family, the p300 / CBP family, the nuclear receptor coactivator family, the TAFII250 family, and the TFIIIC family.
[0003] The acetylation state of lysine, a specific site on histones, is maintained by the cooperation of histone acetylases (HATs) and histone deacetylases (HDACs). The acetylation state of histones directly controls their interaction with DNA, thereby controlling the interaction of DNA with related enzymes in the processes of DNA replication, transcription, repair and recombination. If the balance between the two is lost, abnormalities appear in the acetylation state of histones, which is controlled by HATs, and this has a serious impact on the body's vital functions, causing diseases such as malignant tumors, heart disease, diabetes and neurodegenerative disorders.
[0004] At present, among the histone acetyltransferase (HAT) family, p300 has become the focus of research. Studies have shown that histone acetyltransferase p300 plays an important role in tumor development, the expression of p300 gene is increased in some tumor cells, and knocking out p300 gene inhibits the proliferation of tumor cells.
[0005] At present, there are many studies on HDAC inhibitors, and some inhibitors have been marketed as anticancer drugs. However, compared with HDAC, there are few studies on HAT inhibitors, and no drug-like inhibitors with high affinity and high selectivity have been reported yet. As one of the important targets with two antagonistic functions that balance the acetylation level in the body, the biological significance and current research status of HAT provide a valuable opportunity for the research of new cancer therapeutic targets and the development of new drugs.
[0006] Due to the special biological function of p300 / CBP, research on HAT has mainly focused on histone acetylase p300 inhibitors. Therefore, the development of histone acetylase p300 inhibitors with high affinity and high selectivity is of great importance for the treatment of cancer. Summary of the Invention [Problem to be solved by the invention]
[0007] It is an object of the present invention to provide histone acetylase p300 inhibitors, their preparation and use. [Means for solving the problem]
[0008] The present invention provides compounds of formula (I) or a stereochemical isomer, solvate or pharma- ceutically acceptable salt thereof, or an isotopically substituted form thereof. TIFF0007579249000001.tif5768 (in the formula, A is selected from O, N, S; Ry is selected from absence, H, an alkyl group, a substituted alkyl group, or an alkenyl group; Rv, Rw and Rx are each independently selected from hydrogen, halogen, a cyano group, a nitro group, an alkyl group, a substituted alkyl group, an alkenyl group, an alkynyl group, a cycloalkyl group, a substituted cycloalkyl group, a heterocyclic group, a substituted heterocyclic group, an aryl group, a substituted aryl group, an aromatic heterocyclic group, a substituted aromatic heterocyclic group, a substituted amido group, a substituted guanidino group, a substituted urea group, an amino group, a substituted amino group, an alkoxy group and a substituted alkoxy group; R1, R2, R3, and R4 are each independently selected from H, an alkyl group, and a halogen; or among R1, R2, R3, and R4, R1 and R2 are linked together to form a ring, R2 and R3 are linked together to form a ring, and / or R3 and R4 are linked together to form a ring; R5 is selected from an alkyl group, an alkoxy group, an amino group, a substituted amino group, an amido group, a substituted amido group, an ester group, a carbonyl group, a heterocyclic group, and a substituted heterocyclic group.
[0009] moreover, Rv and Rw are each independently selected from a hydrogen atom, a halogen atom, an alkyl group, and a substituted alkyl group; Rx is selected from a substituted amide group, a substituted guanidino group, a substituted heterocyclic group, a substituted urea group, and an amino group; R1 is selected from H, F, and CH3; R2 is H, F, or CH3; or R1 and R2 are all CH2 and are linked together to form a three-membered ring; R3 is H; or R2 is CH2 and R3 is H and are linked together to form a three-membered ring; and R4 is H; TIFF0007579249000002.tif25170 A substituted alkyl group, a cycloalkyl group or a substituted cycloalkyl group, and R7 is H, an alkyl group, a substituted alkyl group, a cycloalkyl group, a substituted cycloalkyl group, a heterocyclic group, a substituted heterocyclic group, an aryl group, a substituted aryl group, an aromatic heterocyclic group or a substituted aromatic heterocyclic group, or R6 and R7 are linked to form a heterocycle or a substituted heterocycle.
[0010] moreover, The structure of said compound is shown in Formula II. TIFF0007579249000003.tif5275(in the formula, TIFF0007579249000004.tif34170Methyl group, halomethyl group, -YR a Selected from R a is selected from a methyl group or a cyclopropyl group, Y is selected from NH or O, Rv and Rw are each independently selected from hydrogen, halogen, and a methyl group; R1 is selected from H, F, and CH3; R2 is H, F, or CH3, and R3 is H; or R1 and R2 are all CH2 and are linked together to form a three-membered ring; or R2 is CH2 and R3 is H and are linked together to form a three-membered ring; A is O or S; R6 is H, an alkyl group, a substituted alkyl group, a cycloalkyl group, or a substituted cycloalkyl group; R7 is H, an alkyl group, a substituted alkyl group, a cycloalkyl group, a substituted cycloalkyl group, a heterocyclic group, a substituted heterocyclic group, an aryl group, a substituted aryl group, an aromatic heterocyclic group, or a substituted aromatic heterocyclic group; and in R6 and R7, the substituents in the substituted alkyl group, substituted cycloalkyl group, substituted heterocyclic group, substituted aryl group, and substituted aromatic heterocyclic group are each independently TIFF0007579249000005.tif19170, or R6 and R7 are linked to form a heterocycle or a substituted heterocycle.
[0011] moreover, The R6 and R7 are linked to form a heterocycle or a substituted heterocycle, and the heterocycle or substituted heterocycle is a 4- to 6-membered ring.
[0012] moreover, TIFF0007579249000006.tif50170, wherein X is CH2, NH, O, S, or SO2, m, n, and s are each independently selected from integers of 1 to 5, and R c , R d , R e are each independently a hydrogen atom, a halogen atom, a cyano group, a carboxyl group, a nitro group, an alkyl group, a substituted alkyl group, an alkoxy group, TIFF0007579249000007.tif28170 is selected from an alkyl group, a substituted cycloalkyl group, a heterocyclic group, a substituted heterocyclic group, an aryl group, a substituted aryl group, an aromatic heterocyclic group, a substituted aromatic heterocyclic group, a bridged ring, a fused ring or a parallel ring; R f , R g is a halogen, The substituents on the bridged ring, fused ring or parallel ring are each independently a Boc group, a fluoro C 1~6 is selected from an alkyl group, a substituted or unsubstituted heterocyclic group, and an alkanoyl group, preferably TIFF0007579249000008.tif30154 R c , R d , R e The above substituents are each independently halogen, C 1~6 Alkyl group, haloC 1~6 Alkyl group, C 1~6 Alkoxy group, haloC 1~6 It is selected from an alkoxy group and a hydroxy group.
[0013] moreover, TIFF0007579249000009.tif51170In the above, X is C, N, O, S, or SO2; R8 and R9 are each independently selected from hydrogen, an alkyl group, a substituted alkyl group, an alkoxy group, an alkenyl group, an alkynyl group, a cycloalkyl group, a substituted cycloalkyl group, a heterocyclic group, a substituted heterocyclic group, an aryl group, a substituted aryl group, an aromatic heterocyclic group, and a substituted aromatic heterocyclic group; R0 is absent, H or an alkoxy group, or R8 and R9 are linked to form a fused or bridged ring; R 10 , R 11 , R 12 , R 13 , R 14 are each independently selected from hydrogen, halogen, a cyano group, a carboxy group, a nitro group, an alkyl group, a substituted alkyl group, a cycloalkyl group, a substituted cycloalkyl group, a heterocyclic group, a substituted heterocyclic group, an aryl group, a substituted aryl group, an aromatic heterocyclic group, and a substituted aromatic heterocyclic group, or R 10 , R 11 are linked to form a ring, The R8, R9, and R 10 , R 11 , R 12 , R 13 , R 14 The above substituents are each independently halogen, C 1~6 Alkyl group, haloC 1~6 Alkyl group, C 1~6 Alkoxy group, haloC 1~6 It is selected from an alkoxy group and a hydroxy group.
[0014] moreover, X is C or O; R8 and R9 are each independently selected from hydrogen, an alkyl group, a substituted alkyl group, an aryl group, a substituted aryl group, an aromatic heterocyclic group, and a substituted aromatic heterocyclic group; R 10 , R 11 , R 12 , R 13 , R 14 are each independently selected from hydrogen, a cyano group, a carboxy group, an alkyl group, an alkenyl group, a substituted alkyl group, a cycloalkyl group, a substituted cycloalkyl group, a heterocyclic group, a substituted heterocyclic group, an aryl group, a substituted aryl group, an aromatic heterocyclic group, and a substituted aromatic heterocyclic group, or R 10 , R 11 are all alkyl groups, they are linked together to form a ring, The R8, R9, and R 10 , R 11 , R 12 , R 13 , R 14 The above substituents are as defined above.
[0015] moreover, R8 and N are linked to the same carbon atom and are selected from a phenyl group or a substituted phenyl group; R9 is selected from a hydrogen atom, an alkyl group, and a substituted alkyl group; R 10 , R 11 are each independently hydrogen, C 1~6 Alkyl group, cyano group, carboxy group, substituted alkyl group, C 3~6 Cycloalkyl groups, C 2~6 alkenyl groups, or R 10 , R11 are all CH2 and are linked to form a three-membered ring, R 12 , R 13 are each independently selected from hydrogen, a methyl group, a phenyl group, a substituted phenyl group, an aromatic heterocyclic group, a substituted aromatic heterocyclic group, a cycloalkyl group, and a substituted cycloalkyl group; R 14 is selected from hydrogen and a phenyl group; The R8, R9, and R 10 , R 11 , R 12 , R 13 , R 14 The above substituents are as defined above.
[0016] moreover, A is O.
[0017] moreover, The structure of said compound is shown in Formula III. TIFF0007579249000010.tif5174 (in the formula, Ra is selected from a methyl group or a cyclopropyl group; Y is selected from NH or O; R v , R w are each independently selected from hydrogen, halogen, and a methyl group; R1 is selected from H, F, and CH3, R2 is H, F, or CH3, and R3 is H; or R1 and R2 are all CH2 and are linked together to form a three-membered ring; or R2 is CH2 and R3 is H and are linked together to form a three-membered ring; R 10 , R 11 are each independently hydrogen, C 1~6 Alkyl group, cyano group, carboxy group, substituted C 1~6 Alkyl group, C 3~6 Cycloalkyl groups, C 2~6 alkenyl groups, 1~6 The substituents on the alkyl group are halogens, hydroxy groups, C 1~6 alkyl groups or R 10 , R 11are all CH2 and linked together to form a three-membered ring, preferably R 10 , R 11 are each independently selected from hydrogen, a methyl group, an ethyl group, an isopropyl group, a cyano group, a carboxy group, a halogen-substituted methyl group, a cyclopropyl group, a vinyl group, a methoxy-substituted methyl group, and a hydroxy-substituted methyl group, or R 10 , R 11 are all CH2 and are linked to form a three-membered ring, R 12 , R 13 are each independently selected from hydrogen, a methyl group, a phenyl group, a substituted phenyl group, an aromatic heterocyclic group, a substituted aromatic heterocyclic group, a cycloalkyl group, or a substituted cycloalkyl group, and the cycloalkyl group is a 5- to 6-membered cycloalkyl group; The substituents on the substituted phenyl group, the substituted aromatic heterocyclic group, and the substituted cycloalkyl group are each independently selected from halogen, C 1~3 Alkyl group, haloC 1~3 Alkyl group, C 1~3 Alkoxy group, haloC 1~3 selected from an alkoxy group and a hydroxy group; The isotopically substituted form is a deuterated form.
[0018] moreover, The compound structure is one of the following structures: TIFF0007579249000011.tif162170TIFF0007579249000012.tif112170TIFF00075792490 00013.tif251170TIFF0007579249000014.tif216170TIFF0007579249000015.tif165170
[0019] The present invention further provides a method for preparing the above compound, the method comprising the step of: TIFF0007579249000016.tif76158TIFF0007579249000017.tif9132 (wherein A, Ry, Rv, Rw, Rx, R1, R2, R3, R4, and R5 are as defined above, and R6 and R7 are as defined above.)
[0020] moreover, The reaction temperature is 15 to 30° C., and the reaction time is 0.5 to 2 hours, and preferably, the reaction temperature is 20° C., and the reaction time is 1 hour. The reaction is carried out by the action of DIEA and HATU to give the compound of formula IV: TIFF0007579249000018.tif28148
[0021] The present invention provides the use of the above-mentioned compound or a stereochemical isomer, solvate or pharma- ceutically acceptable salt thereof, or an isotopically substituted form thereof, in the manufacture of a histone acetylase inhibitor.
[0022] Furthermore, said histone acetylase is p300.
[0023] Furthermore, the histone acetylase inhibitor is a pharmaceutical agent for treating cancer, metabolic disease, neurological disease and / or inflammation, preferably, the cancer is prostate cancer, leukemia, lymphoma, breast cancer or multiple myeloma.
[0024] The present invention further provides a pharmaceutical composition, which is a formulation produced using the above compound or a stereoisomer, solvate or pharma- ceutically acceptable salt thereof, or an isotopically substituted form thereof as an active ingredient, in addition to pharma- ceutically acceptable auxiliary materials.
[0025] The present invention further provides a combination pharmaceutical product containing the above compound and an anticancer drug for simultaneous or separate administration in unit dosage forms of the same or different specifications, and a pharma- ceutically acceptable carrier.
[0026] Furthermore, the anticancer drug is a CDK4 / 6 inhibitor, and preferably, the CDK4 / 6 inhibitor is palbociclib.
[0027] In the present invention, an "isotopically substituted form" is a compound in which one or more atoms of the compound are replaced with their corresponding isotopes, for example, hydrogen in the compound is replaced with protium, deuterium, or tritium.
[0028] Experiments have shown that the compound prepared in the present invention can effectively inhibit histone acetylase p300, and can effectively inhibit the proliferation of cancer cells (including prostate cancer cells, leukemia cells, lymphoma cells, breast cancer cells, multiple myeloma cells, etc.), and has a promising future in the manufacture of histone acetylase p300 inhibitors and cancer treatment drugs.In addition, when the compound of the present invention is used in combination with CDK4 / 6 inhibitors, it plays a synergistic effect on the inhibition of proliferation of cancer cells, which proves that it is of great value in the manufacture of combination drugs. Of course, according to the above content of the present invention, various other modifications, substitutions or changes can be made according to the general technical knowledge and common means in this field without departing from the above basic technical concept of the present invention. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0029] The above content of the present invention will be described in more detail below with reference to specific embodiments of Examples and Test Examples. However, it should not be understood that the scope of the above subject matter of the present invention is limited to the following examples. Any technology achieved based on the above content of the present invention belongs to the scope of the present invention.
[0030] Unless otherwise specified, all reagents and test equipment used in the present invention are common commercially available reagents and equipment.
[0031] Composition of TIFF0007579249000019.tif27170-5) TIFF0007579249000020.tif55154
[0032] Synthesis of 5-bromo-1-((trimethylsilyl)oxy)-2,3-dihydro-1H-indene-1-nitrile (Int 1-1) TIFF0007579249000021.tif3795Aluminum trichloride (1.26 g, 9.4 mmol), 5-bromoindanone (10 g, 47 mmol), and 100 mL of dry dichloromethane were added to a 100 mL reaction flask, and trimethylsilyl cyanide (9.4 g, 94 mmol) was slowly added dropwise under ice bath. After the addition was completed, the mixture was stirred at room temperature for 5 hours. The reaction solution was poured into 200 mL of saturated potassium bicarbonate aqueous solution, extracted three times with dichloromethane, and the organic phases were combined, dried and concentrated with anhydrous sodium sulfate. Column chromatography was performed to obtain 10 g of white intermediate Int 1-1 in 68% yield. Mass spectrometry: 310, 312 (M+H + ). 1 H NMR(400MHz,DMSO-d6)δ 7.60(dq,J=1.6,0.8Hz,1H),7.54(ddt,J=8.1,1.6,0.8Hz,1H),7.44(d,J=8.1Hz,1H),3.11-3.02(m,1H) ,3.01-2.91(m,1H),2.72(ddd,J=13.5,7.8,5.8Hz,1H),2.40(ddd,J=13.4,7.8,5.6Hz,1H),0.16(s,9H).
[0033] Synthesis of 5-bromo-1-hydroxy-2,3-dihydro-1H-indene-1-carboximidic acid ethyl ester (Int 1-2) TIFF0007579249000022.tif34107 Intermediate Int. 1-1 (10 g, 32.3 mmol) was dissolved in 60 mL of dry ethanol, and HCl gas (homemade, dry) was introduced for TLC detection. After the reaction was completed, the mixture was concentrated as it was to obtain 9.6 g of a crude pale yellow solid, which was used as it was in the next step reaction.
[0034] TIFF0007579249000023.tif54170 9.6 g of intermediate Int. 1-2 was suspended in 120 mL of dry THF, and triethylamine (20 mL, 5 e.q.) was added under ice bath, followed by the batchwise addition of triphosgene (3.8 g, 0.4 eq). After the addition was completed, the mixture was stirred for another 2 h under ice bath, gently adjusted to pH < 5 with HCl (2N, aq), stirred for 1 h, extracted with EA, dried and concentrated over anhydrous sodium sulfate. Beat with EA / PE = 1 / 1 to obtain 5.3 g of white intermediate Int. 1-3, the second step yield was 58.3%. Mass spectrometry: 282,284 (M+H + ).
[0035] TIFF0007579249000024.tif28170 synthesis TIFF0007579249000025.tif41137Chiral separation conditions: Instrument: SFC-80 (Thar, Waters); Chiral separation column: CHIRALCEL AD (30*250mm 5μm) (Daicel); Column temperature: 35℃; Mobile phase: A=CO2, B=MeOH; Peak appearance time: t1=12.1min, t2=15min. Intermediate Int. 1-3 (5 g) was subjected to chiral separation to obtain intermediate Int. 1-4 (t1 = 12.1 min, 2.3 g). ee = 99%, [α] 20 D =+28°(c1.0,MeOH). 1 H NMR (400MHz, DMSO-d6): δ 12.18 (s, 1H), 7.71 (d, J = 1.9Hz, 1H), 7.61 (m, 1H), 7.44-7.28 (m, 1H), 3.14-3.02 (m, 1H), 3.02-2.90 (m, 1H), 2.66 (m, 1H), 2.59-2.39 (m, 1H); intermediate Int. 1-5 (t2 = 15min, 2.3g) was obtained. ee = 99%, [α] 20 D =-30°(c1.0,MeOH). 1H NMR(400MHz,DMSO-d6):δ 12.18(s,1H),7.71(d,J=1.9Hz,1H),7.61(m,1H),7.44-.28(m,1H),3.14-3.02(m,1H),3.02-2.90(m,1H),2.66(m,1H),2.59-2.39(m,1H).
[0036] Composition of TIFF0007579249000026.tif17170-10) TIFF0007579249000027.tif46162
[0037] TIFF0007579249000028.tif61170 Intermediate Int. 1-3 (10 g, 35.4 mmol), t-butyl bromoacetate (7.5 g, 38.4 mmol) and potassium carbonate (7.3 g, 52.9 mmol) were added to 100 mL of DMF and stirred at room temperature for 4 h. 200 mL of water was added and extracted three times with ethyl acetate. The organic phases were combined, dried over anhydrous sodium sulfate, concentrated, triturated with petroleum ether and filtered to give 12 g of white solid in 86% yield. Mass spectrometry: 396,398 (M+H) + ).
[0038] Composition of TIFF0007579249000029.tif191701-7) TIFF0007579249000030.tif36160 Intermediate Int. 1-3 (11.5 g, 29 mmol), benzophenone imine (7 g, TIFF0007579249000031.tif19170 and cesium carbonate (13.2 g, 40 mmol) were added to 50 mL of toluene, and the mixture was heated to 100° C. under a nitrogen gas atmosphere and stirred for 4 hours. The mixture was concentrated and subjected to column chromatography to obtain 12 g of a gray solid in a yield of 83.1%. Mass spectrometry: 497 (M+H + ).
[0039] TIFF0007579249000032.tif60170 Intermediate Int. 1-7 (12 g, 24 mmol) was dissolved in 20 mL of tetrahydrofuran, and 10 mL of hydrochloric acid (2N) was added at room temperature and stirred for 30 minutes. Extracted three times with ethyl acetate, the organic phases were combined, dried over anhydrous sodium sulfate, concentrated, and subjected to column chromatography to obtain 6.9 g of a yellow solid in 86% yield. Mass spectrometry: 289 (M-43).
[0040] Composition of TIFF0007579249000033.tif18170-9) TIFF0007579249000034.tif38147Triphosgene (3.5g, 12mmol) was added to 25mL of dichloromethane, and a solution of intermediate Int. 1-8 (6.9g, 20mmol) and triethylamine (20g, 200mmol) in dichloromethane (25mL) was slowly added dropwise to the reaction flask under ice bath. After the addition was completed, the mixture was stirred for 1 hour, and methylamine hydrochloride (7g, 104mmol) was added and stirred for 4 hours. 100mL of water was added, the organic layer was separated, extracted with dichloromethane, the organic phases were combined, dried over anhydrous sodium sulfate, concentrated, and subjected to column chromatography to obtain 5g of a yellow solid in 62% yield. Mass spectrometry: 390 (M+H + ).
[0041] TIFF0007579249000035.tif54170 Intermediate Int. 1-9 (5 g, 13 mmol) was dissolved in 5 mL of trifluoroacetic acid, stirred at room temperature overnight, and concentrated to give 4.1 g of a pale yellow solid in 96% yield. 1 H NMR(400MHz,DMSO-d6):δ 13.52(s,1H),8.78(s,1H),7.53(s,1H),7.31-7.25(m,1H),7.19-7.11(m,1H),6.12 (s,1H),4.38-4.18(m,2H),3.18-2.98(m,2H),2.71-2.57(m,4H),2.55-2.41(m,1H).
[0042] Synthesis of TIFF0007579249000036.tif18170nt 1-15) TIFF0007579249000037.tif47153
[0043] TIFF0007579249000038.tif17170 TIFF0007579249000039.tif42147 Intermediate Int.1-4 (10 g, 35.4 mmol), t-butyl bromoacetate (7.5 g, 38.4 mmol) and potassium carbonate (7.3 g, 52.9 mmol) were dissolved in 100 mL of DMF and stirred at room temperature for 4 h. 200 mL of water was added and extracted three times with ethyl acetate. The organic phases were combined, dried over anhydrous sodium sulfate, concentrated, triturated with petroleum ether and filtered to give 12.2 g of a white solid in 88% yield. Mass spectrometry: 396,398 (M+H) + ).
[0044] Synthesis of TIFF0007579249000040.tif17170nt. 1-12) TIFF0007579249000041.tif40154 Intermediate Int. 1-11 (11.5 g, 29 mmol), benzophenone imine (7 g, TIFF0007579249000042.tif16170 and cesium carbonate (13.2 g, 40 mmol) were dissolved in 50 mL of toluene, purged with nitrogen gas, heated to 100° C., and stirred for 4 hours. Concentration and column chromatography were performed to obtain 12.2 g of a gray solid in 85% yield. Mass spectrometry: 497 (M+H + ).
[0045] TIFF0007579249000043.tif18170 TIFF0007579249000044.tif41129 Intermediate Int. 1-12 (12 g, 24 mmol) was dissolved in 20 mL of tetrahydrofuran, and 10 mL of hydrochloric acid (2N) was added at room temperature and stirred for 30 minutes. Extracted three times with ethyl acetate, the organic phases were combined, dried over anhydrous sodium sulfate, concentrated, and subjected to column chromatography to obtain 7.1 g of a yellow solid in 88% yield. Mass spectrometry: 289 (M-43).
[0046] Composition of TIFF0007579249000045.tif181701-14) TIFF0007579249000046.tif40146Triphosgene (3.5g, 12mmol) was added to 25mL of dichloromethane, and a mixture of intermediate (Int. 1-13) (6.9g, 20mmol), triethylamine (20g, 200mmol) and 25mL of dichloromethane was slowly added dropwise to the reaction flask under ice bath. After the dropwise addition, the mixture was stirred for 1 hour, and methylamine hydrochloride (7g, 104mmol) was added and stirred for 4 hours. 100mL of water was added, and the organic layer was separated and extracted with dichloromethane. The organic phases were combined, dried over anhydrous sodium sulfate, concentrated, and subjected to column chromatography to obtain 5.2g of a yellow solid in 64% yield. Mass spectrometry: 390 (M+H + ).
[0047] TIFF0007579249000047.tif17170 synthesis TIFF0007579249000048.tif40134 Intermediate Int. 1-14 (5 g, 13 mmol) was dissolved in 5 mL of trifluoroacetic acid, stirred at room temperature overnight, and concentrated to give 4.2 g of a pale yellow solid in 98% yield. MS: 334 (M+H + ); 1 H NMR(400MHz,DMSO):δ 13.52(s,1H),8.78(s,1H),7.53(s,1H),7.31-7.25(m,1H),7.19-7.11(m,1H),6.12 (s,1H),4.38-4.18(m,2H),3.18-2.98(m,2H),2.71-2.57(m,4H),2.55-2.41(m,1H). [α] 20 D =+53.3°(c 1.0,MeOH)
[0048] Synthesis of TIFF0007579249000049.tif17170nt 1-20) TIFF0007579249000050.tif49159
[0049] TIFF0007579249000051.tif19170 TIFF0007579249000052.tif43149 Intermediate Int. 1-5 (10 g, 35.4 mmol), t-butyl bromoacetate (7.5 g, 38.4 mmol) and potassium carbonate (7.3 g, 52.9 mmol) were dissolved in DMF (100 mL) and stirred at room temperature for 4 h. Water (200 mL) was added and extracted three times with ethyl acetate. The organic phases were combined, dried over anhydrous sodium sulfate, concentrated, triturated with petroleum ether and filtered to give 12.1 g of a white solid in 86% yield. Mass spectrometry: 396,398 (M+H) + ).
[0050] Synthesis of TIFF0007579249000053.tif19170nt. 1-17) TIFF0007579249000054.tif36151 Intermediate Int. 1-16 (11.5 g, 29 mmol), benzophenone imine (7 g, TIFF0007579249000055.tif10170TIFF0007579249000056.tif9170 and cesium carbonate (13.2 g, 40 mmol) were dissolved in 50 mL of toluene, purged with nitrogen gas, heated to 100°C, and stirred for 4 hours. Concentration and column chromatography were performed to obtain 12.1 g of a gray solid in 84% yield. Mass spectrometry: 497 (M+H + ).
[0051] TIFF0007579249000057.tif18170 TIFF0007579249000058.tif38131 Intermediate Int. 1-17 (12 g, 24 mmol) was dissolved in 20 mL of tetrahydrofuran, and 10 mL of hydrochloric acid (2N) was added at room temperature and stirred for 30 minutes. Extracted three times with ethyl acetate, the organic phases were combined, dried over anhydrous sodium sulfate, concentrated, and subjected to column chromatography to obtain 7 g of a yellow solid in 88% yield. Mass spectrometry: 289 (M-43).
[0052] Composition of TIFF0007579249000059.tif181701-19) TIFF0007579249000060.tif36154 Triphosgene (3.5g, 12mmol) was added to 25mL of dichloromethane, and 25mL of a mixture of intermediate Int. 1-18 (6.9g, 20mmol) and triethylamine (20g, 200mmol) in dichloromethane was slowly added dropwise to the reaction flask under ice bath. After the addition, the mixture was stirred for 1 hour, and methylamine hydrochloride (7g, 104mmol) was added and stirred for 4 hours. 100mL of water was added, and the organic layer was separated and extracted with dichloromethane. The organic phases were combined, dried over anhydrous sodium sulfate, concentrated, and subjected to column chromatography to obtain 5.1g of a yellow solid in 63% yield. Mass spectrometry: 390 (M+H + ).
[0053] TIFF0007579249000061.tif18170 synthesis TIFF0007579249000062.tif41135 Intermediate Int. 1-19 (5 g, 13 mmol) was dissolved in 5 mL of trifluoroacetic acid, stirred at room temperature overnight, and concentrated to give 4.09 g of a pale yellow solid in 96% yield. MS: 334 (M+H + ); 1 H NMR(400MHz,DMSO):δ 13.52(s,1H),8.78(s,1H),7.53(s,1H),7.31-7.25(m,1H),7.19-7.11(m,1H),6.12 (s,1H),4.38-4.18(m,2H),3.18-2.98(m,2H),2.71-2.57(m,4H),2.55-2.41(m,1H).
[0054] TIFF0007579249000063.tif9170-2-Phenylpiperazin-1-yl)ethyl)-2,3-dihydrospiro[indene-1 TIFF0007579249000064.tif471602Add DMF (3 mL) to a 5 mL reaction flask, then add Int 1-20 (333 mg, 1 mmol), SM1 (97 mg, 1 mmol), DIEA (N,N-diisopropylethylamine, 387 mg, 3 mmol), and finally HATU (O-(7-aminoethyl)amine, 100 mg, 1 mmol). TIFF0007579249000065.tif10170Fluorophosphate, 381 mg, 1 mmol) was added and the system was reacted at 20 °C for 1 hour. After the reaction was completed, the reaction solution was poured into 20 mL of water and extracted with 30 mL of ethyl acetate (10 mL x 3), the organic phases were combined, dried over anhydrous sodium sulfate, and purified by column chromatography to obtain compound 1 (248 mg) in a yield of 52%. Mass spectrometry: 477 (M+H + ).
[0055] TIFF0007579249000066.tif10170-2-Phenylpiperazin-1-yl)ethyl)-2,3-dihydrospiro[indene-1 TIFF0007579249000067.tif4615625mL reaction flask was added with DMF (3mL), then Int 1-15 (333mg, 1mmol), SM1 (97mg, 1mmol), DIEA (387mg, 3mmol), and finally HATU (381mg, 1mmol) were added, and the system was reacted at 20°C for 1 hour. After the reaction was completed, the reaction solution was poured into 20mL water, extracted with 30mL ethyl acetate (10mL x 3), the organic phase was combined, dried over anhydrous sodium sulfate, and purified by column chromatography to obtain compound 2 (252mg) in 53% yield. Mass spectrometry: 477 (M+H + ).
[0056] Composite of TIFF0007579249000068.tif27170 TIFF0007579249000069.tif3815625mL reaction flask was added with DMF (3mL), then Int 1-15 (333mg, 1mmol), SM 3 (111mg, 1mmol), DIEA (387mg, 3mmol), and finally HATU (381mg, 1mmol) were added, and the system was reacted at 20°C for 1 hour. After the reaction was completed, the reaction solution was poured into 20mL water, extracted with 30mL ethyl acetate (10mL x 3), the organic phase was combined, dried over anhydrous sodium sulfate, and purified by column chromatography to obtain compound 3 (226mg) in 53% yield. Mass spectrometry: 427 (M+H + ).
[0057] TIFF0007579249000070.tif9170-2-Benperidol-1-yl)ethyl)-2,3-dihydrospiro[indene-1,5 TIFF0007579249000071.tif4615625mL reaction flask was added with DMF (3mL), then Int 1-20 (333mg, 1mmol), SM4 (161mg, 1mmol), DIEA (387mg, 3mmol), and finally HATU (381mg, 1mmol) were added, and the system was reacted at 20°C for 1 hour. After the reaction was completed, the reaction solution was poured into water (20mL), extracted with ethyl acetate 30mL (10mL x 3), the organic phase was combined, dried over anhydrous sodium sulfate, and purified by column chromatography to obtain compound 4 (300mg) in 63% yield. Mass spectrometry: 477 (M+H + ).
[0058] TIFF0007579249000072.tif9170-2-Benperidol-1-yl)ethyl)-2,3-dihydrospiro[indene-1,5 TIFF0007579249000073.tif4615725mL reaction flask was added with DMF (3mL), then Int 1-15 (333mg, 1mmol), SM1 (161mg, 1mmol), DIEA (387mg, 3mmol), and finally HATU (381mg, 1mmol) were added, and the system was reacted at 20°C for 1 hour. After the reaction was completed, the reaction solution was poured into water (20mL), extracted with 30mL of ethyl acetate (10mL x 3), the organic phase was combined, dried over anhydrous sodium sulfate, and purified by column chromatography to obtain compound 5 (300mg) in 63% yield. Mass spectrometry: 477 (M+H + ).
[0059] Composite of TIFF0007579249000074.tif27170 TIFF0007579249000075.tif3715225mL reaction flask was added with DMF (3mL), then Int 1-15 (333mg, 1mmol), SM4 (97mg, 1mmol), DIEA (387mg, 3mmol), and finally HATU (381mg, 1mmol) were added, and the system was reacted at 20°C for 1 hour. After the reaction was completed, the reaction solution was poured into water (20mL), extracted with 30mL of ethyl acetate (10mL x 3), the organic phase was combined, dried over anhydrous sodium sulfate, and purified by column chromatography to obtain compound 7 (260mg) in 63% yield. Mass spectrometry: 413 (M+H + ).
[0060] TIFF0007579249000076.tif26170 Synthesis of element (8) TIFF0007579249000077.tif72170 Synthesis of intermediate (4-(4-fluoro-2-methylphenyl)-4-oxobutyl) t-butylcarbamate (Int.8-1) TIFF0007579249000078.tif3593SM 5 (2.36 g, 10 mmol) was added to a reaction flask containing dry THF (23 mL), and a solution of isopropyl magnesium bromide in tetrahydrofuran (10 mL, 1 M in THF) was added to the flask under nitrogen gas protection and ice-water bath conditions. Then, the ice-water bath was removed and the mixture was stirred at room temperature for 7 hours. Finally, N-Boc-2-pyrrolidone (1.85 g, 10 mmol) was added and the mixture was reacted at room temperature for 12 hours. The reaction solution was poured into a saturated aqueous ammonium chloride solution, extracted with 30 mL of ethyl acetate (10 mL x 3), and the organic phases were combined, dried over anhydrous sodium sulfate, and purified by column chromatography to obtain Int. 8-1 (1.47 g, 5 mmol) in a 50% yield. Mass spectrometry: 296 (M+H + ). Synthesis of intermediate 5-(4-fluoro-2-methylphenyl)-3,4-dihydro-2H-pyrrole (Int.8-2) TIFF0007579249000079.tif4672 Int 8-1 (1.47 g, 5 mmol) was dissolved in 15 mL of DCM, 3.7 mL of TFA was added, and the mixture was stirred at room temperature. TLC detection was performed. After the reaction was completed, the pH was adjusted to neutral with saturated aqueous sodium bicarbonate solution, extracted with DCM (10 mL x 3), dried over anhydrous sodium sulfate, and the solvent was removed by rotary evaporation to obtain Int.8-2 (0.79 g; 90%). Mass spectrometry: 178 (M+H + ). Synthesis of intermediate 2-(4-fluoro-2-methylphenyl)pyrrolidine (Int.8-3) TIFF0007579249000080.tif4359Int.8-2 (0.79 g; 4.5 mmol) was added to a reaction flask containing 8 mL of methanol, and sodium borohydride (0.68 g; 18 mmol) was added batchwise while stirring at room temperature. After the addition was completed, the mixture was further stirred at room temperature and TLC detection was performed. After the reaction was completed, the reaction solution was poured into water and extracted with 30 mL of EA (10 mL x 3). The organic phases were combined, dried over anhydrous sodium sulfate, and separated by column chromatography to obtain Int.8-3 (0.79 g; 97%). Mass spectrometry: 180 (M+H + ). TIFF0007579249000081.tif6317025mL reaction flask was added with DMF (3mL), then Int. 1-15 (333mg, 1mmol), Int.8-3 (179mg, 1mmol), DIEA (387mg, 3mmol), and finally HATU (381mg, 1mmol) were added, and the system was reacted at 20°C for 1 hour. After the reaction was completed, the reaction solution was poured into water (20mL), extracted with ethyl acetate 30mL (10mL x 3), the organic phase was combined, dried over anhydrous sodium sulfate, and purified by column chromatography to obtain compound 8 (280mg) in 56% yield. Mass spectrometry: 495 (M+H + ). 1 H NMR(400MHz,CDCl3)δ 7.33(d,J=38.5Hz,2H),7.06(s,1H),6.94(d,J=9.8Hz,2H),6.83 ~ 6.74(m,1H),5.13(s,1H),3.93~ 3.68(m,3H),3.12(s,1H),3.01(s,1H),2.82(s,2H),2.72(s,4H),2.49(s,2H),2.39(s,2H),2.24(d,J=3.9Hz,1H),1.77(s,1H),1.25(s,1H).
[0061] Example 10 Compound (1S,4S)-5-(2-((R)-5-(3-methylurea)- TIFF0007579249000082.tif181702-Synthesis of t-butyl carboxylate (10) TIFF0007579249000083.tif3315225mL reaction flask was added with DMF (3mL), then Int. 1-15 (333mg, 1mmol), SM6 (198mg, 1mmol), DIEA (387mg, 3mmol), and finally HATU (381mg, 1mmol) were added, and the system was reacted at 20°C for 1 hour. After the reaction was completed, the reaction solution was poured into water (20mL), extracted with ethyl acetate 30mL (10mL x 3), the organic phase was combined, dried over anhydrous sodium sulfate, and purified by column chromatography to obtain compound 10 (370mg) in 72% yield. Mass spectrometry: 514 (M+H + ). 1 H NMR(400MHz,CDCl3)δ 7.52(s,1H),7.32(d,J=7.8Hz,1H),6.94(d,J=8.3Hz,1H),4.88(s,1H),4.44(m,4H),3.62 ~ 3.33(m,4H),3.14(s,1H),3.03(s,1H),2.76(s,3H),2.54(s,1H),1.99 ~ 1.78(m,2H),1.47(s,9H),1.26(d,J=9.1Hz,1H).
[0062] TIFF0007579249000084.tif10170(2-(o-tolyl)pyrrolidin-1-yl)ethyl)-2,3-dihydrospiro[indole TIFF0007579249000085.tif9154TIFF0007579249000086.tif36154Add DMF (3mL) to a 25mL reaction flask, then add Int 1-15 (333mg, 1mmol), SM 7 (198mg, 1mmol), DIEA (387mg, 3mmol), and finally add HATU (381mg, 1mmol), and react the system at 20°C for 1 hour. After the reaction was completed, water (20mL) was poured into the reaction solution, and extracted with 30mL of ethyl acetate (10mL x 3), and the organic phase was combined, dried over anhydrous sodium sulfate, and purified by column chromatography to obtain compound 11 (233mg, 50% yield). Mass spectrometry: 477 (M+H + ). 1 H NMR(400MHz,DMSO):δ 8.94-8.45(m,1H),7.54(d,J=9.5Hz,1H),7.36-7.26(m,1H),7.26-7.1 0(m,2H),7.10-6.77(m,3H),6.24-5.88(m,1H),5.43-5.11(m,1H),4.7 1-4.00(m,2H),3.84(d,J=11.5Hz,3H),3.78-3.44(m,2H),3.09(m,1H) ,3.03-2.89(m,1H),2.67-2.55(m,4H),2.55-2.50(m,1H),2.50-2.25(m 1H), 2.02-1.59(m,3H).
[0063] TIFF0007579249000087.tif6317025mL reaction flask was added with DMF (3mL), then Int 1-15 (333mg, 1mmol), SM 8 (139mg, 1mmol), DIEA (387mg, 3mmol), and finally HATU (381mg, 1mmol) were added, and the system was reacted at 20°C for 1 hour. After the reaction was completed, water (20mL) was poured into the reaction solution, and extracted with 30mL of ethyl acetate (10mL x 3), the organic phase was combined, dried over anhydrous sodium sulfate, and purified by column chromatography to obtain compound 12 (227mg, 50% yield). Mass spectrometry: 455 (M+H + ). 1H NMR(400MHz,DMSO):δ 8.72(s,1H),7.55(s,1H),7.35-7.33(m,1H),7.25-7.17(m,1H),6.12-6.06(m 1H),4.66-4.21(m,2H),4.20-3.47(m,2H),3.33-2.78(m,4H),2.74-2.55(m,4H),2.55-2.50(m,1H)1.91-1.20(m,12H).
[0064] TIFF0007579249000088.tif11170(2-(2-(trifluoromethoxy)phenyl)pyrrolidin-1-yl)ethyl)-2, TIFF0007579249000089.tif10170 Synthesis of element (13) TIFF0007579249000090.tif70152 Synthesis of intermediate 4-oxo-4-(2-(trifluoromethoxy)phenyl)butyl) t-butylcarbamate (Int.13-1) TIFF0007579249000091.tif34101 Dry THF (30 mL) was added to the reaction flask, then SM 9 (2.88 g, 10 mmol) was added, and isopropyl magnesium bromide (10 mL, 1M in THF) was added under nitrogen gas protection under ice-water bath conditions, and then reacted at room temperature for 7 hours, and finally t-butyl-2-oxopyrrolidine-1-carboxylate (1.85 g, 10 mmol) was added, and then reacted at room temperature for 12 hours. The reaction solution was poured into a saturated aqueous ammonium chloride solution, extracted with 30 mL of ethyl acetate (10 mL x 3), and the organic phases were combined, dried over anhydrous sodium sulfate, and purified by column chromatography to obtain Int 13-2 (1.74 g, 5 mmol) in 50% yield. Mass spectrometry: 348 (M+H + ). Synthesis of intermediate 5-(2-(trifluoromethoxy)phenyl)-3,4-dihydro-2H-pyrrole (Int. 13-2) TIFF0007579249000092.tif3570 DCM (20 mL) was added to a reaction flask, followed by Int 13-2 (1.74 g, 5 mmol), followed by TFA (5 mL), and then reacted at room temperature for 7 hours. The reaction was poured into saturated aqueous sodium bicarbonate, extracted with 30 mL of DCM (10 mL x 3), and the organic phases were combined, dried over anhydrous sodium sulfate, and purified by column chromatography to give Int 13-3 (1.04 g, 4.5 mmol) in 90% yield. Mass spectrometry: 230 (M+H + ). Synthesis of intermediate 2-(2-(trifluoromethoxy)phenyl)pyrrolidine (Int. 13-4) TIFF0007579249000093.tif3564Methanol (15 mL) was added to the reaction flask, followed by Int 13-3 (1.04 g, 4.5 mmol), followed by sodium borohydride (0.76 g, 20 mmol) in batches, and then reacted at room temperature for 1 h. The reaction solution was poured into water, extracted with 30 mL of ethyl acetate (10 mL x 3), and the organic phases were combined, dried over anhydrous sodium sulfate, and concentrated to give Int 13-4 (1.04 g, 4.5 mmol) in 98% yield. Mass spectrometry: 232 (M+H + ). TIFF0007579249000094.tif9170(Trifluoromethoxy)phenyl)pyrrolidin-1-yl)ethyl)-2,3-dihydro TIFF0007579249000095.tif8170 synthesis TIFF0007579249000096.tif3515125mL reaction flask was added with DMF (3mL), then Int 1-15 (333mg, 1mmol), Int13-3 (231mg, 1mmol), DIEA (387mg, 3mmol), and finally HATU (381mg, 1mmol) were added, and the system was reacted at 20°C for 1 hour. After the reaction was completed, the reaction solution was poured into water (20mL), extracted with ethyl acetate 30mL (10mL x 3), the organic phase was combined, dried over anhydrous sodium sulfate, and purified by column chromatography to obtain compound 13 (273mg) in 50% yield. Mass spectrometry: 547 (M+H+ ). 1 H NMR(400MHz,CDCl3):δ 7.65-7.29(m,5H),7.19-6.98(m,2H),5.49-5.27(m,2H),4.54-4.41(m,1H),3.80(m,2H), 3.10-3.02(m,1H),3.01-2.88(m,1H),2.66(s,3H),2.59-2.41(m,4H),2.06-1.83(m,4H).
[0065] TIFF0007579249000097.tif27170Synthesis of ethyl urea (14) TIFF0007579249000098.tif79154 Synthesis of intermediate (S)-t-butyl-(4-(4-fluorophenyl)-3-methyl-4-oxybutyl)carbamate (Int. 14-1) TIFF0007579249000099.tif3990Add dry THF (25mL) to a 100mL reaction flask, then add 1-fluoro-4-iodobenzene (5g, 22.5mmol), and slowly add isopropylmagnesium chloride (10mL, 2.0mol / L in THF) under ice-water bath cooling. After the addition is complete, remove the ice-water bath, return to room temperature, and stir for 3 hours. The raw material (S)-2-methyl-5-oxopyrrolidine-1-carboxylate-t-butyl (4.9g, 24.8mmol) was dissolved in THF (10mL), quickly added to the above reaction solution, and reacted at room temperature for 3 hours. After the reaction was completed, the reaction was quenched by adding saturated aqueous ammonium chloride solution (30 mL), extracted with 90 mL of ethyl acetate (30 mL x 3), and the organic phases were combined, dried over anhydrous sodium sulfate, and concentrated to obtain the crude product Int. 14-1 (8 g). Mass spectrometry: 296 (M+H + ). Synthesis of intermediate (S)-5-(4-fluorophenyl)-2-methyl-3,4-dihydro-2H-pyrrole (Int. 14-2) TIFF0007579249000100.tif4563 The crude product from the previous step was dissolved in DCM (50 mL), TFA (5 mL) was added, and the mixture was reacted at room temperature with stirring for 16 hours. After the reaction was completed, the mixture was concentrated, water (50 mL) was added, and the pH was adjusted to 8-9 with sodium bicarbonate. The mixture was extracted with 90 mL of ethyl acetate (30 mL x 3). The organic phases were combined, dried over anhydrous sodium sulfate, concentrated, and then purified by column chromatography to obtain compound Int. 14-2 (2.4 g, mmol), and the two-stage yield was 60%. Mass spectrometry: 178 (M+H + ). Synthesis of intermediate (2S,5S)-2-(4-fluorophenyl)-5-methylpyrrolidine Int.14-3 TIFF0007579249000101.tif4658 DCM (1 mL) was added to the reaction flask, followed by Int 14-2 (2 g, 11.3 mmol), followed by DIBAL-H (12 mL, 1 M in hexane) in an ice-water bath, followed by reaction at room temperature for 1 hour. After quenching with a small amount of water, the mixture was filtered, washed with DCM (1 mL x 3), and concentrated to give Int 14-3 (1.82 g, 10.17 mmol) in 90% yield. Mass spectrometry: 180 (M+H + ). 1 H NMR(400MHz,CDCl3)δ 7.41-7.29(m,2H),7.05-6.91(m,2H),4.14(t,J=8.0Hz,1H),3.32(dd,J=13.9,7.2Hz,1H),2.24-2.08(m,1H),2.04 -1.93(m,1H),1.72(dddd,J=12.5,10.1,8.4,5.9Hz,1H),1.57(brs,1H),1.53-1.43(m,1H),1.24(d,J=6.2Hz,3H). Composition of TIFF0007579249000102.tif261704) TIFF0007579249000103.tif4015425mL reaction flask was added with DMF (3mL), then Int 1-15 (333mg, 1mmol), Int 14-3 (179mg, 1mmol), DIEA (387mg, 3mmol), and finally HATU (381mg, 1mmol) were added, and the system was reacted at 20°C for 1 hour. After the reaction was completed, the reaction solution was poured into 20mL of water, extracted with 30mL of ethyl acetate (10mL x 3), the organic phase was combined, dried over anhydrous sodium sulfate, and purified by column chromatography to obtain compound 14 (247mg) in 50% yield. Mass spectrometry: 495 (M+H + ). 1 H NMR(400MHz,CDCl3)δ 7.44-7.35(m,2H),7.33-7.27(m,2H),7.12(td,J=8.6,2.4Hz,2H),7.04(d,J=8.2 Hz,1H),4.98-4.89(m,1H),4.41(d,J=6.7Hz,1H),4.21-4.09(m,2H),3.63(s,1H), 3.17(dd,J=15.8,7.4Hz,1H),3.07(s,1H),2.89(s,3H),2.79(d,J=1.4Hz,3H),2.7 2(d,J=6.7Hz,1H),2.56-2.41(m,1H),2.04(dd,J=21.7,13.1Hz,2H),1.65(s,1H).
[0066] TIFF0007579249000104.tif26170 Synthesis of element (15) TIFF0007579249000105.tif81155 Synthesis of intermediate (5S)-2-(4-fluorophenyl)-5-methylpyrrolidine (Int 15-3) TIFF0007579249000106.tif4560Int 14-2 (2 g, 11.3 mmol) was dissolved in methanol (50 mL), sodium borohydride (0.86 g, 22.6 mmol) was added batchwise, and the mixture was reacted at room temperature with stirring for 2 hours, concentrated, water (50 mL) was added, and the mixture was extracted with ethyl acetate (10 mL x 3). The organic phases were combined, dried over anhydrous sodium sulfate, and purified to give Int 15-3 (1.72 g, 9.6 mmol) in 85% yield. Mass Spectrometry: 180 (M+H + ). Composite of TIFF0007579249000107.tif26170 TIFF0007579249000108.tif4115425mL reaction flask was added with DMF (3mL), then Int 1-15 (333mg, 1mmol), Int 15-3 (179mg, 1mmol), DIEA (387mg, 3mmol), and finally HATU (381mg, 1mmol) were added, and the system was reacted at 20°C for 1 hour. After the reaction was completed, the reaction solution was poured into 20mL of water, extracted with 30mL of ethyl acetate (10mL x 3), the organic phase was combined, dried over anhydrous sodium sulfate, and purified by column chromatography to obtain compound 15 (260mg) in 52% yield. Mass spectrometry: 495 (M+H + ).
[0067] TIFF0007579249000109.tif6317025mL reaction flask was added with DMF (3mL), then Int 1-10 (333mg, 1mmol), SM 11 (97mg, 1mmol), DIEA (387mg, 3mmol), and finally HATU (381mg, 1mmol) were added, and the system was reacted at 20°C for 1 hour. After the reaction was completed, the reaction solution was poured into water (20mL), extracted with 30mL of ethyl acetate (10mL x 3), the organic phase was combined, dried over anhydrous sodium sulfate, and purified by column chromatography to obtain compound 16 (206mg) in 50% yield. Mass spectrometry: 413 (M+H + ). 1H NMR(400MHz,CDCl3):δ 7.48(m,2H),7.32(m,1H),6.89(m,1H),5.39-5.22(m,1H),4.52(m,1H),4.36-4.12(m,2H),3.43(m,1) H),3.24-3.08(m,2H),3.01(m,1H),2.74(m,3H),2.58-2.46(m,1H),1.77(m,3H),1.31-1.22(m,4H).
[0068] TIFF0007579249000110.tif27170Synthesis of methylurea (17) TIFF0007579249000111.tif78153 Synthesis of intermediate (R)-t-butyl-(4-(4-fluorophenyl)-3-methyl-4-oxybutyl)carbamate (Int 17-1) TIFF0007579249000112.tif3990Add dry THF (25mL) to a 100mL reaction flask, then add 1-fluoro-4-iodobenzene (5g, 22.5mmol), and slowly add isopropylmagnesium chloride (10mL, 2.0mol / L in THF) in an ice water bath. After the addition is complete, remove the ice water bath, return to room temperature, and stir for 3 hours. The raw material (R)-2-methyl-5-oxopyrrolidine-1-carboxylate-t-butyl (4.9g, 24.8mmol) was dissolved in THF (10mL), quickly added to the above reaction solution, and reacted at room temperature for 3 hours. After the reaction was completed, the reaction was quenched by adding saturated aqueous ammonium chloride solution (30 mL), extracted with 90 mL of ethyl acetate (30 mL x 3), and the organic phases were combined, dried over anhydrous sodium sulfate, and concentrated to obtain the crude product Int 17-1 (7.5 g). Mass spectrometry: 296 (M+H + ). Synthesis of intermediate (R)-5-(4-fluorophenyl)-2-methyl-3,4-dihydro-2H-pyrrole (Int 17-2) TIFF0007579249000113.tif4566 The crude product from the previous step was dissolved in DCM (50 mL), TFA (5 mL) was added, and the mixture was reacted at room temperature for 16 hours with stirring. After the reaction was completed, the mixture was concentrated, water (50 mL) was added, and the pH was adjusted to 8-9 with sodium bicarbonate. The mixture was extracted with ethyl acetate (30 mL x 3). The organic phases were combined, dried over anhydrous sodium sulfate, concentrated, and then purified by column chromatography to obtain compound Int 17-2 (2.2 g). The two-stage yield was 59%. Mass spectrometry: 178 (M+H + ). Synthesis of intermediate (2R,5R)-2-(4-fluorophenyl)-5-methylpyrrolidine Int 17-3 TIFF0007579249000114.tif4561 DCM (1 mL) was added to the reaction flask, followed by Int 17-2 (2 g, 11.3 mmol), followed by DIBAL-H (12 mL, 1 M in hexane) in an ice-water bath, followed by reaction at room temperature for 1 hour. After quenching with a small amount of water, the mixture was filtered, washed with DCM (1 mL x 3), and concentrated to give Int 17-3 (1.82 g, 10.17 mmol) in 90% yield. Mass spectrometry: 180 (M+H + ). 1 H NMR(400MHz,CDCl3)δ 7.41-7.29(m,2H),7.05-6.91(m,2H),4.14(t,J=8.0Hz,1H),3.32(dd,J=13.9,7.2Hz,1H),2.24-2.08(m,1H),2.04 -1.93(m,1H),1.72(dddd,J=12.5,10.1,8.4,5.9Hz,1H),1.57(brs,1H),1.53-1.43(m,1H),1.24(d,J=6.2Hz,3H). Composition of TIFF0007579249000115.tif271707) TIFF0007579249000116.tif4115425mL reaction flask was added with DMF (3mL), then Int 1-15 (333mg, 1mmol), Int 17-3 (179mg, 1mmol), DIEA (387mg, 3mmol), and finally HATU (381mg, 1mmol) were added, and the system was reacted at 20°C for 1 hour. After the reaction was completed, the reaction solution was poured into water (20mL), extracted with ethyl acetate 30mL (10mL x 3), the organic phase was combined, dried over anhydrous sodium sulfate, and purified by column chromatography to obtain compound 17 (233mg) in 48% yield. Mass spectrometry: 495 (M+H + ). 1 H NMR(400MHz,CDCl3)δ 7.44-7.35(m,2H),7.33-7.27(m,2H),7.12(td,J=8.6,2.4Hz,2H),7.04(d,J=8.2 Hz,1H),4.98-4.89(m,1H),4.41(d,J=6.7Hz,1H),4.21-4.09(m,2H),3.63(s,1H), 3.17(dd,J=15.8,7.4Hz,1H),3.07(s,1H),2.89(s,3H),2.79(d,J=1.4Hz,3H),2.7 2(d,J=6.7Hz,1H),2.56-2.41(m,1H),2.04(dd,J=21.7,13.1Hz,2H),1.65(s,1H).
[0069] TIFF0007579249000117.tif26170Synthesis of urea (18) TIFF0007579249000118.tif78158 Synthesis of intermediate (5R)-2-(4-fluorophenyl)-5-methylpyrrolidine Int 18-3 TIFF0007579249000119.tif455617-2 (2 g, 11.3 mmol) was dissolved in methanol (50 mL), sodium borohydride (0.86 g, 22.6 mmol) was added in batches, and the mixture was reacted at room temperature for 2 hours while stirring. After the reaction was completed, the mixture was concentrated, water (50 mL) was added, and the mixture was extracted with 90 mL of ethyl acetate (30 mL x 3). The organic phases were combined, dried over anhydrous sodium sulfate, concentrated, and then purified by column chromatography to obtain compound Int 18-3 (1.72 g, 9.6 mmol) in a yield of 85%. Mass spectrometry: 180 (M+H + ). Composite of TIFF0007579249000120.tif27170 TIFF0007579249000121.tif4115525mL reaction flask was added with DMF (3mL), then Int 1-15 (333mg, 1mmol), Int 18-3 (179mg, 1mmol), DIEA (387mg, 3mmol), and finally HATU (381mg, 1mmol) were added, and the system was reacted at 20°C for 1 hour. After the reaction was completed, the reaction solution was poured into 20mL water, extracted with 30mL ethyl acetate (10mL x 3), the organic phase was combined, dried over anhydrous sodium sulfate, and purified by column chromatography to obtain compound 18 (223mg) in 48% yield. Mass spectrometry: 495 (M+H+).
[0070] TIFF0007579249000122.tif26170-Synthesis of 3-methylurea (21) TIFF0007579249000123.tif73154 Synthesis of intermediate (R)-(4-(4-fluoro-2-methylphenyl)-3-methyl-4-oxobutyl) t-butylcarbamate (Int 21-1) TIFF0007579249000124.tif3993SM 5 (2.36 g, 10 mmol) was added to a reaction flask with dry THF (23 mL), and isopropyl magnesium bromide (10 mL, 1M in THF) was added to the flask under nitrogen gas protection and ice-water bath conditions, then the ice-water bath was removed and the mixture was stirred at room temperature for 7 hours, and finally, (R)-2-methyl-5-oxopyrrolidine-1-carboxylate-t-butyl (1.99 g, 10 mmol) was added and reacted at room temperature for 12 hours. The reaction solution was poured into a saturated aqueous ammonium chloride solution, extracted with 30 mL of ethyl acetate (10 mL x 3), and the organic phase was combined, dried over anhydrous sodium sulfate, and purified by column chromatography to obtain Int 21-1 (2.59 g, 8.5 mmol) in 85% yield. Mass spectrometry: 306 (M+H + ). Synthesis of intermediate (R)-5-(4-fluoro-2-methylphenyl)-2-methyl-3,4-dihydro-2H-pyrrole (Int 21-2) TIFF0007579249000125.tif4568 Int 21-1 (2.59 g, 8.5 mmol) was dissolved in 26 mL of DCM, 2.6 mL of TFA was added, and the mixture was stirred at room temperature. TLC detection was performed. After the reaction was completed, the pH was adjusted to neutral with saturated aqueous sodium bicarbonate, extracted with DCM (10 mL x 3), dried over anhydrous sodium sulfate, and the solvent was removed by rotary evaporation to obtain Int 21-2 (1.46 g; 90%). Mass spectrometry: 192 (M+H + ). Synthesis of intermediate (2R,5R)-2-(4-fluoro-2-methylphenyl)-5-methylpyrrolidine Int 21-3 TIFF0007579249000126.tif4556Int 21-2 (1.46 g; 7.65 mmol) was added to a reaction flask containing 8 mL of methanol, and sodium borohydride (1.16 g; 30.6 mmol) was added batchwise while stirring at room temperature. After the addition was completed, the mixture was further stirred at room temperature and TLC detection was performed. After the reaction was completed, the reaction solution was poured into water and extracted with 30 mL of EA (10 mL x 3). The organic phases were combined, dried over anhydrous sodium sulfate, and separated by column chromatography to obtain Int 21-3 (1.35 g; 91%). Mass spectrometry: 194 (M+H + ). TIFF0007579249000127.tif25170 Synthesis of element (21) TIFF0007579249000128.tif38154Int 1-15 (30 mg; 0.09 mmol), Int 21-3 (17 mg; 0.09 mmol), DIEA (18 mg; 0.14 mmol) and HATU (34 mg; 0.09 mmol) were added to a 25 mL round bottom flask containing 1 mL of DMF, stirred at room temperature and monitored by TLC. After the reaction was completed, HO (5 mL) was added, extracted with EA (5 mL x 3), and purified by blade to obtain white solid powder 21 (30 mg) in 65% yield. Mass spectrometry: 509 (M+H + ).
[0071] TIFF0007579249000129.tif25170Synthesis of (yl)-3-methylurea (25) TIFF0007579249000130.tif70147 Synthesis of intermediate (R)-t-butyl-(5-(4-fluoro-2-(trifluoromethyl)phenyl)-5-oxopentan-2-yl)carbamate (Int 25-1) TIFF0007579249000131.tif38101 Dry THF (30 mL) was added to the reaction flask, then SM 12 (2.9 g, 10 mmol) was added, and isopropyl magnesium bromide (10 mL, 1M in THF) was added under nitrogen gas protection under ice-water bath conditions, and then reacted at room temperature for 7 hours, and finally (R)-t-butyl-2-methyl-5-oxopyrrolidine-1-carboxylate (1.99 g, 10 mmol) was added, and then reacted at room temperature for 12 hours. The reaction solution was poured into a saturated aqueous ammonium chloride solution, extracted with 30 mL of ethyl acetate (10 mL x 3), and the organic phases were combined, dried over anhydrous sodium sulfate, and purified by column chromatography to obtain Int 25-1 (1.82 g, 5 mmol) in 50% yield. Mass spectrometry: 364 (M+H + ). Synthesis of intermediate (R)-5-(4-fluoro-2-(trifluoromethyl)phenyl)-2-methyl-3,4-dihydro-2H-pyrrole (Int 25-2) TIFF0007579249000132.tif4474 DCM (20 mL) was added to a reaction flask, followed by Int 25-1 (1.82 g, 5 mmol), followed by TFA (2 mL), and then reacted at room temperature for 7 hours. The reaction was poured into saturated aqueous sodium bicarbonate solution, extracted with 30 mL of DCM (10 mL x 3), the organic phases were combined, dried over anhydrous sodium sulfate, and purified by column chromatography to give Int 25-2 (1.1 g, 4.5 mmol) in 90% yield. Mass spectrometry: 246 (M+H + ). Synthesis of intermediate 2-(4-fluoro-2-(trifluoromethyl)phenyl)-5-methylpyrrolidine (Int 25-3) TIFF0007579249000133.tif4564 Methanol (15 mL) was added to the reaction flask, followed by Int 25-2 (1.1 g, 4.5 mmol), followed by sodium borohydride (0.76 g, 20 mmol) in batchwise fashion, and then reacted at room temperature for 1 h. The reaction solution was poured into water and extracted with EA 30 mL (10 mL x 3), the organic phases were combined, dried over anhydrous sodium sulfate, and concentrated to give an isomeric mixture, which was resolved to give Int 25-3 (0.96 g, 3.9 mmol) in 86% yield. Mass spectrometry: 248 (M+H) + ). TIFF0007579249000134.tif26170Synthesis of methylurea (25) TIFF0007579249000135.tif37151Int 1-15 (30 mg; 0.09 mmol), Int 25-3 (22 mg; 0.09 mmol) and HATU (34 mg; 0.09 mmol) were added to a 25 mL round-bottom flask containing 1 mL of DMF, and the mixture was stirred at room temperature. The reaction was monitored by TLC. After completion of the reaction, HO (10 mL) was added, and the mixture was extracted with EA (5 mL x 3) and purified by blade to obtain white solid powder 25 (27 mg) in a yield of 50%. Mass spectrometry: 563 (M+H + ).
[0072] TIFF0007579249000136.tif27170 Synthesis of element (39) TIFF0007579249000137.tif99152 Synthesis of intermediate compound methyl 4-methyl-4-nitrovalerate (Int 39-1) TIFF0007579249000138.tif2884 DCM (40 mL) was added to a reaction flask, followed by SM 16 (4.4 g, 0.05 mol), methyl acrylate (4.3 g, 0.05 mol), and DBU (3 mL), and then reacted at room temperature for 24 hours. The reaction solution was poured into water, extracted with 30 mL of DCM (10 mL x 3), and the organic phases were combined, dried over anhydrous sodium sulfate, and purified by column chromatography to give Int 39-1 (5.25 g, 0.03 mol) in 60% yield. Synthesis of intermediate compound 5,5-dimethylpyrrolidin-2-one (Int 39-2) TIFF0007579249000139.tif2584MeOH (50 mL) was added to a reaction flask, followed by Int 39-1 (5.2 g, 0.03 mol), Pd / C (400 mg), and then hydrogenation reaction was carried out at room temperature for 24 h. The reaction solution was poured into water, extracted with 30 mL of DCM (10 mL x 3), the organic phases were combined, dried over anhydrous sodium sulfate, and purified by column chromatography to give Int 39-2 (2.6 g, 0.023 mol) in 77% yield. Synthesis of intermediate 2,2-dimethyl-5-oxopyrrolidine-1-carboxylate-t-butyl (Int39-3) TIFF0007579249000140.tif2568 DCM (20 mL) was added to a reaction flask, followed by Int 39-2 (2.6 g, 0.023 mol), DMAP (800 mg), and then reacted at room temperature for 24 hours. The reaction solution was poured into water and extracted with 30 mL of DCM (10 mL x 3), the organic phases were combined, dried over anhydrous sodium sulfate, and purified by column chromatography to give Int 39-3 (3.9 g, 0.018 mol) in 79% yield. Mass spectrometry: 214 (M+H + ). Synthesis of intermediate (5-(4-fluorophenyl)-2-methyl-5-oxopentan-2-yl) t-butylcarbamate (Int 39-4) TIFF0007579249000141.tif4093 Dry THF (30 mL) was added to the reaction flask, followed by Int 39-3 (2.1 g, 10 mmol), followed by isopropylmagnesium bromide (10 mL, 1M in THF) under nitrogen gas protection in ice-water bath conditions, followed by reaction at room temperature for 7 hours, and finally SM 10 (2.13 g, 10 mmol) was added, followed by reaction at room temperature for 12 hours. The reaction solution was poured into saturated aqueous ammonium chloride solution, extracted with ethyl acetate 30 mL (10 mL x 3), the organic phases were combined, dried over anhydrous sodium sulfate, and purified by column chromatography to obtain Int 39-4 (1.7 g, 5.5 mmol) in 55% yield. Mass spectrometry: 310 (M+H+ ). Synthesis of intermediate 5-(4-fluorophenyl)-2,2-dimethyl-3,4-dihydro-2H-pyrrole (Int 39-5) TIFF0007579249000142.tif4668 DCM (20 mL) was added to a reaction flask, followed by Int 39-4 (1.54 g, 5 mmol), followed by TFA (6 mL), and then reacted at room temperature for 7 hours. The reaction was poured into saturated aqueous sodium bicarbonate, extracted with 30 mL of DCM (10 mL x 3), and the organic phases were combined, dried over anhydrous sodium sulfate, and purified by column chromatography to give Int 39-5 (864 mg, 4.5 mmol) in 90% yield. Mass spectrometry: 192 (M+H + ). Synthesis of intermediate 5-(4-fluorophenyl)-2,2-dimethylpyrrolidine (Int 39-6) TIFF0007579249000143.tif4656 Methanol (15 mL) was added to a reaction flask, followed by Int 39-5 (768 g, 4 mmol), followed by sodium borohydride (0.76 g, 20 mmol) in a batchwise manner, and then reacted at room temperature for 1 h. The reaction solution was poured into water and extracted with EA 30 mL (10 mL x 3), the organic phases were combined, dried over anhydrous sodium sulfate, and concentrated to give Int 39-6 (718 mg, 3.7 mmol) in 94% yield. Mass spectrometry: 194 (M+H + ). TIFF0007579249000144.tif27170 synthesis TIFF0007579249000145.tif4015225mL reaction flask was added with DMF (3mL), then Int 1-15 (333mg, 1mmol), Int 39-6 (194mg, 1mmol), DIEA (387mg, 3mmol), and finally HATU (381mg, 1mmol) were added, and the system was reacted at 20°C for 1 hour. After the reaction was completed, the reaction solution was poured into water (20mL), extracted with ethyl acetate 30mL (10mL x 3), the organic phase was combined, dried over anhydrous sodium sulfate, and purified by column chromatography to obtain compound 39 (280mg) in 55% yield. Mass spectrometry: 509 (M+H + ).
[0073] TIFF0007579249000146.tif17170TIFF0007579249000147.tif9170Synthesis of methylurea (43) TIFF0007579249000148.tif82152 Synthesis of intermediate (R)-(1-(4-fluorophenyl)-4-oxohexyl) t-butylcarbamate (Int 43-1) TIFF0007579249000149.tif4387 Dry THF (30 mL) was added to a reaction flask, followed by SM 18 (2.8 g, 10 mmol), followed by ethyl magnesium bromide (10 mL, 1M in THF) under nitrogen gas protection in an ice-water bath, followed by reaction at room temperature for 12 hours. The reaction solution was poured into a saturated aqueous ammonium chloride solution, extracted with 30 mL of ethyl acetate (10 mL x 3), the organic phases were combined, dried over anhydrous sodium sulfate, and purified by column chromatography to obtain Int 43-1 (2.17 g, 7 mmol) in 70% yield. Mass spectrometry: 310 (M+H + ). Synthesis of intermediate (S)-5-ethyl-2-(4-fluorophenyl)-3,4-dihydro-2H-pyrrole (Int 43-2) TIFF0007579249000150.tif4472 DCM (20 mL) was added to a reaction flask, followed by Int 43-1 (1.54 g, 5 mmol), followed by TFA (6 mL), and then reacted at room temperature for 7 hours. The reaction was poured into saturated aqueous sodium bicarbonate solution, extracted with 30 mL of DCM (10 mL x 3), and the organic phases were combined, dried over anhydrous sodium sulfate, and purified by column chromatography to give Int 43-2 (764 mg, 4 mmol) in 80% yield. Mass spectrometry: 192 (M+H + ). Synthesis of intermediate (2S,5S)-2-ethyl-5-(4-fluorophenyl)pyrrole (Int 43-3) TIFF0007579249000151.tif4462 DCM (15 mL) was added to the reaction flask, followed by Int 43-2 (764 mg, 4 mmol), and then DIBAL-H (5 mL, 1 M in hexane) was added under ice-water bath conditions, followed by reaction at room temperature for 1 hour. After quenching with a small amount of water, the mixture was filtered, washed with DCM (15 mL x 3), and concentrated to obtain Int 43-3 (694 mg, 3.6 mmol) in 90% yield. Mass spectrometry: 194 (M+H + ). 1 H NMR(400MHz,CDCl3)δ 7.37(dt,J=9.1,4.7Hz,2H),6.99(t,J=8.7Hz,2H),4.15(dd,J=14.6,7.0Hz,1H),3.13(dd,J=13.9,7.0Hz,1H),2.23- 2.08(m,1H),2.07-1.94(m,1H),1.80-1.65(m,1H),1.63-1.46(m,3H),1.25(m,1H),0.95(ddd,J=9.6,5.5,2.5Hz,3H). Combination of TIFF0007579249000152.tif18170 and TIFF0007579249000153.tif101703) TIFF0007579249000154.tif4115425mL reaction flask was added with DMF (3mL), then Int 1-15 (333mg, 1mmol), Int 43-3 (193mg, 1mmol), DIEA (387mg, 3mmol), and finally HATU (381mg, 1mmol) were added, and the system was reacted at 20°C for 1 hour. After the reaction was completed, the reaction solution was poured into water (20mL), extracted with ethyl acetate 30mL (10mL x 3), the organic phase was combined, dried over anhydrous sodium sulfate, and purified by column chromatography to obtain compound 43 (279mg) in 55% yield. Mass spectrometry: 509 (M+H + ).
[0074] TIFF0007579249000155.tif261703-Synthesis of methylurea (47) TIFF0007579249000156.tif88152 Synthesis of intermediate (S)-(1-(4-fluorophenyl)-5-methyl-4-oxohexyl) t-butylcarbamate (Int 47-1) TIFF0007579249000157.tif4287 Dry THF (30 mL) was added to a reaction flask, followed by SM 18 (2.8 g, 10 mmol), followed by isopropylmagnesium bromide (10 mL, 1M in THF) under nitrogen gas protection in an ice-water bath, followed by reaction at room temperature for 12 hours. The reaction solution was poured into a saturated aqueous ammonium chloride solution, extracted with 30 mL of ethyl acetate (10 mL x 3), the organic phases were combined, dried over anhydrous sodium sulfate, and purified by column chromatography to give Int 47-1 (2.2 g, 7 mmol) in 70% yield. Mass spectrometry: 324 (M+H + ). Synthesis of intermediate (S)-2-(4-fluorophenyl)-5-isopropyl-3,4-dihydro-2H-pyrrole (Int 47-2) TIFF0007579249000158.tif4872 DCM (20 mL) was added to a reaction flask, followed by Int 47-1 (1.62 g, 5 mmol), followed by TFA (2 mL), and then reacted at room temperature for 7 hours. The reaction solution was poured into saturated aqueous sodium bicarbonate solution, extracted with 30 mL of DCM (10 mL x 3), the organic phases were combined, dried over anhydrous sodium sulfate, and purified by column chromatography to give Int 47-2 (820 mg, 4 mmol) in 80% yield. Mass spectrometry: 206 (M+H + ). Synthesis of intermediate (2S,5R)-2-(4-fluorophenyl)-5-isopropylpyrrolidine (Int 47-3) TIFF0007579249000159.tif4964 DCM (15 mL) was added to a reaction flask, followed by Int 47-2 (820 mg, 4 mmol), followed by DIBAL-H (5 mL, 1 M in hexane) in an ice-water bath, followed by reaction at room temperature for 1 hour. After quenching with a small amount of water, the mixture was filtered, washed with DCM (15 mL x 3), and concentrated to give Int 43-7 (749 mg, 3.6 mmol) in 90% yield. Mass spectrometry: 208 (M+H + ). 1 H NMR(400MHz,CDCl3)δ 7.42-7.34(m,2H),7.03-6.94(m,2H),4.14(t,J=7.8Hz,1H),2.90(q,J=7.7Hz,1H),2.12(dddd,J=11.9,9.4,6.8,5.2H z,1H),1.98-1.88(m,1H),1.72-1.64(m,1H),1.61-1.53(m,1H),1.25(m,1H),0.97(d,J=6.6Hz,3H),0.93-0.85(m,4H). TIFF0007579249000160.tif26170 Synthesis of element (47) TIFF0007579249000161.tif4615925mL reaction flask was added with DMF (3mL), then Int 1-15 (333mg, 1mmol), Int 47-3 (208mg, 1mmol), DIEA (387mg, 3mmol), and finally HATU (381mg, 1mmol) were added, and the system was reacted at 20°C for 1 hour. After the reaction was completed, the reaction solution was poured into 20mL of water, extracted with 30mL of ethyl acetate (10mL x 3), the organic phase was combined, dried over anhydrous sodium sulfate, and purified by column chromatography to obtain compound 47 (266mg) in 51% yield. Mass spectrometry: 523 (M+H + ).
[0075] TIFF0007579249000162.tif26170Synthesis of ethyl urea (57) TIFF0007579249000163.tif78145 Synthesis of intermediate (5-(2-ethyl-4-fluorophenyl)-5-oxopentan-2-yl) t-butylcarbamate (Int 57-1) TIFF0007579249000164.tif3994Compound SM 19 (400 mg, 2 mmol) and tetrahydrofuran (4 mL) were added to a 50 mL reaction flask, and the mixture was cooled to -70 °C under nitrogen gas protection, and butyl lithium (2.5 M in hexane, 0.8 mL, 2 mmol) was added dropwise to the reaction solution. After reacting at this temperature for 2 to 3 hours, a solution of 2-methyl-5-oxopiperidone-N-t-butyl formate (400 mg, 2 mmol) in tetrahydrofuran (3 mL) was added. After the addition was completed, the mixture was allowed to naturally rise in temperature. After the reaction was completed, a saturated aqueous ammonium chloride solution (5 mL) was added, and the mixture was extracted with ethyl acetate (5 mL x 3). The organic phases were combined, dried over anhydrous sodium sulfate, and purified by column chromatography to obtain compound Int 57-1 (440 mg, 68% yield). Mass spectrometry: 324.2 (M+H + ). Synthesis of intermediate 5-(2-ethyl-4-fluorophenyl)-2-methyl-3,4-dihydro-2H-pyrrole (Int 57-2) TIFF0007579249000165.tif446925mL reaction flask was charged with crude Int 57-1 (440mg, 1.4mmol) and dichloromethane (4mL), trifluoroacetic acid (0.4mL) was further added, and the reaction was carried out at room temperature overnight. After the reaction was completed, the solvent was removed by rotary evaporation in vacuum, sodium bicarbonate aqueous solution was added to adjust the pH to 7, and the mixture was extracted with ethyl acetate (5mL x 3). The organic phase was combined, dried over anhydrous sodium sulfate, and the solvent was removed by rotary evaporation in vacuum to obtain crude compound Int 57-2 (260mg, 93% yield). Mass spectrometry: 206.1 (M+H + ). Synthesis of intermediate 2-(2-ethyl-4-fluorophenyl)-5-methylpyrrolidine (Int 57-3) TIFF0007579249000166.tif4455Int 57-2 (260 mg, 1.3 mmol) and methanol (3 mL) were added to a 50 mL reaction flask, and sodium borohydride (48 mg, 1.3 mmol) was added in a batchwise manner under ice bath. After the reaction was completed, water (5 mL) was added, and the mixture was extracted with ethyl acetate (5 mL x 3). The organic phases were combined and dried over anhydrous sodium sulfate, and the solvent was removed by rotary evaporation in vacuum to obtain a crude compound. The compound was separated to obtain Int 57-3 (251 mg). Mass spectrometry: 208.1 (M+H + ). Composition of TIFF0007579249000167.tif271707) TIFF0007579249000168.tif461562 Compound Int 1-15 (33 mg, 0.1 mmol), Int 57-3 (31 mg, 0.15 mmol), DIEA (39 mg, 0.3 mmol), and DMF (1 mL) were added to a 5 mL reaction flask. HATU (57 mg, 0.15 mmol) was added while stirring. After stirring overnight at room temperature, the reaction was completed. Water (5 mL) was added to the reaction solution, and the solution was extracted with ethyl acetate (5 mL x 3). The organic phases were combined, dried over anhydrous sodium sulfate, and purified by column chromatography to obtain compound 57 (20 mg, 38% yield). Mass spectrometry: 523.2 (M+H + ). 1H NMR(400MHz,DMSO)δ 8.72(s,1H),7.53(d,J=7.1Hz,1H),7.30-6.87(m,5H),6.09(d,J=4.7Hz,1H),5.22(dt,J=15.9,7.1Hz,1H),4.68(dd ,J=24.4,16.7Hz,1H),4.47-4.16(m,2H),3.44(t,J=17.1Hz,1H),3.08(dt,J=15.6,7.6Hz,1H),3.01-2.91(m,1H),2. 89(s,1H),2.82-2.72(m,1H),2.63(t,J=3.9Hz,3H),2.42(ddd,J=10.8,9.9,5.5Hz,2H),2.05(dt,J=14.0,7.3Hz,1H ),1.73(ddd,J=20.2,13.2,7.1Hz,1H),1.53(td,J=12.1,6.2Hz,1H),1.42(dd,J=6.2,4.3Hz,3H),1.26-1.20(m,3H).
[0076] TIFF0007579249000169.tif9170phenyl)-5-(trifluoromethyl)pyrrolidin-1-yl)-2-oxoethyl)- Synthesis of 5-methyl-3-ylurea (74) TIFF0007579249000171.tif209153 Synthesis of intermediate (3R,7aR)-7a-(4-fluorophenyl)-3-phenyltetrahydropyrrolidine[2,1-b]oxazol-5(6H)-one (Int 74-2) TIFF0007579249000172.tif38125 Intermediate Int 73-1 (6.1 g, 31 mmol) and (R)-2-amino-1-phenylethan-1-ol (4.3 g, 31 mmol) were added to 50 mL of toluene, separated using a water separator, and reacted at 148 °C for 20 hours. Concentration and column chromatography were performed to obtain 6 g of white solid Int 74-2 in 66% yield. Mass spectrometry: 298 (M + H + ). Synthesis of intermediate (S)-5-(4-fluorophenyl)-1-((R)-2-hydroxy-1-phenylethyl)pyrrolidin-2-one (Int 74-3) TIFF0007579249000173.tif35127 Intermediate Int 74-2 (6 g, 20 mmol) and triethylsilane (7.5 g, 65 mmol) were added to 100 mL of dichloromethane, and titanium tetrachloride solution (20 mL, 1 M in hexane) was added dropwise at -78°C. After the addition was completed, the mixture was slowly returned to room temperature and stirred for 4 hours. A saturated aqueous solution of ammonium chloride was added, and the mixture was extracted with ethyl acetate, dried and concentrated with anhydrous sodium sulfate. The crude product was used as it was in the next step of the reaction. Synthesis of intermediate (S)-5-(4-fluorophenyl)-1-((R)-2-chloro-1-phenylethyl)pyrrolidin-2-one (Int 74-4) TIFF0007579249000174.tif351132 In a 50 mL reaction flask, Int 74-3 (10 g, 33 mmol) and tetrahydrofuran (100 mL) were added, and thionyl chloride (8 g, 67 mmol) was slowly added under ice bath, and the reaction was allowed to warm to room temperature naturally, and further reacted at room temperature for 2 hours. After the reaction was completed, the solvent was removed by rotary evaporation in vacuum to obtain crude compound Int 74-4 (13 g, 122% yield). Mass spectrometry: 318.1 (M+H + ). Synthesis of intermediate (S)-5-(4-fluorophenyl)-1-(1-phenylvinyl)pyrrolidin-2-one (Int 74-5) TIFF0007579249000175.tif351072 Add crude Int 74-4 (13 g, 41 mmol) and t-butanol (130 mL) to a 50 mL reaction flask, then add sodium t-butoxide (7.9 g, 82 mmol), heat the reaction to 40 °C for 2-3 h, after the reaction is complete, remove the solvent by rotary evaporation, add water (50 mL), extract with ethyl acetate (5 mL × 3), combine the organic phase, dry with anhydrous sodium sulfate, remove the solvent by rotary evaporation to obtain crude compound Int 74-5 (11 g, 96% yield). Mass spectrometry: 282.1 (M+H + ). Synthesis of intermediate (R)-5-(4-fluorophenyl)pyrrolidin-2-one (Int 74-6) TIFF0007579249000176.tif361002 Crude Int 74-5 (11 g, 39 mmol), 2N aqueous hydrochloric acid (50 mL), and tetrahydrofuran (60 mL) were added to a 50 mL reaction flask, the reaction was heated to 80 °C and reacted for 2-3 hours, after the reaction was completed, the pH was adjusted to 7 with saturated aqueous sodium bicarbonate solution, extracted with ethyl acetate (50 mL x 3), the organic phases were combined, dried over anhydrous sodium sulfate, the solvent was removed by rotary evaporation in vacuum, and the obtained solid was beaten with ethyl acetate (20 mL) for 1 hour and filtered to obtain compound Int 74-6 (5 g, 74% yield). Mass spectrometry: 180.1 (M+H + ). Synthesis of intermediate (S)-2-(4-fluorophenyl)-5-oxopyrrolidine-1-carboxylate-t-butyl (Int 74-7) TIFF0007579249000177.tif3785 Crude Int 74-6 (5 g, 28 mmol), di-t-butyl dicarbonate (7.4 g, 34 mmol), and dichloromethane (50 mL) were added to a 100 mL reaction flask, and finally, 4-dimethylaminopyridine (3.4 g, 28 mmol) was added in batches and stirred at room temperature overnight. After the reaction was completed, 0.5 N aqueous hydrochloric acid (20 mL) was added and separated, the organic phase was dried over anhydrous sodium sulfate, the solvent was removed by rotary evaporation in vacuum, and the compound Int 74-7 (7.5 g, 96% yield) was obtained by purification by column chromatography. Mass spectrometry: 280.1 (M+H + ). Synthesis of intermediate (5S)-5-(4-fluorophenyl)-2-oxo-3-(2,2,2-trifluoroacetyl)pyrrolidine-1-carboxylate-t-butyl (Int 74-8) TIFF0007579249000178.tif3798 Intermediate Int 74-7 (2.8 g, 10 mmol) and ethyl trifluoroacetate (2.8 g, 20 mmol) were dissolved in 50 mL of tetrahydrofuran, sodium hydride (0.8 g, 20 mmol) was added, and the mixture was heated to 50° C. and reacted for 4 hours. The reaction liquid was poured into cold water, the pH was adjusted to 5-6 with 2N hydrochloric acid, extracted with ethyl acetate, dried and concentrated with anhydrous sodium sulfate, and the crude product was used as it was in the next step reaction. Synthesis of intermediate (S)-2-(4-fluorophenyl)-5-(trifluoromethyl)-3,4-dihydro-2H-pyrrole (Int 74-9) TIFF0007579249000179.tif3399 The crude product obtained in the previous step was dissolved in 10 mL of dioxane, and 30 mL of concentrated hydrochloric acid was added. The mixture was heated to 100 °C and stirred overnight. The pH was adjusted to 7-8 with sodium bicarbonate, extracted with ethyl acetate, dried over anhydrous sodium sulfate, and concentrated. The crude product obtained in the previous step was dissolved in 20 mL of dichloromethane, and 1 mL of trifluoroacetic acid was added. The mixture was stirred at room temperature overnight and concentrated. Water was added to adjust the pH to 7-8, extracted with ethyl acetate, dried over anhydrous sodium sulfate, and concentrated. The mixture was subjected to column chromatography to obtain 1.5 g of colorless liquid Int 74-9, with a two-stage yield of 65%. Mass spectrometry: 232 (M+H + ). Synthesis of intermediate (2S,5R)-2-(4-fluorophenyl)-5-(trifluoromethyl)pyrrolidine (Int 74-10) TIFF0007579249000180.tif32106 Intermediate Int 74-9 (1.65 g, 5 mmol) was dissolved in 50 mL of dichloromethane, and DIBAL-H (5.5 mL, 1 M in hexane) was added in an ice bath and stirred for 4 hours. Diatomaceous earth and 10 mL of water were added, filtered, extracted with ethyl acetate, dried over anhydrous sodium sulfate, concentrated, and subjected to column chromatography to obtain pale yellow liquid Int 74-10 (740 mg) in a 65% yield. 1 H NMR(400MHz,CDCl3)δ 7.42-7.36(m,2H),7.03-6.96(m,2H),4.32(dd,J=9.7,5.2Hz,1H),3.81(dd d,J=14.1,12.5,6.9Hz,1H),2.16-2.03(m,3H),1.70(dq,J=9.6,8.5Hz,1H). Synthesis of intermediate 2-bromo-1-((2S,5R)-2-(4-fluorophenyl)-5-(trifluoromethyl)pyrrolidin-1-yl)ethan-1-one (Int 74-12) TIFF0007579249000181.tif4099 Intermediate Int 74-10 (233 mg, 10 mmol) was dissolved in 10 mL of dichloromethane, and bromoacetyl bromide (200 mg, 10 mmol) was added dropwise in an ice bath, stirred for 1 hour, extracted with dichloromethane, and subjected to column chromatography to obtain white solid Int 74-12 in 90% yield. Mass spectrometry: 354,356 (M+H + ). TIFF0007579249000182.tif9168)-5-(trifluoromethyl)pyrrolidin-1-yl)-2-oxoethyl)-2, TIFF0007579249000183.tif9170t 74-13) synthesis TIFF0007579249000184.tif44132 Int 1-4 (140 mg, 5 mmol), intermediate Int 74-12 (176 mg, 5 mmol) and potassium carbonate (140 mg, 10 mmol) were dissolved in 10 mL of N,N-dimethylformamide, stirred at room temperature for 4 hours, added with 50 mL of water, filtered and dried to obtain 500 mg of white solid Int 74-13 in 90% yield. Mass spectrometry: 555,557 (M+H + ). TIFF0007579249000185.tif91682-(4-Fluorophenyl)-5-(trifluoromethyl)pyrrolidin-1-yl)- TIFF0007579249000186.tif62170 Intermediate Int 74-13 (100 mg, 0.28 mmol), benzophenone imine (62 mg, 0.34 mmol), palladium acetate (13 mg, 0.06 mmol), (±)-2, TIFF0007579249000187.tif81701) and cesium carbonate (136 mg, 0.42 mmol) were dissolved in 5 mL of toluene, purged with nitrogen gas, heated to 100°C, and stirred for 4 hours. Concentration and column chromatography were performed to obtain a gray solid Int 74-14 in 84% yield. Mass spectrometry: 656 (M+H + ). TIFF0007579249000188.tif9168)-5-(trifluoromethyl)pyrrolidin-1-yl)-2-oxoethyl)-2, TIFF0007579249000189.tif8170t 74-15) synthesis TIFF0007579249000190.tif44143 Intermediate Int 74-14 (110 mg, 0.24 mmol) was dissolved in 5 mL of tetrahydrofuran, and 2N hydrochloric acid (5 mL) was added at room temperature and stirred for 30 minutes. Extracted three times with ethyl acetate, the organic phases were combined, dried over anhydrous sodium sulfate, concentrated, and subjected to column chromatography to obtain a yellow solid Int 74-15 (62 mg) in 88% yield. Mass spectrometry: 448 (M-43). TIFF0007579249000191.tif271703-Synthesis of methylurea (74) TIFF0007579249000192.tif40152Triphosgene (35 mg, 0.12 mmol) was added to 5 mL of dichloromethane, and a mixture of intermediate Int 74-15 (62 mg, 0.2 mmol), triethylamine (200 mg, 2 mmol) and 5 mL of dichloromethane was slowly added dropwise to the reaction flask under ice bath. After the dropwise addition, the mixture was stirred for 1 hour, and methylamine hydrochloride (33 mg, 0.5 mmol) was added and stirred for 4 hours. 10 mL of water was added, and the organic layer was separated and extracted with dichloromethane. The organic phases were combined, dried over anhydrous sodium sulfate, concentrated, and subjected to column chromatography to obtain 30 mg of a yellow solid (74) in a yield of 45%. Mass spectrometry: 549 (M+H + ).
[0077] TIFF0007579249000193.tif26170 TIFF0007579249000194.tif78152 Synthesis of intermediate (5-cyclohexyl-5-oxopentan-2-yl) t-butylcarbamate (Int 96-1) TIFF0007579249000195.tif3684 Dry THF (30 mL) was added to a reaction flask, followed by SM 28 (10 mL, 10 mmol), followed by 2-methyl-5-oxopyrrolidine-1-carboxylate-t-butyl (2 g, 10 mmol) under nitrogen gas protection in an ice-water bath, followed by reaction at room temperature for 12 hours. The reaction solution was poured into a saturated aqueous ammonium chloride solution, extracted with 30 mL of ethyl acetate (10 mL x 3), the organic phases were combined, dried over anhydrous sodium sulfate, and purified by column chromatography to obtain Int 96-1 (1.6 g, 5.5 mmol) in 55% yield. Mass spectrometry: 284 (M+H + ). Synthesis of intermediate 5-cyclohexyl-2-methyl-3,4-dihydro-2H-pyrrole (Int96-2) TIFF0007579249000196.tif3963 DCM (20 mL) was added to a reaction flask, followed by Int 96-1 (1.42 g, 5 mmol), followed by TFA (2 mL), and then reacted at room temperature for 7 hours. The reaction was poured into saturated aqueous sodium bicarbonate solution, extracted with 30 mL of DCM (10 mL x 3), the organic phases were combined, dried over anhydrous sodium sulfate, and purified by column chromatography to give Int 96-2 (660 mg, 4 mmol) in 80% yield. Mass spectrometry: 166 (M+H + ). Synthesis of intermediate 2-cyclohexyl-5-methylpyrrolidine (Int 96-3) TIFF0007579249000197.tif3952 Methanol (15 mL) was added to the reaction flask, followed by Int 96-2 (660 g, 4 mmol), followed by sodium borohydride (0.76 g, 20 mmol) in batchwise fashion, and then reacted at room temperature for 1 h. The reaction solution was poured into water and extracted with EA 30 mL (10 mL x 3), the organic phases were combined, dried over anhydrous sodium sulfate, and concentrated to give Int 96-3 (618 mg, 3.7 mmol) in 94% yield. Mass spectrometry: 168 (M+H) + ). TIFF0007579249000198.tif6817025mL reaction flask was added with DMF (3mL), then Int 1-15 (333mg, 1mmol), Int 96-3 (167mg, 1mmol), DIEA (387mg, 3mmol), and finally HATU (381mg, 1mmol) were added, and the system was reacted at 20°C for 1 hour. After the reaction was completed, the reaction solution was poured into water (20mL), extracted with ethyl acetate 30mL (10mL x 3), the organic phase was combined, dried over anhydrous sodium sulfate, and purified by column chromatography to obtain compound 96 (266mg) in 55% yield. Mass spectrometry: 483 (M+H + ).
[0078] TIFF0007579249000199.tif26170-Synthesis of 3-methylurea (97) TIFF0007579249000200.tif133155 Synthesis of intermediate 6-bromo-1-methyl-2,3-dihydro-1H-indene (Int 97-1) TIFF0007579249000201.tif30100Methyltriphenylphosphine bromide (35.6 g, 100 mmol) was dissolved in THF (300 mL), and t-BuOK (11.2 g, 100 mmol) was added batchwise under nitrogen gas protection under ice-water bath conditions. After the addition was completed, the mixture was reacted at this temperature for a certain time to obtain a solution, which was ready for use. SM 29 (21 g, 100 mmol) was dissolved in THF (300 mL), and cooled under ice-water bath conditions. The solution ready for use was added dropwise to the THF solution of SM 29, and after the addition was completed, the reaction was continued for half an hour in the ice-water bath. The reaction solution was poured into water (1 L), extracted three times with ethyl acetate, and the organic phase was washed with saturated saline and concentrated to obtain the crude product, which was then subjected to column chromatography to obtain Int 97-1 (12 g) in 60% yield. 1 H NMR(400MHz,CDCl3)δ 7.59(m,1H),7.32-7.28(m,1H),7.11(m,1H),5.43(m,1H),5.06(m,1H),2.97-2.84(m,2H),2.84-2.71(m,2H). TIFF0007579249000202.tif8168 (Int 97-2) synthesis TIFF0007579249000203.tif2885 Diiodomethane (26.8g, 100mmol) was dissolved in DCM (50mL), cooled to -70℃ under nitrogen gas protection, added dropwise with organic solution of diethylzinc (100mL, 1N in ?), then reacted at -45℃ for 2 hours, then added dropwise with dichloromethane solution of trichloroacetic acid (16.3g, 100mmol), then reacted at -15℃ for 2 hours, finally added dropwise with dichloromethane solution of Int 97-1 (10.4g, 50mmol), then reacted at room temperature for 12 hours. The reaction liquid was poured into water, extracted with dichloromethane three times, the organic phase was washed with saturated saline, concentrated to obtain the crude product, and then subjected to column chromatography to obtain Int 97-2 (8.8g) in 80% yield. 1 H NMR(400MHz,CDCl3)δ 7.20-7.18(m,1H),7.05-7.03(m,1H),6.76(s,1H),2.99-2.95(m,2H),2.14-2.08(m,2H),0.96-0.87(m,4H). TIFF0007579249000204.tif8169On (Int 97-3) Composition TIFF0007579249000205.tif3097Int 97-2 (8.8 g, 40 mmol) was dissolved in acetone (100 mL), water (100 mL) was added, potassium permanganate (15.8 g, 100 mmol), copper sulfate pentahydrate (25 g, 100 mmol) were added, and then the mixture was reacted at room temperature for 24 hours. The reaction solution was poured into water, extracted 10 times with ethyl acetate, and the organic phase was washed with saturated saline and concentrated to obtain a crude product, which was subjected to column chromatography to obtain Int 97-3 (3.8 g) in a yield of 40%. Mass spectrometry: 237, 239 (M+H + ). TIFF0007579249000206.tif18170 TIFF0007579249000207.tif2995Int 97-3 (3.8 g, 16 mmol) was dissolved in DCM (100 mL), TMSCN (2 g, 20 mmol), NMO (580 mg, 5 mmol) were added, and the mixture was reacted at room temperature for 16 hours. The reaction mixture was poured into saturated aqueous NaHCO3 solution, extracted three times, and the organic phase was washed with saturated brine and concentrated to obtain the crude product, which was subjected to column chromatography to obtain Int 97-4 (2.7 g, 8 mmol) in 50% yield. Mass spectrometry: 336,338 (M+H) + ). TIFF0007579249000208.tif52170 Int 97-4 (2.7 g, 8 mmol) was dissolved in EtOH (30 mL) and dried HCl gas was introduced continuously for 5 h. The reaction solution was concentrated to dryness and dried to give Int 97-5 (2.8 g, 8 mmol) in 100% yield. TIFF0007579249000209.tif55170Int 97-5 (2.8 g, 8 mmol) was dissolved in THF (20 mL), and DIEA (5.2 g, 40 mmol) was added under ice-water bath conditions, stirred for 5 minutes, and then triphosgene (2.4 g, 8 mmol) was added in batches, and then reacted for 1 hour. The reaction solution was poured into water, extracted with ethyl acetate three times, and the organic phase was washed with saturated saline and concentrated to obtain the crude product, which was subjected to column chromatography to obtain Int 97-6 (1.96 g, 6.4 mmol) in 80% yield. Mass spectrometry: 308, 310 (M+H + ). Composition of TIFF0007579249000210.tif171707-7) TIFF0007579249000211.tif39136Int 97-6 (1.96 g, 6.4 mmol) was dissolved in DMF (20 mL), and t-butyl bromoacetate (1.36 g, 7 mmol) and potassium carbonate (1.38 g, 10 mmol) were added and reacted for 3 hours. The reaction solution was poured into water and extracted three times. The organic phase was washed with saturated saline and concentrated to obtain the crude product, which was then subjected to column chromatography to obtain Int 97-7 (2.42 g, 5.76 mmol) in a yield of 90%. Mass spectrometry: 422,424 (M+H + ). TIFF0007579249000212.tif17170Synthesis of t-butyl acetate (Int 97-8) TIFF0007579249000213.tif37150Int97-7 (2.42 g, 5.76 mmol), benzophenone imine (1.05 g, 5.76 mmol), cesium carbonate (1.88 g, 5.76 mmol), palladium acetate (224 mg, 1 mmol), BINAP (311 mg, 0.5 mmol) were dissolved in toluene (20 mL), substituted with nitrogen gas three times, heated to 100 ° C and reacted for 5 hours. The reaction liquid was poured into water, extracted with ethyl acetate three times, the organic phase was washed with saturated saline and concentrated to obtain a crude product, which was subjected to column chromatography to obtain Int 97-8 (2.4 g, 4.6 mmol) in 80% yield. Mass spectrometry: 523 (M + H + ). Composition of TIFF0007579249000214.tif171707-9) TIFF0007579249000215.tif41110Int 97-8 (2.4 g, 4.6 mmol) was dissolved in THF (20 mL), and hydrochloric acid solution (10 mL, 1N) was added and reacted at room temperature for 2 hours. The reaction solution was treated with NaHCO3 solution, extracted with ethyl acetate three times, and the organic phase was washed with saturated saline and concentrated to obtain the crude product, which was subjected to column chromatography to obtain Int 97-9 (1.64 g, 4.6 mmol) in 100% yield. Mass spectrometry: 315 (M-43). TIFF0007579249000216.tif19170 Composite of Chill (Int 97-10) TIFF0007579249000217.tif37153Int 97-9 (1.64 g, 4.6 mmol) was dissolved in THF (15 mL), triphosgene (1.4 g, 4.6 mmol) was added, and the mixture was reacted at room temperature for 10 minutes. Then, DIEA (3.9 g, 30 mmol) was added, and finally, methylamine hydrochloride (310 mg, 4.6 mmol) was added, and the mixture was reacted at room temperature for 1 hour. The reaction solution was poured into water, extracted three times with ethyl acetate, and the organic phase was washed with saturated saline and concentrated to obtain the crude product, which was subjected to column chromatography to obtain Int 97-10 (1.7 g, 4.1 mmol) in 90% yield. Mass spectrometry: 416 (M+H + ). Composition of TIFF0007579249000218.tif1717097-11) TIFF0007579249000219.tif42134 Int 97-10 (1.7 g, 4.1 mmol) was dissolved in DCM (15 mL), TFA (1.5 mL) was added, and the mixture was reacted at room temperature for 1 hour. The mixture was concentrated to dryness to give Int 97-11 (1.47 g, 4.1 mmol) in 100% yield. Mass spectrometry: 360 (M+H + ). TIFF0007579249000220.tif27170Synthesis of urea (97) TIFF0007579249000221.tif46153 Intermediate Int 97-11 (30 mg, 89 μmol) was dissolved in DMF (1 mL), DIEA (35 mg, 270 μmol) and HATU (41 mg, 108 μmol) were added, and then SM 30 (20 mg, 0.1 mmol) was added and stirred at room temperature for 16 hours. Water (10 mL) was added to the reaction solution, and the mixture was stirred, extracted twice with ethyl acetate, and the organic phase was washed with saturated saline and concentrated to obtain the crude product, which was subjected to column chromatography to obtain the nearly white solid product 97 (26 mg) in 50% yield. Mass spectrometry: 521.2 (M+H + ). 1H NMR(400MHz,DMSO):δ 8.71(s,1H),7.44-7.35(m,1H),7.32-7.19(m,3H),7.17-7.03(m,3H),6.13-6.00(m,1H),5.26-4.92( m,1H),4.52(m,2H),4.27-3.41(m,1H),2.77(m,1H),2.62(t,J=3.8Hz,3H),2.39(dd,J=13.6,7.7Hz,2H ),2.01(ddd,J=11.8,10.4,6.5Hz,1H),1.95-1.84(m,1H),1.74(dd,J=49.7,7.9Hz,1H),1.52(dd,J=1 1.0,4.1Hz,1H),1.38(dd,J=6.1,3.8Hz,3H),1.10-1.05(m,1H),1.03-0.95(m,1H),0.93-0.83(m,1H).
[0079] TIFF0007579249000222.tif27170Synthesis of [lysine]-5-yl)-3-methylurea (98) TIFF0007579249000223.tif106170-Synthesis of (4-fluorobenzyl)-N-((S)-1,1,1-trifluoroprop-2-yl)acetamide (Int 98-1) TIFF0007579249000224.tif49152Int 308-3 (3.27 g, 5.76 mmol), benzophenone imine (1.05 g, 5.76 mmol), cesium carbonate (1.88 g, 5.76 mmol), palladium acetate (224 mg, 1 mmol), BINAP (311 mg, 0.5 mmol) were dissolved in toluene (30 mL), substituted with nitrogen gas three times, heated to 100 ° C and reacted for 5 hours. The reaction liquid was poured into water, extracted with ethyl acetate three times, the organic phase was washed with saturated saline, concentrated to obtain a crude product, and column chromatography was performed to obtain Int 98-1 (3 g, 4.6 mmol) in 80% yield. Mass spectrometry: 670 (M + H + ). TIFF0007579249000225.tif17170-Synthesis of N-((S)-1,1,1-trifluoroprop-2-yl)acetamide (Int 98-2) TIFF0007579249000226.tif53144Int 98-1 (3 g, 4.6 mmol) was dissolved in THF (20 mL), and hydrochloric acid solution (10 mL, 1N) was added and reacted at room temperature for 2 hours. The reaction solution was treated with NaHCO3 solution, extracted with ethyl acetate three times, and the organic phase was washed with saturated saline and concentrated to obtain the crude product, which was subjected to column chromatography to obtain Int 98-2 (2.3 g, 4.6 mmol) in 100% yield. Mass spectrometry: 462 (M-43). TIFF0007579249000227.tif18170Synthesis of (fluorobenzyl)-N-((S)-1,1,1-trifluoroprop-2-yl)acetamide (98) TIFF0007579249000228.tif45151Int 98-2 (2.3 g, 4.6 mmol) was dissolved in THF (20 mL), triphosgene (1.4 g, 4.6 mmol) was added, and the mixture was reacted at room temperature for 10 minutes. Then, DIEA (3.9 g, 30 mmol) was added, and finally, methylamine hydrochloride (310 mg, 4.6 mmol) was added, and the mixture was reacted at room temperature for 1 hour. The reaction solution was poured into water, extracted three times with ethyl acetate, and the organic phase was washed with saturated saline and concentrated to obtain the crude product. The crude product was obtained by column chromatography, and compound 98 (1.15 g, 2.05 mmol) was obtained in a yield of 45%. Mass spectrometry: 563 (M+H + ). 1 H NMR(400MHz,CDCl3):δ 7.32(m,2H),7.13(m,2H),6.94(m,3H),5.55-5.39(m,1H),4.69(m,2H),4.43(m,1H), 4.24(m,1H),2.90(m,1H),2.79(s,3H),2.44(m,1H),1.33(m,3H),1.16-1.00(m,4H).
[0080] Example 99 Compound N-((3S,5S,7S)-adamantan-1-yl)-2-((R TIFF0007579249000229.tif55170 Compound Int 1-15 (30 mg, 0.09 mmol), DMF (1 mL), DIEA (35 mg, 0.27 mmol), and HATU (41 mg, 0.108 mmol) were added to a 30 mL reaction flask, followed by SM 32 (21 mg, 0.14 mmol) and stirring at room temperature for 16 hours. Water (5 mL) was added to the reaction solution, and the mixture was extracted with ethyl acetate (5 mL x 3). The organic phase was washed with saturated saline and concentrated to obtain the crude product, which was subjected to column chromatography to obtain the nearly white solid product 99 (18 mg) in 43% yield. Mass spectrometry: 467.2 (M+H + ). 1 H NMR(400MHz,DMSO)δ:8.72(s,1H),7.82(s,1H),7.55(s,1H),7.33-7.06(m,2H),6.10(q,J=4.4Hz,1H),4.09(q,J=16.6Hz,2H),3.66-3.55(m,1H) ,3.18-3.05(m,1H),3.05-2.92(m,1H),2.68-2.56(m,4H),2.49-2.40(m, 1H),2.02(s,3H),1.93(d,J=2.0Hz,6H),1.82-1.68(m,1H),1.63(s,6H).
[0081] TIFF0007579249000230.tif64170 Compound Int 1-15 (30 mg, 90 μmol), DMF (1 mL), DIEA (35 mg, 270 μmol), and HATU (41 mg, 108 μmol) were added to a 30 mL reaction flask, followed by SM 33 (18 mg, 135 μmol) and stirring at room temperature for 16 hours. Water (5 mL) was added to the reaction solution, and the mixture was extracted with ethyl acetate (5 mL x 3). The organic layers were combined, dried over anhydrous sodium sulfate, and concentrated to obtain the crude product, which was then subjected to column chromatography to obtain product 100 (20 mg, 50% yield). Mass spectrometry: 449.2 (M+H + ). 1H NMR(400MHz,DMSO):δ 8.74(s,1H),7.56(s,1H),7.37(d,J=8.4Hz,1H),7.30-7.00(m,5H),6.10(q,J=4.4Hz,1H),4.78(s,1H),4.73-4.44(m,3H) ),3.78-3.71(m,2H),3.17-3.09(m,1H),3.05-2.91(m,2H),2.82(t,J=6.0Hz,1H),2.70-2.57(m,4H),2.55-2.51(m,1H).
[0082] TIFF0007579249000231.tif10170-((S)-3-Phenylpyrrolidin-1-yl)ethyl)-2,3-dihydrospiro[i TIFF0007579249000232.tif45167Compound Int 1-15 (30 mg, 90 μmol), DMF (1 mL), DIEA (35 mg, 270 μmol), and HATU (41 mg, 108 μmol) were added to a 30 mL reaction flask, followed by SM 34 (20 mg, 135 μmol) and stirring at room temperature for 16 h. Water (5 mL) was added to the reaction solution, and the mixture was extracted with ethyl acetate (5 mL x 3). The organic layers were combined, dried over anhydrous sodium sulfate, and concentrated to obtain the crude product, which was then subjected to column chromatography to obtain product 101 (16 mg, 38% yield). Mass spectrometry: 463 (M+H + ).
[0083] TIFF0007579249000233.tif9170(3-Phenylpyrrolidin-1-yl)ethyl)-2,3-dihydrospiro[indene-1, TIFF0007579249000234.tif11145TIFF0007579249000235.tif36153Compound Int 1-15 (30 mg, 90 μmol), DMF (1 mL), DIEA (35 mg, 270 μmol), and HATU (41 mg, 108 μmol) were added to a 30 mL reaction flask, followed by SM 35 (20 mg, 135 μmol) and stirring at room temperature for 16 hours. Water (5 mL) was added to the reaction solution, and the mixture was extracted with ethyl acetate (5 mL x 3). The organic layers were combined, dried over anhydrous sodium sulfate, and concentrated to obtain the crude product, which was then subjected to column chromatography to obtain product 102 (18 mg, 43% yield). Mass spectrometry: 463 (M+H + ). 1 H NMR(400MHz,DMSO):δ 8.73(s,1H),7.57(s,1H),7.44-7.30(m,5H),7.30-7.04(m,2H),6.09(d,J=4.5 Hz,1H),4.58-4.34(m,2H),3.95-3.82(m,1H),3.71-3.61(m,1H),3.56-3.49(m ,1H),3.43-3.38(m,1H),3.35-3.21(m,1H),3.15-3.09(m,1H),3.03-3.00(m,1 H),2.71-2.56(m,4H),2.57-2.51(m,1H),2.42-2.16(m,1H),2.15-1.83(m,1H).
[0084] TIFF0007579249000236.tif27170-Synthesis of methylurea (103) TIFF0007579249000237.tif37154 Intermediate Int 1-15 (30 mg, 90 μmol) was dissolved in DMF (1 mL), DIEA (35 mg, 270 μmol) and HATU (41 mg, 108 μmol) were added, followed by SM 36 (15 mg, 0.1 mmol) and stirred at room temperature for 16 hours. Water (5 mL) was added to the reaction solution, and the mixture was extracted twice with ethyl acetate. The organic phase was washed with saturated saline and concentrated to obtain the crude product, which was subjected to column chromatography to obtain the nearly white solid product 103 (20 mg) in 50% yield. Mass spectrometry: 415 (M+H + ).
[0085] Example 105 Compound (R)-N-(3-hydroxy-2,2,4,4-tetramethylcyclohexane TIFF0007579249000238.tif18170 TIFF0007579249000239.tif34154Int 1-15 (30 mg, 90 μmol) was dissolved in DMF (1 mL), DIEA (35 mg, 270 μmol) and HATU (41 mg, 108 μmol) were added, and then SM 37 (19 mg, 135 μmol) was added and stirred at room temperature for 16 hours. Water (10 mL) was added to the reaction solution, and the mixture was extracted twice with ethyl acetate. The organic phase was washed with saturated saline and concentrated to obtain the crude product, which was subjected to column chromatography to obtain the nearly white solid product 105 (17 mg) in 65% yield. Mass spectrometry: 459 (M+H + ).
[0086] TIFF0007579249000240.tif91702-(2-phenylazetidin-1-yl)ethyl)-2,3-dihydrospiro[indene TIFF0007579249000241.tif44157Compound Int 1-15 (30 mg, 90 μmol), DMF (1 mL), DIEA (35 mg, 270 μmol), and HATU (41 mg, 108 μmol) were added to a 30 mL reaction flask, followed by SM 38 (18 mg, 135 μmol) and stirring at room temperature for 16 h. Water (5 mL) was added to the reaction solution, and the mixture was extracted with ethyl acetate (5 mL x 3). The organic layers were combined, dried over anhydrous sodium sulfate, and concentrated to obtain the crude product, which was then subjected to column chromatography to obtain product 106 (16 mg, 40% yield). Mass spectrometry: 449 (M+H + ). 1H NMR(400MHz,DMSO):δ 8.72(s,1H),8.72(s,1H),7.63-7.50(m,2H),7.47(t,J=6.9Hz,1H),7.42-7.08(m,5H),6.07(d,J=2.9Hz,1H),5.76-5.14(m,1H),4. 51-3.87(m,4H),3.19-3.03(m,1H),3.03-2.75(m,1H),2.86-2.74(m,1H),2.69-2.56(m,4H),2.48-2.35(m,1H),2.25-1.94(m,1H).
[0087] TIFF0007579249000242.tif10170-((S)-3-Phenylmorpholinyl)ethyl)-2,3-dihydrospiro[indene- TIFF0007579249000243.tif43157Compound Int 1-15 (30 mg, 90 μmol), DMF (1 mL), DIEA (35 mg, 270 μmol), and HATU (41 mg, 108 μmol) were added to a 30 mL reaction flask, followed by SM 39 (22 mg, 135 μmol) and stirring at room temperature overnight. Water (5 mL) was added to the reaction solution, and the mixture was extracted with ethyl acetate (5 mL x 3). The organic layers were combined, dried over anhydrous sodium sulfate, and concentrated to obtain the crude product, which was then subjected to column chromatography to obtain product 107 (19 mg, 44% yield). Mass spectrometry: 479 (M+H + ). 1 H NMR(400MHz,DMSO)δ 8.72(s,1H),7.56(s,1H),7.44(d,J=7.2Hz,1H),7.40-7.15(m,6H),6.09(d,J=4.4H) z,1H),5.31(d,J=113.0Hz,1H),4.92-4.51(m,2H),4.43(d,J=12.2Hz,1H),4.24-3.9 0(m,1H),3.89-3.72(m,2H),3.56(dt,J=23.1,10.7Hz,1H),3.28(d,J=11.3Hz,1H),3 .13(dt,J=15.5,7.5Hz,1H),3.06-2.95(m,1H),2.65(t,J=11.3Hz,4H),2.52(s,1H).
[0088] TIFF0007579249000244.tif26170Synthesis of ethyl urea (108) TIFF0007579249000245.tif65154 Synthesis of intermediate (4S)-2-t-butyl-4-phenylazolidine (Int 108-1) TIFF0007579249000246.tif3691 Compound (S)-2-amino-2-phenylethanol (10 g, 73 mmol), SM 40 (45 g, 80 mmol), triethylamine (707 mg, 7.3 mmol), and toluene (100 mL) were added to a 250 mL reaction flask, and the reaction solution was refluxed for about 7 to 8 hours. After the reaction was completed, the solvent was removed by rotary evaporation under reduced pressure to obtain the crude product, which was then subjected to column chromatography to obtain Int 108-1 (2.3 g, 15% yield). Mass spectrometry: 206 (M+H + ). TIFF0007579249000247.tif68170Compound Int 1-15 (30 mg, 90 μmol), DMF (1 mL), DIEA (35 mg, 270 μmol), and HATU (41 mg, 108 μmol) were added to a 30 mL reaction flask, followed by Int 108-1 (28 mg, 135 μmol) and stirring at room temperature overnight. Water (5 mL) was added to the reaction solution, and the mixture was extracted with ethyl acetate (5 mL x 3). The organic layers were combined, dried over anhydrous sodium sulfate, and concentrated to obtain the crude product, which was then subjected to column chromatography to obtain product 108 (13 mg, 28% yield). Mass spectrometry: 521.2 (M+H + ). 1H NMR(400MHz,DMSO)δ 8.73(d,J=4.4Hz,1H),7.49(dt,J=14.7,10.3Hz,5H),7.34(t,J=6.8Hz,1H),7.30-7.18 (m,2H),6.10(dd,J=4.4,2.0Hz,1H),5.55(t,J=6.2Hz,1H),5.33(s,1H),4.72(t,J=15. 9Hz,1H),4.52(t,J=7.0Hz,1H),4.17-4.12(m,1H),4.08-3.93(m,1H),3.18-3.05(m,1H) ),2.99(dd,J=12.6,9.6Hz,1H),2.71-2.56(m,4H),2.44(s,1H),0.87(d,J=6.5Hz,9H).
[0089] TIFF0007579249000248.tif121701H-Pyrazol-3-yl)-7-(trifluoromethyl)-3,4-dihydroquinoline TIFF0007579249000249.tif88170 Synthesis of intermediate 6-bromo-7-(trifluoromethyl)-1,2,3,4-tetrahydroquinoline (Int 109-1) TIFF0007579249000250.tif2781 Compound SM 41 (200 mg, 1 mmol) and dichloromethane (3 mL) were added to a 30 mL reaction flask, followed by N-bromosuccinimide (178 mg, 1 mmol) and stirred at room temperature overnight. Water (5 mL) was added to the reaction solution, and the mixture was extracted with dichloromethane (5 mL x 3). The organic layers were combined, dried over anhydrous sodium sulfate, and concentrated to obtain the crude product. The crude product was purified by column chromatography to obtain product Int 109-1 (94 mg, 34% yield). Mass spectrometry: 280 (M+H + ). Synthesis of intermediate 6-(1-methyl-1H-pyrazol-3-yl)-7-(trifluoromethyl)-1,2,3,4-tetrahydroquinoline (Int 109-2) TIFF0007579249000251.tif40111Add compound Int 109-1 (94 mg, 0.34 mmol), 1-methyl-1H-pyrazole-5-boronic acid pinacol ester (84 mg, 0.4 mmol), sodium carbonate (139 mg, 1 mmol), DMF (3 mL), and water (0.1 mL). TIFF0007579249000252.tif13170 Radium dichloride (30 mg, 0.04 mmol) was added, and the reaction solution was stirred at 90°C overnight under nitrogen gas protection. After the reaction was completed, water (5 mL) was added to the reaction solution, and the mixture was extracted with ethyl acetate (5 mL x 3). The organic layers were combined, dried over anhydrous sodium sulfate, and concentrated to obtain the crude product, which was then subjected to column chromatography to obtain the product Int 109-2 (35 mg, 36% yield). Mass spectrometry: 282 (M+H + ). TIFF0007579249000253.tif13170(3-yl)-7-(trifluoromethyl)-3,4-dihydroquinoline-1-(2H) TIFF0007579249000254.tif52170 Compounds Int 1-15 (30 mg, 90 μmol), Int 109-2 (25 mg, 90 μmol), dichloromethane (1 mL), and water (1 mL) were added to a 30 mL reaction flask, and finally 2-ethoxy-1-ethoxycarbonyl-1,2-dihydroquinoline (34 mg, 135 μmol) was added and stirred at room temperature overnight. Water (5 mL) was added to the reaction solution, and it was extracted with dichloromethane (5 mL × 3). The organic layers were combined, dried over anhydrous sodium sulfate, and concentrated to obtain the crude product, which was then subjected to column chromatography to obtain product 109 (15 mg, 28% yield). Mass spectrometry: 597.2 (M+H +). 1H NMR (400MHz, DMSO) δ 8.75(s,1H),8.26(s,1H),7.89(s,1H),7.56(d,J=5.3Hz,2H),7.39(s,1H),7. 26(dt,J=8.5,5.1Hz,2H),6.14-6.05(m,1H),4.74(s,2H),3.89(s,5H),3.14( dt,J=15.6,7.6Hz,1H),3.01(ddd,J=16.3,8.6,3.3Hz,1H),2.85(t,J=6.3Hz, 2H),2.66(dd,J=18.8,6.3Hz,4H),2.54(s,1H),1.98(dd,J=12.4,6.5Hz,2H).
[0090] TIFF0007579249000255.tif22170-Oxazolidine-5-yl)-3-methylurea (110) Synthesis TIFF0007579249000256.tif26154 Intermediate (R)-2-Oxo-2-phenylethyl-2-(5-(3-methylurea)- TIFF0007579249000257.tif55170Compound Int 1-15 (20 mg, 60 μmol), 2-bromo-1-acetophenone (12 mg, 60 μmol), DMF (1 mL), and DIEA (9 mg, 72 μmol) were added to a 30 mL reaction flask. The mixture was stirred at room temperature overnight. After the reaction was completed, water (5 mL) was added to the reaction solution, and the mixture was extracted with ethyl acetate (5 mL x 3). The organic layers were combined, dried over anhydrous sodium sulfate, and concentrated to obtain the crude product Int 110-1 (27 mg, 100% yield). Mass spectrometry: 452.1 (M+H + ). TIFF0007579249000258.tif21170Synthesis of (5-methyl)-3-methylurea (110) TIFF0007579249000259.tif38153Compound Int 110-1 (27 mg, 60 μmol), ammonium acetate (14 mg, 180 μmol), acetic acid (2 mL), and DMF (0.5 mL) were added to a 30 mL reaction flask, and the mixture was heated to 80 °C and stirred for 5-6 hours. Water (5 mL) was added to the reaction solution, and the mixture was extracted with ethyl acetate (5 mL × 3). The organic layers were combined, dried over anhydrous sodium sulfate, and concentrated to obtain the crude product, which was then subjected to column chromatography to obtain product 110 (12 mg, 46% yield). Mass spectrometry: 432.2 (M+H + ). 1H NMR(400MHz,DMSO)δ 12.28(s,1H),8.75(d,J=9.2Hz,1H),7.78(d,J=7.2Hz,1H),7.66-7.58(m,2H),7.53(d,J=8.2Hz,1H),7.44-7.16(m,5H),6.13-6.0 5(m,1H),4.89-4.71(m,2H),3.14(dd,J=15.8,7.9Hz,1H),3.01(ddd,J=16.3,8.7,3.3Hz,1H),2.78-2.61(m,4H),2.59-2.52(m,1H)
[0091] TIFF0007579249000260.tif29170 Synthesis of urea (111) TIFF0007579249000261.tif73154 Synthesis of intermediate (4-(1-methyl-1H-imidazol-2-yl)-4-oxobutyl) t-butylcarbamate (Int 111-1) TIFF0007579249000262.tif3495SM 42 (2.08 g, 10 mmol) was added to a reaction flask with dry THF (20 mL), and a solution of isopropyl magnesium bromide in tetrahydrofuran (10 mL, 1 M in THF) was added to the flask under nitrogen gas protection and ice-water bath conditions. Then, the ice-water bath was removed and the mixture was stirred at room temperature for 7 hours. Finally, N-Boc-2-pyrrolidone (1.85 g, 10 mmol) was added and the mixture was reacted at room temperature for 12 hours. The reaction solution was poured into a saturated aqueous ammonium chloride solution, extracted with 30 mL of ethyl acetate (10 mL x 3), and the organic phases were combined, dried over anhydrous sodium sulfate, and purified by column chromatography to obtain Int 111-1 (1.34 g, 5 mmol) in a yield of 50%. Mass spectrometry: 268 (M+H + ). Synthesis of 2-(3,4-dihydro-2H-pyrrol-5-yl)-1-methyl-1H-imidazole (Int 111-2) TIFF0007579249000263.tif3165Int 111-1 (1.34 g, 5 mmol) was dissolved in 13 mL DCM, 1.3 mL of TFA was added, and the mixture was stirred at room temperature. TLC detection was performed. After the reaction was completed, the pH was adjusted to neutral with saturated aqueous sodium bicarbonate solution, extracted with DCM (10 mL x 3), dried over anhydrous sodium sulfate, and the solvent was removed by rotary evaporation to obtain Int 111-2 (0.67 g; 90%). Mass spectrometry: 150 (M+H + ). Synthesis of 1-methyl-2-(pyrrolidin-2-yl)-1H-imidazole (Int 111-3) TIFF0007579249000264.tif3159Int 111-2 (0.67 g; 4.5 mmol) was added to a reaction flask containing 6 mL of methanol, and sodium borohydride (0.68 g; 18 mmol) was added batchwise while stirring at room temperature. After the addition was completed, the mixture was further stirred at room temperature and TLC detection was performed. After the reaction was completed, the reaction solution was poured into water and extracted with 30 mL of EA (10 mL x 3). The organic phases were combined, dried over anhydrous sodium sulfate, and separated by column chromatography to obtain Int111-3 (0.61 g; 90%). Mass spectrometry: 152 (M+H +). Composition of TIFF0007579249000265.tif301701) TIFF0007579249000266.tif37152Int 1-15 (30 mg, 90 μmol) was dissolved in DMF (1 mL), DIEA (35 mg, 270 μmol) and HATU (41 mg, 108 μmol) were added, and then Int 111-3 (20.3 mg, 135 μmol) was added and stirred at room temperature for 16 hours. Water (10 mL) was added to the reaction solution, and the mixture was extracted twice with ethyl acetate. The organic phase was washed with saturated saline and concentrated to obtain the crude product, which was then subjected to column chromatography to obtain the nearly white solid product 111 (17 mg, 63% yield). Mass spectrometry: 467 (M+H + ).
[0092] TIFF0007579249000267.tif30170-Synthesis of methylurea (112) TIFF0007579249000268.tif71156 Synthesis of intermediate t-butyl-3-(benzo[d][1,3]dioxin-4-carbonyl)-2-oxopyrrolidine-1-carboxylate (Int 112-1) TIFF0007579249000269.tif4393t-Butyl-2-oxopyrrolidine-1-carboxylate (1.8 g, 10 mmol) and methyl benzo[d][1,3]dioxin-4-carboxylate (1.8 g, 10 mmol) were dissolved in tetrahydrofuran (50 mL), sodium hydride (0.8 g, 20 mmol) was added, and the mixture was heated to 50° C. and reacted for 4 hours. The reaction solution was poured into cold water, the pH was adjusted to 5-6 with 2N hydrochloric acid, extracted with ethyl acetate, dried and concentrated with anhydrous sodium sulfate, and the crude product was used as it was in the next step of the reaction. Synthesis of intermediate 5-(benzo[d][1,3]dioxol-4-yl)-3,4-dihydro-2H-pyrrole (Int 112-2) TIFF0007579249000270.tif3974 The crude product obtained in the previous step was dissolved in dioxane (10 mL), concentrated hydrochloric acid (30 mL) was added, heated to 100 °C, and stirred overnight. The pH was adjusted to 7-8 with sodium bicarbonate, extracted with ethyl acetate, dried over anhydrous sodium sulfate, and concentrated. The crude product obtained in the previous step was dissolved in dichloromethane (20 mL), trifluoroacetic acid (2 mL) was added, stirred at room temperature overnight, concentrated, water was added, the pH was adjusted to 7-8, extracted with ethyl acetate, dried over anhydrous sodium sulfate, concentrated, and subjected to column chromatography to obtain a colorless liquid Int 112-2 (0.7 g), the two-stage yield was 37%. Mass spectrometry: 190 (M+H + ). Synthesis of intermediate 2-(benzo[d][1,3]dioxol-4-yl)pyrrolidine (Int 112-3) TIFF0007579249000271.tif3962 Intermediate Int 112-2 (0.7 g, 3.7 mmol) was dissolved in methanol (10 mL), and NaBH4 (0.38 g, 10 mmol) was added in an ice bath. The mixture was stirred for 4 hours, and then diatomaceous earth and water (10 mL) were added. The mixture was filtered and extracted with ethyl acetate. The mixture was dried over anhydrous sodium sulfate, concentrated, and subjected to column chromatography to obtain a pale yellow liquid Int 112-3 (650 mg) in a yield of 93%. Mass spectrometry: 192 (M+H + ). Composition of TIFF0007579249000272.tif3017012) TIFF0007579249000273.tif37154Int 1-15 (30 mg, 90 μmol) was dissolved in DMF (1 mL), DIEA (35 mg, 270 μmol) and HATU (41 mg, 108 μmol) were added, and then Int 112-3 (25.8 mg, 135 μmol) was added and stirred at room temperature for 16 hours. Water (10 mL) was added to the reaction solution, and the mixture was extracted twice with ethyl acetate. The organic phase was washed with saturated saline and concentrated to obtain the crude product, which was then subjected to column chromatography to obtain the nearly white solid product 112 (17 mg, 61% yield). Mass spectrometry: 507 (M+H + ).
[0093] TIFF0007579249000274.tif31170Synthesis of 114 TIFF0007579249000275.tif104155 Synthesis of intermediate 2-bromo-1-((2S,5S)-2-(4-fluorophenyl)-5-(methyl)pyrrolidin-1-yl)-1-one (Int 114-1) TIFF0007579249000276.tif3696 Intermediate Int 14-3 (900 mg, 5 mmol) was dissolved in dichloromethane (10 mL), and bromoacetyl bromide (200 mg, 10 mmol) was added dropwise under ice bath, stirred for 1 hour, extracted with dichloromethane, and subjected to column chromatography to obtain white solid Int 114-1 (1.35 g) in 90% yield. Mass spectrometry: 300, 302 (M+H + ). TIFF0007579249000277.tif13170)-5-(methyl)pyrrolidin-1-yl)-2-oxoethyl)-2,3-dihydrosulfonyl Composite of TIFF0007579249000278.tif13170 TIFF0007579249000279.tif38129 Intermediate Int 1-4 (500 mg, 1.8 mmol), intermediate Int 114-1 (550 mg, 1.8 mmol) and potassium carbonate (500 mg, 3.6 mmol) were dissolved in N,N-dimethylformamide (10 mL), stirred at room temperature for 4 hours, water (50 mL) was added, filtered and dried to obtain a white solid Int 114-2 (800 mg) in 89% yield. Mass spectrometry: 501, 503 (M+H + ). TIFF0007579249000280.tif121702-(4-Fluorophenyl)-5-(methyl)pyrrolidin-1-yl)-2-oxoethane TIFF0007579249000281.tif13170on (Int 114-3) composite TIFF0007579249000282.tif47155 Intermediate Int 114-2 (800 mg, 1.6 mmol), benzophenone imine (350 mg, 1.9 mmol), palladium acetate (13 mg, 0.06 mmol), (±)-2, TIFF0007579249000283.tif13170l) and cesium carbonate (780 mg, 2.4 mmol) were dissolved in toluene (5 mL), purged with nitrogen gas, heated to 100° C., and stirred for 4 hours. Concentration and column chromatography were performed to obtain a gray solid Int 114-3 (770 mg) in 80% yield. Mass spectrometry: 602 (M+H + ). TIFF0007579249000284.tif12170)-5-Methylpyrrolidin-1-yl)-2-oxoethyl)-2,3-dihydrospiro TIFF0007579249000285.tif13170 synthesis TIFF0007579249000286.tif39145 Intermediate Int 114-3 (770 mg, 1.3 mmol) was dissolved in tetrahydrofuran (10 mL), and hydrochloric acid (10 mL, 2N) was added at room temperature and stirred for 30 min. Extracted three times with ethyl acetate, the organic phases were combined, dried over anhydrous sodium sulfate, concentrated, and subjected to column chromatography to obtain a yellow solid Int 114-4 (400 mg) in 70% yield. Mass spectrometry: 394 (M-43). Composition of TIFF0007579249000287.tif301704) TIFF0007579249000288.tif43146 Intermediate Int 114-4 (30 mg, 0.2 mmol) and triethylamine (60 mg, 0.6 mmol) were dissolved in dichloromethane (5 mL), and acetyl chloride (24 mg, 0.3 mmol) was slowly added dropwise to the reaction flask under ice bath. After the addition, the mixture was stirred for 1 hour. Water (10 mL) was added, and the organic layer was separated and extracted with dichloromethane. The organic phases were combined, dried over anhydrous sodium sulfate, concentrated, and subjected to column chromatography to obtain yellow solid 114 (20 mg) in 58% yield. Mass spectrometry: 480.2 (M+H + ).
[0094] TIFF0007579249000289.tif26170Synthesis of methyl phosphate (115) TIFF0007579249000290.tif42152 Intermediate Int 114-4 (30 mg, 0.2 mmol) and triethylamine (60 mg, 0.6 mmol) were dissolved in dichloromethane (5 mL), and methoxyformyl chloride (34 mg, 0.3 mmol) was slowly added dropwise to the reaction flask under ice bath. After the addition, the mixture was stirred for 1 hour. Water (10 mL) was added, and the organic layer was separated and extracted with dichloromethane. The organic phases were combined, dried over anhydrous sodium sulfate, concentrated, and subjected to column chromatography to obtain yellow solid 115 (23 mg) in 60% yield. Mass spectrometry: 496.2 (M+H + ).
[0095] TIFF0007579249000291.tif9168TIFF0007579249000292.tif17170-3-Synthesis of Methylurea (201) TIFF0007579249000293.tif83154 Synthesis of intermediate (S)-(5-(3,4-difluorophenyl)-5-oxopentan-2-yl) t-butylcarbamate (Int 201-1) TIFF0007579249000294.tif4297 Dry THF (30 mL) was added to the reaction flask, then SM 44 (2.4 g, 10 mmol) was added, and isopropyl magnesium bromide (10 mL, 1M in THF) was added under nitrogen gas protection under ice-water bath conditions, and then reacted at room temperature for 7 hours, and finally (S)-2-methyl-5-oxopyrrolidine-1-carboxylate-t-butyl (2 g, 10 mmol) was added, and then reacted at room temperature for 12 hours. The reaction solution was poured into a saturated aqueous ammonium chloride solution, extracted with 30 mL of ethyl acetate (10 mL x 3), and the organic phases were combined, dried over anhydrous sodium sulfate, and purified by column chromatography to obtain Int 201-1 (1.72 g, 5.5 mmol) in 55% yield. Mass spectrometry: 314 (M+H + ). Synthesis of intermediate (S)-5-(3,4-difluorophenyl)-2-methyl-3,4-dihydro-2H-pyrrole (Int 201-2) TIFF0007579249000295.tif4678 DCM (20 mL) was added to a reaction flask, followed by Int 201-1 (1.56 g, 5 mmol), followed by TFA (2 mL), and then reacted at room temperature for 7 hours. The reaction was poured into saturated aqueous sodium bicarbonate solution, extracted with 30 mL of DCM (10 mL x 3), the organic phases were combined, dried over anhydrous sodium sulfate, and purified by column chromatography to give Int 201-2 (780 mg, 4 mmol) in 80% yield. Mass spectrometry: 196 (M+H + ). 1 H NMR(400MHz,CDCl3):δ 7.71(ddd,J=11.3,7.8,2.1Hz,1H),7.63-7.50(m,1H),7.18(dt,J=10.0,8.3Hz,1H),4.39-4.14 (m,1H),3.01(m,1H),2.93-2.71(m,1H),2.28(m,1H),1.68-1.51(m,1H),1.36(d,J=6.8Hz,3H). Synthesis of Int 201-3(Int 201-3) TIFF0007579249000296.tif4865Add DCM (15mL) to the reaction flask, then add Int 201-2 (780mg, 4mmol), and then add DIBAL-H (16mL, 1M in hexane) under ice-water bath conditions, and then react at room temperature for 1 hour. After quenching by adding a small amount of water, the mixture was filtered, washed with DCM (15mL x 3) and concentrated to obtain Int 201-3 (752mg, 3.8mmol) in 95% yield. Mass spectrometry: 198 (M+H + ). 1 H NMR(400MHz,CDCl3):δ 7.25-7.16(m,1H),7.09-7.04(m,2H),4.22-3.95(m,1H),3.38-3.27(m,1H),2.20-2. 10(m,1H),1.96(m,1H),1.73-1.58(m,1H),1.51-1.38(m,1H),1.24(d,J=6.2Hz,3H). TIFF0007579249000297.tif18170TIFF0007579249000298.tif9170Synthesis of element (201) TIFF0007579249000299.tif4215425mL reaction flask was added with DMF (3mL), then Int 1-15 (333mg, 1mmol), Int 201-3 (197mg, 1mmol), DIEA (387mg, 3mmol), and finally HATU (381mg, 1mmol) were added, and the system was reacted at 20°C for 1 hour. After the reaction was completed, the reaction solution was poured into water (20mL), extracted with ethyl acetate 30mL (10mL x 3), the organic phase was combined, dried over anhydrous sodium sulfate, and purified by column chromatography to obtain compound 201 (282mg) in 55% yield. Mass spectrometry: 513 (M+H + ). 1 H NMR(400MHz,DMSO):δ 8.71(s,1H),7.54(d,J=5.7Hz,2H),7.44-7.33(m,1H),7.29-7.15(m,3H),6.08(s,1H),5.29-4.91(m,1H),4.41(m,2H),3.52(m,1H),3 .18-2.93(m,2H),2.63(t,J=3.8Hz,3H),2.60-2.53(m,1H),2.45-2.31(m,2H),1.99(s,2H),1.85-1.62(m,1H),1.36(d,J=6.4Hz,3H).
[0096] TIFF0007579249000300.tif25170 Synthesis of (3-methyl)-2-phenylurea (205) TIFF0007579249000301.tif76154 Synthesis of intermediate (S)-(5-oxo-5-(3,4,5-trifluorophenyl)pent-2-yl) t-butylcarbamate (Int 205-1) TIFF0007579249000302.tif4299 Add dry THF (30 mL) to the reaction flask, then add SM 45 (2.57 g, 10 mmol), add isopropylmagnesium bromide (10 mL, 1M in THF) under nitrogen gas protection in ice-water bath condition, then react at room temperature for 7 hours, finally add (S)-2-methyl-5-oxopyrrolidine-1-carboxylate-t-butyl (2 g, 10 mmol), then react at room temperature for 12 hours. The reaction liquid was poured into saturated ammonium chloride aqueous solution, extracted with ethyl acetate 30 mL (10 mL x 3), the organic phase was combined, dried over anhydrous sodium sulfate, and purified by column chromatography to obtain Int 205-1 (2 g, 6 mmol) in 60% yield. Mass spectrometry: 332 (M+H + ). Synthesis of intermediate (S)-2-methyl-5-(3,4,5-trifluorophenyl)-3,4-dihydro-2H-pyrrole (Int 205-2) TIFF0007579249000303.tif4777 DCM (20 mL) was added to a reaction flask, followed by Int 205-1 (1.66 g, 5 mmol), followed by TFA (2 mL), and then reacted at room temperature for 7 hours. The reaction was poured into saturated aqueous sodium bicarbonate solution, extracted with 30 mL of DCM (10 mL x 3), the organic phases were combined, dried over anhydrous sodium sulfate, and purified by column chromatography to give Int 205-2 (852 mg, 4 mmol) in 80% yield. Mass spectrometry: 214 (M+H + ). Synthesis of intermediate (2S,5S)-2-methyl-5-(3,4,5-trifluorophenyl)-3,4-dihydro-2H-pyrrole (Int 205-3) TIFF0007579249000304.tif4668 DCM (15 mL) was added to the reaction flask, followed by Int 205-2 (852 g, 4 mmol), followed by DIBAL-H (16 mL, 1 M in hexane) in an ice-water bath, followed by reaction at room temperature for 1 hour. After quenching with a small amount of water, the mixture was filtered, washed three times with DCM (15 mL x 3), and concentrated to give Int 205-3 (774 mg, 3.6 mmol) in 90% yield. Mass spectrometry: 216 (M+H + ). 1 H NMR(400MHz,CDCl3):δ 7.09-6.99(m,2H),4.12(t,J=7.7Hz,1H),3.34(m,1H),2.33(m,1H),2.16(m,1 H),1.94(m,1H),1.69-1.54(m,1H),1.52-1.34(m,1H),1.23(d,J=6.2Hz,3H). TIFF0007579249000305.tif25170Synthesis of ethyl urea (205) TIFF0007579249000306.tif4215225mL reaction flask was added with DMF (3mL), then Int 1-15 (333mg, 1mmol), Int 205-3 (215mg, 1mmol), DIEA (387mg, 3mmol), and finally HATU (381mg, 1mmol) were added, and the system was reacted at 20℃ for 2 hours. After the reaction was completed, the reaction solution was poured into water (20mL), extracted with ethyl acetate 30mL (10mL×3), the organic phase was combined, dried over anhydrous sodium sulfate, and purified by column chromatography to obtain compound 205 (265mg) in 50% yield. Mass spectrometry: 531 (M+H + ). 1H NMR(400MHz,DMSO):δ 8.72(s,1H),7.54(d,J=4.3Hz,1H),7.33-7.21(m,2H),7.17(s,1H),7.10(dd,J=8.9,6.8Hz ,1H),6.16-6.00(m,1H),5.08(m,1H),4.77-4.34(m,2H),3.60(dd,J=7.5,5.4Hz,1H),3.11 (dd,J=16.0,7.7Hz,1H),2.98(dd,J=10.9,5.6Hz,1H),2.70-2.57(m,4H),2.43-2.31(m,1H ),2.16-1.79(m,2H),1.79-1.71(m,1H),1.48(d,J=6.3Hz,1H),1.35(dd,J=6.3,2.4Hz,3H).
[0097] TIFF0007579249000307.tif8169Difluorocyclohexyl)-5-methylpyrrolidin-1-yl)-2-oxoethyl) TIFF0007579249000308.tif8170-5-yl)-3-methylurea (209) Synthesis TIFF0007579249000309.tif214156 Synthesis of intermediate 1,1-di-t-butyl 2-ethylethane-1,1,2-tricarboxylate (Int 209-1) TIFF0007579249000310.tif43140SM 46 (21.6 g; 0.1 mol) was dissolved in THF (220 mL), NaH (6.67 g; 60%; 0.1 mol) was added, and the mixture was stirred at room temperature for 30 min. Then, SM 47 (16.7 g; 0.1 mol) was added to the reaction flask, and the mixture was stirred at room temperature and monitored by TLC. After the reaction was completed, the reaction solution was poured into ice water (220 mL), extracted twice with ethyl acetate, and the organic phase was washed with saturated saline and concentrated to obtain the crude product, which was subjected to column chromatography to obtain the nearly oily product Int 209-1 (25.6 g; 85%). Mass spectrometry: 303 (M+H + ). Synthesis of intermediate 4,4-difluorocyclohexanecarbonyl chloride (Int 209-2) TIFF0007579249000311.tif3997SM 48 (16.4 g, 0.1 mol) was dissolved in DCM (17 mL), 1 drop of DMF was added, and oxalyl chloride (14 g, 0.11 mol) was added dropwise. After the addition was completed, the mixture was stirred at room temperature for 4 hours. The crude product Int 209-2 (18.2 g, 100%) was obtained by concentration. It was used directly in the next step. Synthesis of intermediate 2,2-di-t-butyl-1-ethyl-3-(4,4-difluorocyclohexyl)-3-oxopropane-1,2,2-tricarboxylate (Int 209-3) TIFF0007579249000312.tif56127Int 209-1 (25.6 g; 85 mmol) was dissolved in THF (250 mL), NaH (5.6 g; 60%; 85 mmol) was added, and the mixture was stirred at room temperature for 30 minutes. A THF solution (182 mL) of Int 209-2 (18.2 g, 100 mmol) was added dropwise, and the mixture was reacted at room temperature for 4 hours. The reaction solution was poured into ice water (250 mL), extracted twice with ethyl acetate, and the organic phases were combined, washed with saturated saline, and dried over anhydrous sodium sulfate. The crude product was concentrated, and column chromatography was performed to obtain the oily product Int 209-3 (34.3 g, 90%). Mass spectrometry: 449 (M+H + ). Synthesis of intermediate ethyl 4-(4,4-difluorocyclohexyl)-4-oxobutyrate (Int 209-4) TIFF0007579249000313.tif54121 Int 209-3 (34.3 g, 76 mmol) was added to toluene (340 mL), p-toluenesulfonic acid (1.3 g; 7.6 mmol) was added, refluxed and monitored by TLC. After completion of the reaction, the solvent was removed by vacuum distillation and separated by column chromatography to give oily Int 209-4 (15.4 g, 82%). Mass spectrometry: 249 (M+H + ). Synthesis of intermediate 4-(4,4-difluorocyclohexyl)-4-oxobutyric acid (Int 209-5) TIFF0007579249000314.tif35129Int 209-4 (15.4 g, 62 mmol) was added to a mixed solvent of water / methanol (1 / 10, 15 mL), lithium hydroxide monohydrate (13.0 g; 310 mmol) was added, stirred at room temperature, and monitored by TLC. After completion of the reaction, most of the solvent was removed by vacuum distillation, the pH was adjusted to 2-3 with HCl (2N) solution, extracted with DCM (100 mL x 3), the organic phase was combined, washed with saturated saline, dried over anhydrous sodium sulfate, and the solvent was removed by vacuum distillation to obtain the product Int. 209-5 (12.5 g, 92%). Mass spectrometry: 221 (M+H + ). Synthesis of intermediate (3R,7aR)-7a-(4,4-difluorocyclohexyl)-3-phenyltetrahydropyrrolo[2,1-b]oxazol-5(6H)-one (Int 209-6) TIFF0007579249000315.tif44128Int 209-5 (12.5 g, 57 mmol) and D-phenylglycinol (7.8 g, 57 mmol) were added to toluene (130 mL), refluxed, separated, and monitored by TLC. After completion of the reaction, the product Int 209-6 (14.4 g, 79%) was obtained by separation by column chromatography. Mass spectrometry: 322 (M+H + ). Synthesis of intermediate (S)-5-(4,4-difluorocyclohexyl)-1-((R)-2-hydroxy-1-phenylethyl)pyrrolidin-2-one (Int 209-7) TIFF0007579249000316.tif39131Int 209-6 (14.4 g, 45 mmol) and Et3SiH (17.21 g, 148.5 mmol) were added to DCM (150 mL), cooled to -70 °C under nitrogen gas protection, and TiCl4 THF solution (99 ml, 1 M, 99 mmol) was added dropwise, and the reaction temperature was controlled to be lower than -65 °C. After the dropwise addition was completed, the mixture was allowed to naturally rise to room temperature and stirred, and monitored by TLC. After the reaction was completed, it was washed with saturated NaHCO3 solution, washed with saturated saline, dried over anhydrous sodium sulfate, and distilled under reduced pressure to obtain the product Int 209-7 (13.8 g, 95%). Mass spectrometry: 324 (M+H + ). Synthesis of intermediate (S)-1-((R)-2-chloro-1-phenylethyl)-5-(4,4-difluorocyclohexyl)pyrrolidin-2-one (Int 209-8) TIFF0007579249000317.tif38116Int 209-7 (13.8 g, 43 mmol) was added to THF (140 mL) and thionyl chloride (10.2 g, 86 mmol) was added dropwise, stirred at room temperature and monitored by TLC. After completion of the reaction, it was washed with saturated NaHCO3 solution, washed with saturated saline, dried over anhydrous sodium sulfate and distilled under reduced pressure to obtain the product Int 209-8 (13.9 g, 95%). Mass spectrometry: 342 (M+H + ). Synthesis of intermediate (S)-5-(4,4-difluorocyclohexyl)-1-(1-phenylvinyl)pyrrolidin-2-one (Int 209-9) TIFF0007579249000318.tif39116Int 209-8 (13.9 g, 40 mmol) was dissolved in t-BuOH (70 mL), sodium t-butoxide (7.68 g, 80 mmol) was added, stirred at 45 °C and monitored by TLC. After completion of the reaction, a part of the solvent was removed by rotary evaporation, water (70 mL) was added, extracted with DCM (50 mL x 3), washed with saturated brine, dried over anhydrous sodium sulfate, and distilled under reduced pressure to give Int 209-9 (11.6 g, 95%). Mass spectrometry: 306 (M+H + ). Synthesis of intermediate (S)-5-(4,4-difluorocyclohexyl)pyrrolidin-2-one (Int 209-10) TIFF0007579249000319.tif39115Int 209-9 (11.6 g, 38 mmol) was dissolved in THF (120 mL), HCl (1N; 12 mL) was added, heated to reflux and monitored by TLC. After completion of the reaction, the pH was adjusted to 7-8 with saturated NaHCO3 solution, extracted with DCM (50 mL x 3), the organic phases were combined, washed with saturated brine, dried over anhydrous sodium sulfate and subjected to column chromatography to obtain the product Int 209-10 (7.37 g, 95%). Mass spectrometry: 204 (M+H + ). Synthesis of intermediate (S)-2-(4,4-difluorocyclohexyl)-5-oxopyrrolidine-1-carboxylate-t-butyl (Int 209-11) TIFF0007579249000320.tif44107Int 209-10 (7.37 g, 36 mmol) was dissolved in DCM (70 mL), DMAP (0.44 g, 3.6 mmol) and (Boc)2O (7.84 g, 36 mmol) were added, stirred at room temperature, and monitored by TLC. After the reaction was completed, the product Int 209-11 (10.36 g, 95%) was obtained by washing with HCl (0.5 N; 70 mL x 2), washing with saturated saline, drying over anhydrous sodium sulfate, and distillation under reduced pressure. Mass spectrometry: 304 (M+H + ). Synthesis of intermediate (S)-t-butyl-(1-(4,4-difluorocyclohexyl)-4-oxopentyl)carbamate (Int 209-12) TIFF0007579249000321.tif46101 Int 209-11 (303 mg, 1 mmol) was dissolved in tetrahydrofuran (3 mL) and cooled to 0 °C in an ice-water bath, then a solution of methylmagnesium bromide in tetrahydrofuran (1 M in THF; 1 mL) was added dropwise, and the mixture was allowed to naturally warm to room temperature and stirred, and monitored by TLC. After the reaction was completed, the reaction solution was poured into a saturated aqueous ammonium chloride solution (6 mL), extracted with ethyl acetate (5 mL × 3), and the organic phases were combined, washed with saturated saline, dried over anhydrous sodium sulfate, and distilled under reduced pressure to obtain the product Int 209-12 (223 mg, 70%). Mass spectrometry: 320 (M + H + ). Synthesis of intermediate (S)-2-(4,4-difluorocyclohexyl)-5-methyl-3,4-dihydro-2H-pyrrole (Int 209-13) TIFF0007579249000322.tif4772 Int 209-12 (223 mg, 0.7 mmol) was dissolved in dichloromethane (2 mL), trifluoroacetic acid (0.5 mL) was added, stirred at room temperature, and monitored by TLC. After completion of the reaction, the solvent was directly removed by vacuum distillation to give Int 209-13 (131 mg, 93%). Mass spectrometry: 202 (M+H +). Synthesis of intermediate (2S,5S)-2-(4,4-difluorocyclohexyl)-5-methylpyrrolidine (Int 209-14) TIFF0007579249000323.tif4672Int 209-13 (131 mg, 0.65 mmol) was dissolved in dichloromethane (1.5 mL), cooled to 0°C in an ice-water bath, and a solution of diisobutylaluminum hydride in n-hexane (1 M in hexane; 2.28 mL) was added dropwise. The mixture was allowed to warm to room temperature and stirred, and monitored by TLC. After the reaction was completed, dichloromethane (3 mL) was added, cooled to 0°C in an ice-water bath, water (0.09 mL), 15% aqueous sodium hydroxide solution (0.09 mL), water (0.23 mL), and anhydrous calcium sulfate were added in sequence, stirred for 10 minutes, filtered, and rinsed with dichloromethane. The mixture was dried over anhydrous sodium sulfate and distilled under reduced pressure to obtain the product Int 209-14 (112 mg, 85%). Mass spectrometry: 204 (M+H + ). TIFF0007579249000324.tif271703-Synthesis of methylurea (209) TIFF0007579249000325.tif40160 Compound Int 1-15 (30 mg, 0.06 mmol), DMF (1 mL), Int 209-14 (12 mg, 0.06 mmol), and HATU (34 mg, 0.09 mmol) were added to a 30 mL reaction flask, and the system was reacted at room temperature for 3 hours. After the reaction was completed, the reaction solution was poured into water (30 mL), extracted with 15 mL of ethyl acetate (5 mL x 3), and the organic phase was combined, dried over anhydrous sodium sulfate, and purified by column chromatography to obtain compound 209 (17 mg) in a yield of 57%. Mass spectrometry: 519 (M+H + ).
[0098] TIFF0007579249000326.tif9170Fluorocyclohexyl)-5-ethyl-pyrrolidin-1-yl)-2-oxoethyl)- TIFF0007579249000327.tif91705-Il)-3-methylurea (212) Synthesis TIFF0007579249000328.tif82165 Synthesis of intermediate (S)-(1-(4,4-difluorocyclohexyl)-4-oxohexyl) t-butylcarbamate (Int 212-1) TIFF0007579249000329.tif46108Int 209-11 (303 mg, 1 mmol) was dissolved in tetrahydrofuran (3 mL), cooled to 0 °C in an ice-water bath, and a solution of methylmagnesium bromide in tetrahydrofuran (1 M in THF; 1 mL) was added dropwise, allowed to warm to room temperature, stirred, and monitored by TLC. After completion of the reaction, the reaction solution was poured into a saturated aqueous ammonium chloride solution (6 mL), extracted with ethyl acetate (5 mL × 3), and the organic phases were combined, washed with saturated saline, dried over anhydrous sodium sulfate, and distilled under reduced pressure to obtain the product Int 212-1 (243 mg, 73%). Mass spectrometry: 334 (M + H + ). Synthesis of intermediate (S)-2-(4,4-difluorocyclohexyl)-5-ethyl-3,4-dihydro-2H-pyrrole (Int 212-2) TIFF0007579249000330.tif4774 Int 212-1 (243 mg, 0.7 mmol) was dissolved in dichloromethane (2 mL), trifluoroacetic acid (0.2 mL) was added, and the mixture was stirred at room temperature and monitored by TLC. After the reaction was completed, the solvent was removed directly by vacuum distillation to give Int 212-2 (138 mg, 88%). Mass spectrometry: 216 (M+H + ). Synthesis of intermediate (2S,5S)-2-(4,4-difluorocyclohexyl)-5-ethylpyrrolidine (Int 212-3) TIFF0007579249000331.tif4877Int 212-2 (138 mg, 0.64 mmol) was dissolved in dichloromethane (1.5 mL), cooled to 0°C in an ice-water bath, and a solution of diisobutylaluminum hydride in n-hexane (1 M in hexane; 2.28 mL) was added dropwise. The mixture was allowed to warm to room temperature and stirred, and monitored by TLC. After the reaction was completed, dichloromethane (3 mL) was added, cooled to 0°C in an ice-water bath, water (0.09 mL), 15% aqueous sodium hydroxide solution (0.09 mL), water (0.23 mL), and anhydrous calcium sulfate were added in sequence, stirred for 10 minutes, filtered, and rinsed with dichloromethane. The mixture was dried over anhydrous sodium sulfate and distilled under reduced pressure to obtain the product Int 212-3 (111 mg, 80%). Mass spectrometry: 218 (M+H + ). TIFF0007579249000332.tif26170-Synthesis of methylurea (212) TIFF0007579249000333.tif44159Compound Int 1-15 (30 mg, 0.06 mmol), DMF (1 mL), Int 212-3 (13 mg, 0.06 mmol), and HATU (34 mg, 0.09 mmol) were added to a 30 mL reaction flask, and the system was reacted at room temperature for 3 hours. After the reaction was completed, the reaction solution was poured into water (30 mL), extracted with 15 mL of ethyl acetate (5 mL x 3), and the organic phase was combined, dried over anhydrous sodium sulfate, and purified by column chromatography to obtain compound 212 (25 mg) in 78% yield. Mass spectrometry: 533 (M+H + ).
[0099] TIFF0007579249000334.tif91704-Fluorophenyl)-5-methylpyrrolidin-1-yl)-2-oxoethyl)-2 TIFF0007579249000335.tif10170 Synthesis of (3-methyl-2-yl)urea (213) TIFF0007579249000336.tif81157 Synthesis of intermediate (S)-(5-(3-chloro-4-fluorophenyl)-5-oxopentan-2-yl) t-butylcarbamate (Int 213-1) TIFF0007579249000337.tif4396Add dry THF (25mL) to a 100mL reaction flask, then add 1-fluoro-2-chloro-4-iodobenzene (5g, 19.5mmol), cool to 0°C in an ice-water bath, slowly add isopropylmagnesium chloride (10mL, 2.0M in THF), and after the addition is complete, remove the ice-water bath, return to room temperature, and stir for 3 hours. The raw material (S)-2-methyl-5-oxopyrrolidine-1-carboxylate-t-butyl (4.9g, 24.8mmol) was dissolved in THF (10mL), quickly added to the above reaction solution, and reacted at room temperature for 3 hours. After the reaction was completed, the reaction was quenched by adding saturated aqueous ammonium chloride solution (30 mL), extracted with ethyl acetate (30 mL x 3), and the organic phases were combined, dried over anhydrous sodium sulfate, and concentrated to obtain the crude product Int 213-1 (8 g). Mass spectrometry: 330 (M+H) + . Synthesis of intermediate (S)-5-(3-chloro-4-fluorophenyl)-2-methyl-3,4-dihydro-2H-pyrrolidine (Int 213-2) TIFF0007579249000338.tif4983 The crude product Int 213-1 was dissolved in DCM (50 mL), TFA (5 mL) was added, and the mixture was reacted at room temperature for 16 hours with stirring. After the reaction was completed, the mixture was concentrated, water (50 mL) was added, and the pH was adjusted to 7-8 with sodium bicarbonate. The mixture was extracted with ethyl acetate (30 mL x 3). The organic phases were combined, dried over anhydrous sodium sulfate, concentrated, and then purified by column chromatography to obtain compound Int 213-2 (2.4 g). The two-stage yield was 60%. Mass spectrometry: 212 (M+H) + . Synthesis of intermediate (2S,5S)-2-(3-chloro-4-fluorophenyl)-5-methylpyrrolidine (Int 213-3) TIFF0007579249000339.tif4877Int 213-2 (2 g, 9.4 mmol) was dissolved in DCM (50 mL), DIBAL-H (22 mmol, 1 M in hexane) was added in an ice-water bath, and the mixture was reacted at room temperature for 2 hours while stirring. After the reaction was completed, the mixture was concentrated, water (50 mL) was added, and the mixture was extracted with DCM (30 mL x 3). The organic phases were combined, dried over anhydrous sodium sulfate, concentrated, and then purified by column chromatography to obtain compound Int 213-3 (650 mg) in a yield of 33%. Mass spectrometry: 180 (M+H) + . 1 H NMR(400MHz,CDCl3)δ 7.45(dd,J=7.2,2.1Hz,1H),7.23(dddd,J=8.4,4.6,2.2,0.4Hz,1H),7.06(t,J=8.7Hz,1H),4.11(t,J=7.9Hz,1H),3.31(dd,J=14.1,7.0Hz,1H), 2.18-2.09(m,1H),1.95(dddd,J=12.6,8.7,7.1,5.8Hz,1H),1.69-1.59(m,1H),1.44(dddd,J=12.4,10.2,8.1,6.2Hz,1H),1.24(t,J=6.1Hz,3H). TIFF0007579249000340.tif26170Synthesis of methylurea (213) TIFF0007579249000341.tif4515925mL reaction flask was added with DMF (3mL), then Int 1-15 (333mg, 1mmol), Int 213-3 (213mg, 1mmol), DIEA (387mg, 3mmol), and finally HATU (381mg, 1mmol) were added, and the system was reacted at 20°C for 1 hour. After the reaction was completed, the reaction solution was poured into water (20mL), extracted with ethyl acetate 30mL (10mL x 3), the organic phase was combined, dried over anhydrous sodium sulfate, and purified by column chromatography to obtain compound 213 (280mg) in 60% yield. Mass spectrometry: 529 (M+H + ).
[0100] TIFF0007579249000342.tif27170-3-Synthesis of methylurea (217) TIFF0007579249000343.tif43157 Intermediate Int 1-15 (33 mg, 0.1 mmol) was dissolved in DMF (1 mL), DIEA (39 mg, 0.3 mmol) and HATU (38 mg, 0.1 mmol) were added, and then Int 217 (20 mg, 0.1 mmol) was added and stirred at room temperature for 16 hours. Water (10 mL) was added to the reaction solution, and the mixture was extracted twice with ethyl acetate. The organic phase was washed with saturated saline and concentrated to obtain the crude product, which was subjected to column chromatography to obtain the nearly white solid product 217 (17 mg) in 55% yield. Mass spectrometry: 513 (M+H + ). 1 H NMR(400MHz,CDCl3)δ 7.59-7.40(m,1H),7.33(m,1H),7.22-6.68(m,4H),5.29-5.00(m,2H),4.43-4.26(m,1H),4.21- 3.81(m,1H),3.19-2.92(m,2H),2.81-2.60(m,4H),2.50(m,2H),2.29-1.75(m,3H),1.40(m,3H).
[0101] Example 221 Compound (R)-5-(1,4-dimethyl-1H-1,2,3-triazole TIFF0007579249000344.tif10170)-2-oxoethyl-2,3-dihydrospiro[indene-1,pyrrolidin-1-yl] TIFF0007579249000345.tif53157Int 114-2 (50 mg, 0.1 mmol), 1,4-dimethyl-1H-1,2,3-triazole (11 mg, 0.11 mmol), palladium acetate (6 mg, 0.02 mmol), x-phos (8 mg, 0.025 mmol) and potassium acetate (25 mg, 0.2 mmol) were dissolved in t-amyl alcohol (5 mL), purged with nitrogen gas, heated to 120°C, stirred for 4 hours, concentrated, added with water (5 mL), extracted with ethyl acetate, dried over anhydrous sodium sulfate, concentrated, and subjected to column chromatography to obtain pale yellow solid 221 (33 mg) in 64% yield. Mass spectrometry: 518 (M+H + ). 1H NMR(400MHz,DMSO):δ 7.70-7.48(m,3H),7.45-7.10(m,4H),5.11(dt,J=16.3,7.6Hz,1H),4.60(dd,J =148.1,16.6Hz,2H),4.24(dd,J=11.9,6.2Hz,1H),3.93(d,J=7.7Hz,3H),3.22 (m,1H),3.13(m,1H),2.72-2.60(m,1H),2.40(m,1H),2.22(d,J=6.8Hz,3H),2. 10-1.96(m,1H),1.90(m,1H),1.74(m,1H),1.54(m,1H),1.37(d,J=6.4Hz,3H).
[0102] TIFF0007579249000346.tif9170((S)-2-Phenylpyrrolidin-1-yl)ethyl)-2,3-dihydrospiro[in TIFF0007579249000347.tif45163 Intermediate Int 1-15 (33 mg, 0.1 mmol) was dissolved in DMF (1 mL), DIEA (39 mg, 0.3 mmol) and HATU (38 mg, 0.1 mmol) were added, and then SM 50 (20 mg, 0.1 mmol) was added and stirred at room temperature for 16 hours. Water (10 mL) was added to the reaction solution, and the mixture was extracted twice with ethyl acetate. The organic phase was washed with saturated saline and concentrated to obtain the crude product, which was subjected to column chromatography to obtain the nearly white solid product 225 (23 mg) in 50% yield. Mass spectrometry: 463 (M+H +). 1H NMR(400MHz,DMSO)δ 8.73(d,J=5.4Hz,1H),7.54(d,J=5.0Hz,1H),7.40(t,J=7.4Hz,1H),7.30(dt,J=8.4,7.1Hz,3H),7.2 6-7.13(m,3H),6.13-6.04(m,1H),5.21(dd,J=64.8,7.2Hz,1H),4.62-3.88(m,2H),3.71(q,J=9.2Hz ,1H),3.66-3.50(m,1H),3.09(td,J=16.8,8.1Hz,1H),2.96(tdd,J=15.0,10.0,5.3Hz,1H),2.69-2. 55(m,4H),2.41(ddd,J=14.3,8.0,3.4Hz,1H),2.25(ddd,J=18.9,9.4,5.8Hz,1H),1.97-1.68(m,3H).
[0103] TIFF0007579249000348.tif8170(7-(trifluoromethyl)-3,4-dihydroquinolin-1(2H)-yl)ethyl) TIFF0007579249000349.tif9170Synthesis of ethyl urea (300) TIFF0007579249000350.tif38154Compound Int 1-15 (30 mg, 90 μmol), SM 300 (18 mg, 90 μmol), dichloromethane (1 mL), and water (1 mL) were added to a 30 mL reaction flask, and finally EEDQ (34 mg, 135 μmol) was added and stirred at room temperature overnight. Water (5 mL) was added to the reaction solution, and it was extracted with dichloromethane (5 mL × 3). The organic layers were combined, dried over anhydrous sodium sulfate, and concentrated to obtain the crude product. The crude product was purified by column chromatography to obtain product 300 (20 mg) in 43% yield. Mass spectrometry: 517.2 (M+H + ).
[0104] TIFF0007579249000351.tif121701H-pyrazol-4-yl)-3,4-dihydroquinolin-1(2H)-yl)-2-o TIFF0007579249000352.tif13170Synthesis of (5-sazolidinyl)urea (302) TIFF0007579249000353.tif58155 Synthesis of intermediate 6-(1-methyl-1H-pyrazol-4-yl)-1,2,3,4-tetrahydroquinoline (Int 302-1) TIFF0007579249000354.tif341486-Bromo-1,2,3,4-tetrahydroquinoline (212 mg, 1 mmol), 1-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole (208 mg, 1 mmol), potassium acetate (200 mg, 2 mmol) and [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride (73 mg, 0.1 mmol) were added to dioxane (20 mL), purged with nitrogen gas three times, heated to 100 °C, reacted for 4 hours, concentrated, added water, extracted with ethyl acetate, dried over anhydrous sodium sulfate, concentrated, and subjected to column chromatography to obtain a yellow solid Int 302-1 (98 mg) in a yield of 46%. Mass spectrometry: 214 (M+H + ). TIFF0007579249000355.tif12170-4-yl-3,4-dihydroquinolin-1(2H)-yl-2-oxoethyl Synthesis of 5-(2-phenyl)urea (302) TIFF0007579249000357.tif36154 Intermediate Int 1-15 (33 mg, 0.1 mmol), intermediate Int 302 (22 mg, 0.11 mmol), HATU (50 mg, 0.13 mmol) and DIEA (20 mg, 0.15 mmol) were dissolved in DMF (5 mL), stirred overnight, concentrated and subjected to column chromatography to give pale yellow solid 302 (35 mg) in 66% yield. Mass spectrometry: 529 (M+H + ).
[0105] TIFF0007579249000358.tif13170-(2-Phenylpyrrolidin-1-yl)ethyl)-2,3-dihydrospiro[indene- TIFF0007579249000359.tif47156 Intermediate Int 1-15 (33 mg, 0.1 mmol) was dissolved in DMF (1 mL), DIEA (39 mg, 0.3 mmol) and HATU (38 mg, 0.1 mmol) were added, and then SM 52 (20 mg, 0.1 mmol) was added and stirred at room temperature for 16 hours. Water (10 mL) was added to the reaction solution, and the mixture was extracted twice with ethyl acetate, and the organic phase was washed with saturated saline and concentrated to obtain the crude product. The crude product was passed through a silica column to obtain the nearly white solid product 303 (23 mg) in 50% yield. Mass spectrometry: 463 (M+H + ).
[0106] TIFF0007579249000360.tif10170(5H-Pyrrolo[3,4-b]pyridin-6(7H)-yl)ethyl)-2,3-dihydro Composition of TIFF0007579249000361.tif12170 TIFF0007579249000362.tif4215425mL reaction flask was added with DMF (1mL), then Int 1-15 (33mg, 0.1mmol), SM 53 (12mg, 0.1mmol), DIEA (39mg, 0.3mmol), and finally HATU (57mg, 0.15mmol) were added, and the system was reacted at room temperature overnight. After the reaction was completed, water (5mL) was added to the reaction solution, and it was extracted with ethyl acetate (5mL x 3), and the organic phase was combined, dried over anhydrous sodium sulfate, and purified by column chromatography to obtain compound 304 (19mg) in 44% yield. Mass spectrometry: 436.2 (M+H +). 1H NMR (400MHz, DMSO) δ 8.75(s,1H),8.50(d,J=4.3Hz,1H),7.83(d,J=7.7Hz,1H),7.60-7.54(m,1H), 7.42-7.32(m,2H),7.25(ddd,J=8.4,3.6,1.9Hz,1H),6.10(q,J=4.4Hz,1H),5. 06(d,J=18.9Hz,2H),4.74(d,J=26.0Hz,2H),4.67-4.51(m,2H),3.18-3.09(m, 1H),3.01(ddd,J=16.4,8.7,3.3Hz,1H),2.75-2.61(m,4H),2.58-2.52(m,1H).
[0107] Composition of TIFF0007579249000363.tif2717005) TIFF0007579249000364.tif44153 Intermediate Int 1-15 (33 mg, 0.1 mmol), SM 53 (13 mg, 0.11 mmol), HATU (50 mg, 0.13 mmol) and DIEA (20 mg, 0.15 mmol) were dissolved in dichloromethane (5 mL), stirred overnight, concentrated and subjected to column chromatography to give pale yellow solid 305 (33 mg) in 76% yield. Mass spectrometry: 436 (M+H + ).
[0108] TIFF0007579249000365.tif12170((R)-2-Phenylpyrrolidin-1-yl)ethyl)-2,3-dihydrospiro[in TIFF0007579249000366.tif4816725mL reaction flask was added with DMF (1mL), then Int 1-15 (33mg, 0.1mmol), SM 54 (15mg, 0.1mmol), DIEA (39mg, 0.3mmol), and finally HATU (57mg, 0.15mmol) were added, and the system was reacted at room temperature overnight. After the reaction was completed, water (5mL) was added to the reaction solution, and it was extracted with ethyl acetate (5mL x 3), and the organic phase was combined, dried over anhydrous sodium sulfate, and purified by column chromatography to obtain compound 306 (17mg) in 37% yield. Mass spectrometry: 463.2 (M+H +). 1H NMR(400MHz,DMSO)δ 8.70(d,J=8.4Hz,1H),7.54(d,J=5.4Hz,1H),7.41(t,J=7.5Hz,1H),7.30(dt,J=10.4,4.4Hz,3H ),7.23-7.10(m,3H),6.10-6.03(m,1H),5.20(dd,J=65.9,7.6Hz,1H),4.66-3.88(m,2H),3.75-3 .67(m,1H),3.65-3.48(m,1H),3.09(dt,J=13.8,7.3Hz,1H),2.96(ddd,J=16.1,11.2,4.7Hz,1H ),2.65-2.54(m,4H),2.48-2.41(m,1H),2.25(ddd,J=14.9,11.8,7.8Hz,1H),1.98-1.71(m,3H).
[0109] Example 308 Compound 2-(5-(3,5-dimethylisoxazol-4-yl)-2 TIFF0007579249000367.tif20170Synthesis of (trifluoroprop-2-yl)acetamide (308) TIFF0007579249000368.tif67153 Synthesis of intermediate (S)-1,1,1-trifluoro-N-(4-fluorobenzyl)prop-2-amine (Int 308-1) TIFF0007579249000369.tif37104SM 55 (1.88 g, 10 mmol) was dissolved in DMF (15 mL), potassium carbonate (2.76 g, 20 mmol) and (S)-1,1,1-trifluoroisopropylamine hydrochloride (1.5 g, 10 mmol) were added, and the mixture was stirred at room temperature for 6 hours. The reaction mixture was poured into water (60 mL), extracted three times with ethyl acetate, and the organic phase was washed with saturated saline and concentrated to obtain the crude product. The crude product was passed through a silica column to obtain intermediate Int 308-1 (1.8 g, 8 mmol) in 80% yield. Mass spectrometry: 222 (M+H + ). Synthesis of intermediate (S)-2-bromo-N-(4-fluorobenzyl)-N-(1,1,1-trifluoroprop-2-yl)acetamide (Int 308-2) TIFF0007579249000370.tif3789 Intermediate Int 308-1 (1.8 g, 8 mmol) was dissolved in DCM (15 mL), cooled in an ice-water bath, bromoacetyl bromide (1.6 g, 8 mmol) was added, and the mixture was stirred for 3 hours. The reaction mixture was poured into water (60 mL), extracted three times with DCM, and the organic phase was washed with saturated saline and concentrated to obtain the crude product. The crude product was passed through a silica column to obtain intermediate Int 308-2 (2.19 g, 6.4 mmol) in 80% yield. Mass spectrometry: 342, 344 (M+H + ). TIFF0007579249000371.tif20170-Synthesis of N-((S)-1,1,1-trifluoroprop-2-yl)acetamide (Int 308-3) TIFF0007579249000372.tif52149 Intermediate Int 308-2 (2.19 g, 6.4 mmol) and intermediate Int 97-7 (1.97 g, 6.4 mmol) were dissolved in DMF (15 mL), potassium carbonate (1.38 g, 10 mmol) was added, and the mixture was stirred at room temperature for 6 hours. The reaction mixture was poured into water (60 mL), extracted three times with ethyl acetate, and the organic phase was washed with saturated saline and concentrated to obtain the crude product. The crude product was passed through a silica column to obtain intermediate Int 308-3 (3.27 g, 5.76 mmol) in 90% yield. Mass spectrometry: 569,571 (M+H + ). TIFF0007579249000373.tif29170Synthesis of (rop-2-yl)acetamide (308) TIFF0007579249000374.tif42153 Intermediate Int 308-3 (569 mg, 1 mmol), 3,5-dimethylisoxazole-4-boronic acid pinacol ester (223 mg, 1 mmol) were dissolved in dioxane (10 mL), cesium carbonate (652 mg, 2 mmol), Pd(dppf)Cl2 (73 mg, 0.1 mmol) were added, and the mixture was replaced with nitrogen gas three times, heated to 100 ° C and stirred for 6 hours. The reaction solution was poured into water (60 mL), extracted with ethyl acetate three times, and the organic phase was washed with saturated saline and concentrated to obtain a crude product. The crude product was passed through a silica column to obtain compound 308 (351 mg, 0.6 mmol) in a yield of 60%. Mass spectrometry: 586 (M + H + ). 1 H NMR(400MHz,CDCl3):δ 7.66-7.51(m,1H),7.31(m,2H),7.21-7.08(m,3H),6.62(s,1H),5.52(m,1H),4.70(m,2H),4.47(m,1H),4.25(m,1H),2. 99(m,1H),2.56-2.47(m,1H),2.39(m,3H),2.27-2.18(m,3H),1.38-1.28(m,3H),1.22-1.10(m,3H),1.10-1.03(m,1H).
[0110] TIFF0007579249000375.tif10170((R)-2-Phenylpyrrolidin-1-yl)ethyl)-2,3-dihydrospiro[in TIFF0007579249000376.tif47170Int 1-15 (33 mg, 0.1 mmol) was dissolved in DMF (1 mL), DIEA (39 mg, 0.3 mmol) and HATU (38 mg, 0.1 mmol) were added, and then SM 54 (20 mg, 0.1 mmol) was added and stirred at room temperature for 2 hours. Water (10 mL) was added to the reaction solution, and the mixture was extracted twice with ethyl acetate. The organic phase was washed with saturated saline and concentrated to obtain the crude product. The crude product was passed through a silica column to obtain the nearly white solid product 309 (23 mg) in 50% yield. Mass spectrometry: 463 (M+H + ). 1H NMR(400MHz,DMSO):δ 8.71(m,1H),7.54(m,1H),7.45-7.09(m,7H),6.15-6.00(m,1H),5.29-5.13(m,1H),4.53(m,1H),3.93(m,1H),3.71(m,1H),3.65- 3.51(m,1H),3.09(m,1H),3.02-2.90(m,1H),2.73(s,1H),2.68-2.55(m,3H),2.48-2.34(m,1H),2.25(m,1H),1.98-1.67(m,3H).
[0111] TIFF0007579249000377.tif9168((S)-2-Phenylpyrrolidin-1-yl)ethyl)-2,3-dihydrospiro[in TIFF0007579249000378.tif49164Int 1-15 (33 mg, 0.1 mmol) was dissolved in DMF (1 mL), DIEA (39 mg, 0.3 mmol) and HATU (38 mg, 0.1 mmol) were added, and then SM 50 (20 mg, 0.1 mmol) was added and stirred at room temperature for 2 hours. Water (10 mL) was added to the reaction solution, and the mixture was extracted twice with ethyl acetate. The organic phase was washed with saturated saline and concentrated to obtain the crude product. The crude product was passed through a silica column to obtain the nearly white solid product 310 (23 mg) in 50% yield. Mass spectrometry: 463 (M+H + ). H NMR(400MHz,CDCl3):δ 7.37(m,3H),7.28-6.84(m,5H),5.12(m,1H),4.29(s,1H),4.29(m,1H), 3.83(m,2H),2.99(m,2H),2.71(s,3H),2.41(m,2H),2.07-1.82(m,4H).
[0112] TIFF0007579249000379.tif65170Int 1-15 (33 mg, 0.1 mmol) was dissolved in DMF (1 mL), DIEA (39 mg, 0.3 mmol) and HATU (38 mg, 0.1 mmol) were added, and then SM 33 (15 mg, 0.1 mmol) was added and stirred at room temperature for 2 hours. Water (10 mL) was added to the reaction solution, and the mixture was extracted twice with ethyl acetate. The organic phase was washed with saturated saline and concentrated to obtain the crude product. The crude product was passed through a silica column to obtain the nearly white solid product 311 (22 mg) in 50% yield. Mass spectrometry: 449 (M+H + ). 1 H NMR (400MHz, CDCl3): δ 7.50(m,1H),7.36(s,1H),7.25-7.09(m,4H),6.94(s,1H),4.70(m,2H),4.51(s,2H),3.78(m,2H),3.22-2.45(m,9H).
[0113] TIFF0007579249000380.tif12170(3-Phenylpyrrolidin-1-yl)ethyl)-2,3-dihydrospiro[indene-1, TIFF0007579249000381.tif4915825mL reaction flask was added with DMF (1mL), then Int 1-15 (33mg, 0.1mmol), SM 35 (15mg, 0.1mmol), DIEA (39mg, 0.3mmol), and finally HATU (57mg, 0.15mmol) were added, and the system was reacted at 20°C for 1 hour. After the reaction was completed, water (5mL) was added to the reaction solution, and it was extracted with ethyl acetate (5mL x 3), and the organic phase was combined, dried over anhydrous sodium sulfate, and purified by column chromatography to obtain compound 314 (25mg) in 55% yield. Mass spectrometry: 463 (M+H + ). 1H NMR(400MHz,DMSO)δ 8.73(s,1H),7.57(s,1H),7.40-7.31(m,5H),7.26(ddd,J=17.1,9.6,5.2Hz,2H),6.09(d,J=4.5H z,1H),4.45(dtd,J=45.6,17.1,3.6Hz,2H),3.88(dt,J=35.4,8.0Hz,1H),3.65(dt,J=16.6,10.5 Hz,1H),3.51(t,J=9.1Hz,1H),3.44-3.37(m,1H),3.32-3.22(m,1H),3.13(dt,J=15.6,7.6Hz,1H ),3.06-2.94(m,1H),2.70-2.59(m,4H),2.56-2.51(m,1H),2.40-2.20(m,1H),2.13-1.89(m,1H).
[0114] TIFF0007579249000382.tif20170TIFF0007579249000383.tif10170Synthesis of methylurea (315) TIFF0007579249000384.tif43154Int 1-15 (33 mg, 0.1 mmol) was dissolved in DMF (1 mL), DIEA (39 mg, 0.3 mmol) and HATU (38 mg, 0.1 mmol) were added, and then the raw material (1R,4R)-2-oxa-5-azabicyclo[2.2.1]heptane (16 mg, 0.1 mmol) was added and stirred at room temperature for 2 hours. Water (10 mL) was added to the reaction solution, and the mixture was extracted twice with ethyl acetate, and the organic phase was washed with saturated saline and concentrated to obtain a crude product. The crude product was passed through a silica column to obtain a nearly white solid product 315 (26 mg) in 50% yield. Mass spectrometry: 415 (M+H + ). 1 H NMR(400MHz,CDCl3):δ 7.58-7.25(m,2H),7.10-6.87(m,1H),5.00-4.25(m,3H),4.00-3.75(m,2H),3.60-3.40(m,2 H),3.20-2.90(m,2H),2.75(s,3H),2.55-2.45(m,1H),2.00-1.80(m,2H),1.45-1.20(m,2H).
[0115] TIFF0007579249000385.tif111701,3,4-Oxadiazol-2-yl)methyl)-2,3-dihydrospiro[indene- Synthesis of 5-methyl-3-[phenyl]-5-ylurea (Int 317-1) TIFF0007579249000387.tif33152 Intermediate Int 1-15 (66 mg, 0.2 mmol), benzoylhydrazine (27 mg, 0.2 mmol), HATU (100 mg, 0.26 mmol) and DIEA (40 mg, 0.3 mmol) were dissolved in DMF (10 mL), stirred overnight, added with water, extracted with EA, concentrated and subjected to column chromatography to give pale yellow solid Int 317-1 (41 mg) in 46% yield. Mass spectrometry: 452 (M+H + ). TIFF0007579249000388.tif21170Synthesis of [sazolidinyl]-5-yl)-3-methylurea (317) TIFF0007579249000389.tif37153 Intermediate Int 317-1 (41 mg, 0.09 mmol), p-toluenesulfonyl chloride (30 mg, 0.16 mmol), and DIEA (27 mg, 0.2 mmol) were dissolved in acetonitrile (5 mL), stirred at room temperature for 2 hours, concentrated, and subjected to column chromatography to obtain yellow solid 317 (21 mg) in 54% yield. Mass spectrometry: 434 (M+H + ). 1H NMR(400MHz,DMSO)δ 8.76(s,1H),8.07-7.96(m,2H),7.69-7.60(m,3H),7.54(s,1H),7.30-7.21(m,2H),6.10(d,J=4.5Hz,1 H),5.14(d,J=3.0Hz,2H),3.19-3.07(m,1H),3.06-2.97(m,1H),2.75-2.61(m,4H),2.60-2.53(m,1H).
[0116] TIFF0007579249000390.tif12170-(2-m-Methylphenyl)-pyrrolidin-1-yl)ethyl)-2,3-dihydrospiro[a]pyrrolidin-1-yl TIFF0007579249000391.tif10170 TIFF0007579249000392.tif391542Add DMF (1 mL) to a 5 mL reaction flask, then add Int 1-15 (33 mg, 0.1 mmol), SM304 (16 mg, 0.1 mmol), DIEA (39 mg, 0.3 mmol), and finally add HATU (57 mg, 0.15 mmol), and react the system at 20 °C for 1 h. After the reaction was completed, water (5 mL) was added to the reaction solution, and extracted with ethyl acetate (5 mL x 3), and the organic phase was combined, dried over anhydrous sodium sulfate, and purified by column chromatography to obtain compound 318 (20 mg) in 42% yield. Mass spectrometry: 477 (M+H + ). 1 H NMR(400MHz,DMSO)δ 8.74-8.67(m,1H),7.54(d,J=5.3Hz,1H),7.33-6.93(m,6H),6.13-6.02(m,1H),5.15(dd,J=64.2,7.6Hz,1H),4.66-3.87(m,2H),3.76-3.65( m,1H),3.64-3.52(m,1H),3.17-3.03(m,1H),3.01-2.92(m,1H),2.67- 2.54(m,4H),2.45-2.36(m,1H),2.34-2.16(m,4H),2.00-1.66(m,3H).
[0117] TIFF0007579249000393.tif27170 synthesis TIFF0007579249000394.tif3815425mL reaction flask was added with DMF (1mL), then Int 1-15 (33mg, 0.1mmol), SM304 (18mg, 0.1mmol), DIEA (39mg, 0.3mmol), and finally HATU (57mg, 0.15mmol) were added, and the system was reacted at 20°C for 1 hour. After the reaction was completed, water (5mL) was added to the reaction solution, and it was extracted with ethyl acetate (5mL x 3), and the organic phase was combined, dried over anhydrous sodium sulfate, and purified by column chromatography to obtain compound 319 (19mg) in 39% yield. Mass spectrometry: 493 (M+H + ). 1H NMR(400MHz,DMSO)δ 8.75-8.67(m,1H),7.54(d,J=6.0Hz,1H),7.33-7.09(m,5H),7.06-6.98(m,1H),6 .14-6.04(m,1H),5.32(dd,J=82.8,7.9Hz,1H),4.69-3.95(m,2H),3.82-3.68(m,1 H),3.65-3.46(m,1H),3.09(dd,J=15.8,7.7Hz,1H),2.98(dd,J=12.1,8.9Hz,1H) ,2.65-2.52(m,4H),2.45-2.35(m,3H),2.29(d,J=21.6Hz,2H),2.04-1.70(m,3H).
[0118] TIFF0007579249000395.tif9168-(2-Phenylpiperidin-1-yl)ethyl)-2,3-dihydrospiro[indene- TIFF0007579249000396.tif4615525mL reaction flask was added with DMF (1mL), then Int 1-15 (33mg, 0.1mmol), SM304 (16mg, 0.1mmol), DIEA (39mg, 0.3mmol), and finally HATU (57mg, 0.15mmol) were added, and the system was reacted at 20°C for 1 hour. After the reaction was completed, water (5mL) was added to the reaction solution, and it was extracted with ethyl acetate (5mL x 3), and the organic phase was combined, dried over anhydrous sodium sulfate, and purified by column chromatography to obtain compound 322 (18mg) in 38% yield. Mass spectrometry: 477 (M+H + ). 1 H NMR(400MHz,DMSO)δ 8.71(s,1H),7.56(s,1H),7.47-7.13(m,7H),6.08(s,1H),5.52(d,J=1 65.7Hz,1H),4.85-4.31(m,2H),4.20-3.79(m,1H),3.13(dt,J=15.5,7. 6Hz,1H),3.01(dd,J=12.5,9.0Hz,1H),2.64(d,J=2.9Hz,4H),2.41(d,J=12.9Hz,1H),1.89(d,J=82.8Hz,1H),1.61(s,3H),1.49-1.05(m,3H).
[0119] TIFF0007579249000397.tif27170 synthesis TIFF0007579249000398.tif3815225mL reaction flask was added with DMF (1mL), then Int 1-15 (33mg, 0.1mmol), SM304 (17mg, 0.1mmol), DIEA (39mg, 0.3mmol), and finally HATU (57mg, 0.15mmol) were added, and the system was reacted at 20°C for 1 hour. After the reaction was completed, water (5mL) was added to the reaction solution, and it was extracted with ethyl acetate (5mL x 3), and the organic phase was combined, dried over anhydrous sodium sulfate, and purified by column chromatography to obtain compound 323 (20mg) in 42% yield. Mass spectrometry: 481.2 (M+H + ). 1 H NMR(400MHz,DMSO)δ 8.74-8.65(m,1H),7.55(d,J=6.7Hz,1H),7.41-7.08(m,6H),6.12-6.02(m,1H),5.38( dd,J=93.9,7.8Hz,1H),4.66-3.91(m,2H),3.80-3.67(m,1H),3.64-3.52(m,1H),3.10( dd,J=15.5,7.6Hz,1H),3.03-2.93(m,1H),2.66-2.55(m,4H),2.47-2.37(m,1H),2.35- 2.23(m,1H),1.99(dd,J=9.4,5.8Hz,1H),1.88(d,J=7.2Hz,1H),1.73(d,J=7.8Hz,1H).
[0120] TIFF0007579249000399.tif9168-(2-o-methylphenyl)pyrrolidin-1-yl)ethyl)-2,3-dihydrospiro TIFF0007579249000400.tif4417025mL reaction flask was added with DMF (1mL), then Int 1-15 (33mg, 0.1mmol), SM304 (16mg, 0.1mmol), DIEA (39mg, 0.3mmol), and finally HATU (57mg, 0.15mmol) were added, and the system was reacted at 20°C for 1 hour. After the reaction was completed, water (5mL) was added to the reaction solution, extracted with ethyl acetate (5mL x 3), the organic phase was combined, dried over anhydrous sodium sulfate, and purified by column chromatography to obtain compound 324 (22mg) in 46% yield. Mass spectrometry: 477.2 (M+H + ). 1 H NMR(400MHz,DMSO)δ 8.75-8.61(m,1H),7.54(d,J=9.5Hz,1H),7.34-7.25(m,1H),7.26-7.09(m,2H),7.09-6.82(m ,3H),6.12-6.02(m,1H),5.41-5.22(m,1H),4.70-3.92(m,2H),3.84(d,J=11.5Hz,3H),3.75- 3.64(m,1H),3.61-3.49(m,1H),3.09(td,J=14.8,7.0Hz,1H),3.02-2.92(m,1H),2.61(dt,J= 14.1,5.5Hz,4H),2.47-2.39(m,1H),2.25(ddd,J=24.9,16.7,9.3Hz,1H),1.98-1.62(m,3H).
[0121] TIFF0007579249000401.tif9166-2-Phenylpyrrolidin-1-yl)ethyl)-2,3-dihydrospiro[cyclopropane TIFF0007579249000402.tif8170 TIFF0007579249000403.tif39152 Intermediate Int 97-12 (35 mg, 0.1 mmol) was dissolved in DMF (1 mL), DIEA (39 mg, 0.3 mmol) and HATU (38 mg, 0.1 mmol) were added, and then (S)-2-phenylpyrrolidine (22 mg, 0.15 mmol) was added and stirred at room temperature for 2 hours. Water (10 mL) was added to the reaction solution, and the mixture was extracted twice with ethyl acetate, and the organic phase was washed with saturated saline and concentrated to obtain the crude product. The crude product was passed through a silica column to obtain the nearly white solid product 325 (24 mg) in 50% yield. Mass spectrometry: 489 (M+H + ). 1 H NMR(400MHz,CDCl3):δ 7.68-6.18(m,8H),5.11(m,1H),4.57-4.19(m,1H),3.79(m,2H),2.75(m,4) H),2.54-2.23(m,2H),2.16-1.68(m,4H),1.27(m,1H),1.14-0.91(m,3H).
[0122] TIFF0007579249000404.tif9169Chloro[2.2.1]heptane-5-carbonyl)pyrrolidin-1-yl)-2-oxoethane TIFF0007579249000405.tif8170Synthesis of 1-(2-methyl-5-yl)-3-methylurea (328) TIFF0007579249000406.tif61154 Synthesis of intermediate 5-(benzyl-L-prolyl)-2-oxa-5-azabicyclo[2.2.1]heptane (Int 328-1) TIFF0007579249000407.tif30110 Benzyl-L-proline (205 mg, 1 mmol), 2-oxa-5-azabicyclo[2.2.1]heptane (99 mg, 1 mmol), HATU (570 mg, 1.5 mmol) and DIEA (260 mg, 2 mmol) were dissolved in dichloromethane (50 mL), stirred overnight, concentrated and subjected to column chromatography to give a pale yellow solid Int 328-1 (210 mg) in 73% yield. Mass spectrometry: 287 (M+H + ). Synthesis of intermediate 5-(-L-prolyl)-2-oxa-5-azabicyclo[2.2.1]heptane (Int 328-2) TIFF0007579249000408.tif2985 Intermediate Int 328-1 (30 mg, 0.1 mmol) was dissolved in methanol (10 mL), palladium on carbon (2 mg) was added, and the mixture was stirred under hydrogen atmosphere for 2 hours, filtered, and concentrated to give colorless liquid Int 328-2 (28 mg) in 99% yield. Mass spectrometry: 197 (M+H + ). TIFF0007579249000409.tif26170 Synthesis of (3-methyl)-3-methylurea (328) TIFF0007579249000410.tif35153 Intermediate Int 1-15 (33 mg, 0.1 mmol), Int 328-2 (28 mg, 0.11 mmol), HATU (50 mg, 0.13 mmol) and DIEA (20 mg, 0.15 mmol) were dissolved in dichloromethane (5 mL), stirred overnight, concentrated and subjected to column chromatography to give pale yellow solid 328 (38 mg) in 74% yield. Mass spectrometry: 512 (M+H + ). 1 H NMR(400MHz,DMSO):δ 8.73(s,1H),7.57-7.48(m,1H),7.35(t,J=5.6Hz,1H),7.24(dd,J=15.5,5.3Hz,1H),6.08( s,1H),4.71(m,4H),3.99-3.45(m,7H),3.13-2.94(m,2H),2.65(m,5H),2.03-1.69(m,6H).
[0123] TIFF0007579249000411.tif26170 synthesis TIFF0007579249000412.tif65155 Synthesis of intermediate (4-(1H-imidazol-2-yl)-4-oxobutyl) t-butylcarbamate (Int 333-1) TIFF0007579249000413.tif3994SM 330 (1.93 g, 10 mmol) was added to a reaction flask with dry THF (20 mL), and a solution of isopropyl magnesium bromide in tetrahydrofuran (10 mL, 1 M in THF) was added to the flask under nitrogen gas protection and ice-water bath conditions. Then, the ice-water bath was removed and the mixture was stirred at room temperature for 7 hours, and finally, N-Boc-2-pyrrolidone (1.85 g, 10 mmol) was added and reacted at room temperature for 12 hours. The reaction solution was poured into a saturated aqueous ammonium chloride solution, extracted with 30 mL of ethyl acetate (10 mL x 3), and the organic phases were combined, dried over anhydrous sodium sulfate, and purified by column chromatography to obtain Int 330-1 (1.52 g, 6 mmol) in a yield of 60%. Mass spectrometry: 254 (M+H + ). Synthesis of intermediate 2-(3,4-dihydro-2H-pyrrol-5-yl)-1H-imidazole (Int 330-2) TIFF0007579249000414.tif3565Int 330-1 (1.52 g, 6 mmol) was dissolved in 15 mL of DCM, 3.7 mL of TFA was added, and the mixture was stirred at room temperature. TLC detection was performed. After the reaction was completed, the pH was adjusted to neutral with saturated aqueous sodium bicarbonate solution, extracted with DCM (10 mL x 3), dried over anhydrous sodium sulfate, and the solvent was removed by rotary evaporation to obtain Int.330-2 (0.72 g; 89%). Mass spectrometry: 136 (M+H + ). Synthesis of intermediate 2-(pyrrolidin-2-yl)-1H-imidazole (Int 330-3) TIFF0007579249000415.tif3660Int. 330-2 (0.72 g; 5.34 mmol) was added to a reaction flask containing 7 mL of methanol, and sodium borohydride (0.68 g; 18 mmol) was added batchwise while stirring at room temperature. After the addition was completed, the mixture was further stirred at room temperature and TLC detection was performed. After the reaction was completed, the reaction solution was poured into water and extracted with 30 mL of EA (10 mL x 3). The organic phases were combined, dried over anhydrous sodium sulfate, and separated by column chromatography to obtain Int. 330-3 (0.37 g; 50%). Mass spectrometry: 138 (M+H +). TIFF0007579249000416.tif62170 Intermediate Int.1-10 (30 mg, 0.09 mmol) was dissolved in DMF (1 mL), DIEA (35 mg, 0.027 mmol) and HATU (41 mg, 0.011 mmol) were added, and then the raw material Int.330-3 (1.5 eq) was added and stirred at room temperature for 16 hours. Water (10 mL) was added to the reaction solution, and the mixture was extracted twice with ethyl acetate. The organic phase was washed with saturated saline and concentrated to obtain the crude product, which was subjected to column chromatography to obtain the nearly white solid product 330, 25 mg, with a yield of 61%. Mass spectrometry: 453 (M+H + ).
[0124] TIFF0007579249000417.tif6217025mL reaction flask was added with DMF (1mL), then Int 1-15 (33mg, 0.1mmol), SM6 3 (10mg, 0.1mmol), DIEA (39mg, 0.3mmol), and finally HATU (57mg, 0.15mmol) were added, and the system was reacted at room temperature overnight. After the reaction was completed, water (5mL) was added to the reaction solution, extracted with ethyl acetate (5mL x 3), the organic phase was combined, dried over anhydrous sodium sulfate, and purified by column chromatography to obtain compound 331 (17mg, 41% yield). Mass spectrometry: 412.1 (M+H + ). 1 H NMR(400MHz,DMSO)δ 8.74(s,1H),7.56(s,1H),7.31(d,J=8.4Hz,1H),7.24(dd,J=8.4,1.7Hz,1H),6.10(q,J =4.3Hz,1H),4.87(dd,J=7.2,3.7Hz,1H),4.51(dd,J=34.6,17.1Hz,2H),3.86-3.77(m,1 H),3.57(dd,J=15.8,8.7Hz,1H),3.14(dt,J=15.7,7.6Hz,1H),3.00(ddd,J=16.2,8.7, 3.2Hz,1H),2.71-2.62(m,4H),2.59-2.51(m,1H),2.23-2.13(m,2H),2.12-1.99(m,2H).
[0125] TIFF0007579249000418.tif8167-(2-(pyridin-2-yl)pyrrolidin-1-yl)ethyl)-2,3-dihydrospiro[a]pyridin-2-yl TIFF0007579249000419.tif8170 TIFF0007579249000420.tif3815225mL reaction flask was added with DMF (1mL), then Int 1-15 (33mg, 0.1mmol), SM 64 (15mg, 0.1mmol), DIEA (39mg, 0.3mmol), and finally HATU (57mg, 0.15mmol) were added, and the system was reacted at room temperature overnight. After the reaction was completed, water (5mL) was added to the reaction solution, and it was extracted with ethyl acetate (5mL x 3), and the organic phase was combined, dried over anhydrous sodium sulfate, and purified by column chromatography to obtain compound 332 (15mg, 32% yield). Mass spectrometry: 464.2 (M+H + ). 1 H NMR(400MHz,DMSO)δ 8.75-8.67(m,1H),8.53(dd,J=19.4,15.2Hz,1H),7.89-7.68(m,1H),7.54(s,1H),7.40-7.2 8(m,1H),7.28-7.10(m,3H),6.10-6.02(m,1H),5.21(dd,J=90.2,8.1Hz,1H),4.62-3.87(m,2 H),3.71(ddd,J=12.4,11.5,5.9Hz,1H),3.63-3.50(m,1H),3.09(dd,J=14.3,6.4Hz,1H),3. 05-2.92(m,1H),2.70-2.56(m,4H),2.46-2.36(m,1H),2.34-2.19(m,1H),2.05-1.80(m,3H).
[0126] TIFF0007579249000421.tif9168ethyl-1H-pyrazol-5-yl)pyrrolidin-1-yl)-2-oxoethyl)-2 TIFF0007579249000422.tif9169-Synthesis of (yl)urea (333) TIFF0007579249000423.tif3815225mL reaction flask was added with DMF (1mL), then Int 1-15 (33mg, 0.1mmol), SM 65 (15mg, 0.1mmol), DIEA (39mg, 0.3mmol), and finally HATU (57mg, 0.15mmol) were added, and the system was reacted at room temperature overnight. After the reaction was completed, water (5mL) was added to the reaction solution, and it was extracted with ethyl acetate (5mL x 3), and the organic phase was combined, dried over anhydrous sodium sulfate, and purified by column chromatography to obtain compound 333 (14mg, 30% yield). Mass spectrometry: 467.2 (M+H + ).
[0127] TIFF0007579249000424.tif8168-(2-(pyridin-3-yl)pyrrolidin-1-yl)ethyl)-2,3-dihydrospiro[a]pyridin-3-yl TIFF0007579249000425.tif8170 TIFF0007579249000426.tif3915425mL reaction flask was added with DMF (1mL), then Int 1-15 (33mg, 0.1mmol), SM 66 (15mg, 0.1mmol), DIEA (39mg, 0.3mmol), and finally HATU (57mg, 0.15mmol) were added, and the system was reacted at room temperature overnight. After the reaction was completed, water (5mL) was added to the reaction solution, and it was extracted with ethyl acetate (5mL x 3), and the organic phase was combined, dried over anhydrous sodium sulfate, and purified by column chromatography to obtain compound 334 (18mg, 39% yield). Mass spectrometry: 464.2 (M+H + ).
[0128] TIFF0007579249000427.tif26170 synthesis TIFF0007579249000428.tif3815325mL reaction flask was added with DMF (1mL), then Int 1-15 (33mg, 0.1mmol), SM 67 (18mg, 0.1mmol), DIEA (39mg, 0.3mmol), and finally HATU (57mg, 0.15mmol) were added, and the system was reacted at room temperature overnight. After the reaction was completed, water (5mL) was added to the reaction solution, extracted with ethyl acetate (5mL x 3), the organic phase was combined, dried over anhydrous sodium sulfate, and purified by column chromatography to obtain compound 335 (19mg, 39% yield). Mass spectrometry: 493.2 (M+H + ). 1 H NMR(400MHz,DMSO)δ 8.76-8.65(m,1H),7.55(d,J=6.3Hz,1H),7.32(dq,J=10.7,3.4Hz,1H),7.27-7.11 (m,2H),6.90-6.69(m,3H),6.13-6.02(m,1H),5.17(dd,J=61.1,7.1Hz,1H),4.65- 3.89(m,2H),3.79-3.66(m,4H),3.64-3.53(m,1H),3.16-3.05(m,1H),3.02-2.91( m,1H),2.68-2.55(m,4H),2.49-2.39(m,1H),2.40-2.17(m,1H),2.01-1.70(m,3H).
[0129] TIFF0007579249000429.tif27170 TIFF0007579249000430.tif3615225mL reaction flask was added with DMF (1mL), then Int 1-15 (33mg, 0.1mmol), SM 68 (23mg, 0.1mmol), DIEA (39mg, 0.3mmol), and finally HATU (57mg, 0.15mmol) were added, and the system was reacted at room temperature overnight. After the reaction was completed, water (5mL) was added to the reaction solution, extracted with ethyl acetate (5mL x 3), the organic phase was combined, dried over anhydrous sodium sulfate, and purified by column chromatography to obtain compound 336 (16mg, 30% yield). Mass spectrometry: 541.2, 543.2 (M+H + ).1 H NMR(400MHz,DMSO)δ 8.74-8.65(m,1H),7.54(d,J=9.9Hz,1H),7.47-7.09(m,6H),6.09(d,J=4.6Hz,1 H),5.18(dd,J=44.2,8.0Hz,1H),4.70-4.00(m,2H),3.73(dd,J=17.6,8.7Hz,1H) ,3.64-3.52(m,1H),3.18-3.03(m,1H),2.98(ddd,J=13.1,9.1,4.4Hz,1H),2.69- 2.54(m,4H),2.42(dd,J=15.9,7.2Hz,1H),2.36-2.19(m,1H),2.01-1.67(m,3H).
[0130] TIFF0007579249000431.tif261703-Synthesis of methylurea (337) TIFF0007579249000432.tif76155 Synthesis of intermediate (5-(4-fluoro-2-methoxyphenyl)-2-methyl-5-oxobutyl) t-butylcarbamate (Int 337-1) TIFF0007579249000433.tif4296SM 69 (2.52 g, 10 mmol) was added to a reaction flask with dry THF (20 mL), and isopropyl magnesium bromide (10 mL, 1M in Hexane) was added to the flask under nitrogen gas protection and ice-water bath conditions, then the ice-water bath was removed and the mixture was stirred at room temperature for 7 hours, and finally 2-methyl-5-oxopyrrolidine-1-carboxylate-t-butyl (1.99 g, 10 mmol) was added and reacted at room temperature for 12 hours. The reaction solution was poured into a saturated aqueous ammonium chloride solution, extracted with 30 mL of ethyl acetate (10 mL x 3), the organic phase was combined, dried over anhydrous sodium sulfate, and purified by column chromatography to obtain Int 337-1 (2.28 g, 7 mmol) in 70% yield. Mass spectrometry: 326 (M+H + ). Synthesis of intermediate 5-(4-fluoro-2-methoxyphenyl)-2-methyl-3,4-dihydro-2H-pyrrole (Int 337-2) TIFF0007579249000434.tif4775Int 337-1 (2.28 g, 7 mmol) was dissolved in DCM (22 mL), TFA (3.7 mL) was added, and the mixture was stirred at room temperature. TLC detection was performed. After the reaction was completed, the pH was adjusted to neutral with saturated aqueous sodium bicarbonate solution, extracted with DCM (10 mL x 3), dried over anhydrous sodium sulfate, and the solvent was removed by rotary evaporation to obtain Int 337-2 (0.87 g; 90%). Mass spectrometry: 208 (M+H + ). Synthesis of intermediate 2-(4-fluoro-2-methoxyphenyl)-5-methylpyrrolidine (Int337-3) TIFF0007579249000435.tif4761 Int. 337-2 (0.87 g; 4.2 mmol) was added to a reaction flask containing 9 mL of methanol, and sodium borohydride (0.68 g; 18 mmol) was added batchwise while stirring at room temperature. After the addition was completed, the mixture was further stirred at room temperature and TLC detection was performed. After the reaction was completed, the reaction solution was poured into water and extracted with 30 mL of EA (10 mL x 3). The organic phases were combined, dried over anhydrous sodium sulfate, and separated by column chromatography to obtain Int. 337-3 (0.70 g; 80%). Mass spectrometry: 210 (M+H + ). Composite of TIFF0007579249000436.tif26170(337) TIFF0007579249000437.tif39154 Intermediate Int 1-15 (30 mg, 0.09 mmol) was dissolved in DMF (1 mL), DIEA (35 mg, 0.027 mmol) and HATU (41 mg, 0.011 mmol) were added, and then the raw material Int 337-3 (28.2 mg, 0.135 mmol) was added and stirred at room temperature for 16 hours. Water (10 mL) was added to the reaction solution, and the mixture was extracted twice with ethyl acetate. The organic phase was washed with saturated saline and concentrated to obtain the crude product, which was subjected to column chromatography to obtain the nearly white solid product 337 (36 mg) in 76% yield. Mass spectrometry: 525 (M+H + ).
[0131] TIFF0007579249000438.tif26170 TIFF0007579249000439.tif2910825mL reaction flask was added with DMF (5mL), then Int 1-15 (333mg, 1mmol), SM 67 (210mg, 1mmol), DIEA (390mg, 3mmol), and finally HATU (570mg, 1.5mmol) were added, and the system was reacted at room temperature overnight. After the reaction was completed, water (10mL) was added to the reaction solution, and it was extracted with ethyl acetate (10mL x 3), and the organic phase was combined and dried over anhydrous sodium sulfate, and the obtained crude product was subjected to chiral separation to obtain compound 338 (300mg). Mass spectrometry: 493.2 (M+H + ). 1 H NMR(400MHz,DMSO)δ 8.71(d,J=7.3Hz,1H),7.55(d,J=10.7Hz,1H),7.34-7.26(m,1H),7.24-7.10(m,2H),7.09-6.81(m ,3H),6.08(dd,J=7.1,4.6Hz,1H),5.31(dd,J=45.5,7.5Hz,1H),4.69-3.93(m,2H),3.84(d,J=12. 1Hz,3H),3.75-3.64(m,1H),3.55(dd,J=17.9,11.1Hz,1H),3.09(dt,J=12.9,7.2Hz,1H),2.97(dd ,J=10.1,6.5Hz,1H),2.69-2.56(m,4H),2.45-2.38(m,1H),2.37-2.13(m,1H),1.99-1.62(m,3H).
[0132] TIFF0007579249000440.tif27170 Composition of element (340) TIFF0007579249000441.tif75157 Synthesis of intermediate (4-(4-fluoro-2-methoxyphenyl)-4-oxobutyl) t-butylcarbamate (Int 340-1) TIFF0007579249000442.tif3998 Dry THF (30 mL) was added to the reaction flask, then SM 69 (2.5 g, 10 mmol) was added, and 1N isopropyl magnesium bromide (10 mL, 1M in THF) was added under nitrogen gas protection in ice-water bath conditions, then the reaction was carried out at room temperature for 7 hours, and finally 5-oxopyrrolidine-1-carboxylate-t-butyl (1.85 g, 10 mmol) was added, and then the reaction was carried out at room temperature for 12 hours. The reaction solution was poured into a saturated aqueous ammonium chloride solution, extracted with 30 mL of ethyl acetate (10 mL x 3), and the organic phases were combined, dried over anhydrous sodium sulfate, and purified by column chromatography to obtain Int 340-1 (1.7 g, 5.6 mmol) in 56% yield. Mass spectrometry: 312 (M+H + ). Synthesis of intermediate 5-(4-fluoro-2-methoxyphenyl)-3,4-dihydro-2H-pyrrole (Int 340-2) TIFF0007579249000443.tif4375 DCM (20 mL) was added to a reaction flask, followed by Int 340-1 (1.56 g, 5 mmol), followed by TFA (2 mL), and then reacted at room temperature for 7 hours. The reaction was poured into saturated aqueous sodium bicarbonate solution, extracted with 30 mL of DCM (10 mL x 3), and the organic phases were combined, dried over anhydrous sodium sulfate, and purified by column chromatography to give Int 340-2 (772 mg, 4 mmol) in 80% yield. Mass spectrometry: 194 (M+H + ). Synthesis of intermediate 2-(4-fluoro-2-methoxyphenyl)pyrrolidine (Int 340-3) TIFF0007579249000444.tif4259Methanol (15 mL) was added to the reaction flask, followed by Int 340-2 (772 g, 4 mmol), followed by sodium borohydride (0.76 g, 20 mmol) in batchwise fashion, and then reacted at room temperature for 1 h. The reaction solution was poured into water and extracted with EA 30 mL (10 mL x 3), the organic phases were combined, dried over anhydrous sodium sulfate, and concentrated to give Int 340-3 (721 g, 3.7 mmol) in 94% yield. Mass spectrometry: 196 (M+H)+ ). TIFF0007579249000445.tif27170 synthesis TIFF0007579249000446.tif3615325mL reaction flask was added with DMF (3mL), then Int 1-15 (33mg, 0.1mmol), Int 340-3 (19.5mg, 0.1mmol), DIEA (38.7mg, 0.3mmol), and finally HATU (38mg, 0.1mmol) were added, and the system was reacted at 20°C for 1 hour. After the reaction was completed, the reaction solution was poured into water (10mL), extracted with ethyl acetate 30mL (10mL x 3), the organic phase was combined, dried over anhydrous sodium sulfate, and purified by column chromatography to obtain compound 340 (28mg) in 55% yield. Mass spectrometry: 511 (M+H + ).
[0133] Composite of TIFF0007579249000447.tif27170 TIFF0007579249000448.tif391542Add DMF (1 mL) to a 5 mL reaction flask, then add Int 1-15 (33 mg, 0.1 mmol), SM 70 (21 mg, 0.1 mmol), DIEA (39 mg, 0.3 mmol), and finally add HATU (57 mg, 0.15 mmol), and react the system at room temperature overnight. After the reaction was completed, water (5 mL) was added to the reaction solution, and extracted with ethyl acetate (5 mL x 3), and the organic phase was combined, dried over anhydrous sodium sulfate, and purified by column chromatography to obtain compound 341 (19 mg, 36% yield). Mass spectrometry: 523.2 (M+H + ). 1H NMR(400MHz,DMSO)δ 8.71(d,J=6.2Hz,1H),7.55(d,J=11.3Hz,1H),7.34-7.09(m,2H),6.88(dd,J=35.3,8.4Hz,1H),6.64 -6.36(m,2H),6.13-6.00(m,1H),5.23(dd,J=38.6,7.4Hz,1H),4.69-3.89(m,2H),3.82(d,J=12.4Hz ,3H),3.77-3.70(m,3H),3.66(t,J=8.7Hz,1H),3.61-3.46(m,1H),3.17-3.03(m,1H),2.97(d,J=7.3 Hz,1H),2.61(dt,J=14.2,5.6Hz,4H),2.46-2.37(m,1H),2.20(d,J=66.6Hz,1H),1.95-1.60(m,3H).
[0134] TIFF0007579249000449.tif17170 Synthesis of (acetyl)pyrrolidin-2-yl)pyridine-1-oxide (343) TIFF0007579249000450.tif70155 Synthesis of intermediate 2-pyridin-2-ylpyrrolidine-1-carboxylate-t-butyl (Int 343-1) TIFF0007579249000451.tif3771 Intermediate SM 64 (1.48 g, 10 mmol) was dissolved in DCM (20 mL), triethylamine (2 g, 20 mmol) was added, and then (Boc)2O (2.18 g, 10 mmol) was added and stirred at room temperature for 2 hours. Water (20 mL) was added to the reaction solution, and the mixture was extracted three times. The organic phase was washed with saturated saline, dried over sodium sulfate, and concentrated to obtain the crude product, which was subjected to column chromatography to obtain the product Int 343-1 (2.23 g, 9 mmol) in 90% yield. Mass spectrometry: 249 (M+H + ). Synthesis of intermediate 2-(1-t-butoxycarbonyl)pyrrolidin-2-yl)pyridine-1-oxide (Int 343-2) TIFF0007579249000452.tif3768 Intermediate Int 343-1 (2.23 g, 9 mmol) was dissolved in DCM (20 mL), m-CPBA (1.73 g, 10 mmol) was added, and the mixture was stirred at room temperature for 2 h. The reaction was concentrated to remove most of the DCM, and the crude product was directly passed through a reverse phase column to give the product Int 343-2 (1.9, 7.2 mmol) in 80% yield. Mass spectrometry: 265 (M+H + ). Synthesis of intermediate 2-pyrrolidin-2-ylpyridine-1-oxide (Int 343-3) TIFF0007579249000453.tif3562 Intermediate Int 343-2 (1.9 g, 7.2 mmol) was dissolved in DCM (20 mL), TFA (2 mL) was added, and the mixture was stirred at room temperature for 2 hours. The reaction solution was concentrated to give Int 343-3 (1.18 g, 7.2 mmol) in 100% yield. Mass spectrometry: 165 (M+H + ). TIFF0007579249000454.tif17170Synthesis of pyrrolidin-2-yl)pyridine-1-oxide (343) TIFF0007579249000455.tif38152 Intermediate Int 1-15 (33 mg, 0.1 mmol) was dissolved in DMF (1 mL), DIEA (39 mg, 0.3 mmol) and HATU (38 mg, 0.1 mmol) were added, and then Int 343-3 (20 mg, 0.1 mmol) was added and stirred at room temperature for 16 hours. Water (10 mL) was added to the reaction solution, and the mixture was extracted twice with ethyl acetate. The organic phase was washed with saturated saline and concentrated to obtain the crude product, which was subjected to column chromatography to obtain the nearly white solid product 343 (24 mg) in 50% yield. Mass spectrometry: 480 (M+H + ).
[0135] Composite of TIFF0007579249000456.tif27170(347) TIFF0007579249000457.tif76155 Synthesis of intermediate (4-(4-fluoro-2-methylphenyl)-4-oxobutyl) t-butylcarbamate (Int 347-1) TIFF0007579249000458.tif3991SM 5 (2.36 g, 10 mmol) was added to a reaction flask with dry THF (20 mL), and isopropyl magnesium bromide (10 mL, 1M in THF) was added to the flask under nitrogen gas protection and ice-water bath conditions, then the ice-water bath was removed and the mixture was stirred at room temperature for 7 hours, and finally N-Boc-2-pyrrolidone (1.85 g, 10 mmol) was added and reacted at room temperature for 12 hours. The reaction solution was poured into a saturated aqueous ammonium chloride solution, extracted with 30 mL of ethyl acetate (10 mL x 3), the organic phases were combined, dried over anhydrous sodium sulfate, and purified by column chromatography to obtain Int 347-1 (2.36 g, 8 mmol) in 80% yield. Mass spectrometry: 296 (M+H + ). Synthesis of intermediate 5-(4-fluoro-2-methylphenyl)-3,4-dihydro-2H-pyrrole (Int 347-2) TIFF0007579249000459.tif4266 Int 347-1 (2.36 g, 8 mmol) was dissolved in DCM (23 mL), TFA (2.3 mL) was added, and the mixture was stirred at room temperature. TLC detection was performed. After the reaction was completed, the pH was adjusted to neutral with saturated aqueous sodium bicarbonate solution, extracted with DCM (10 mL x 3), dried over anhydrous sodium sulfate, and the solvent was removed by rotary evaporation to obtain Int 347-2 (1.2 g, 85%). Mass spectrometry: 178 (M+H + ). Synthesis of intermediate 2-(4-fluoro-2-methylphenyl)pyrrolidine (Int 347-3) TIFF0007579249000460.tif4361Int 347-2 (1.2 g, 6.8 mmol) was added to a reaction flask containing methanol (12 mL), and sodium borohydride (0.90 g, 23.8 mmol) was added batchwise while stirring at room temperature. After the addition was completed, the mixture was further stirred at room temperature and TLC detection was performed. After the reaction was completed, the reaction solution was poured into water and extracted with EA 30 mL (10 mL x 3). The organic phases were combined, dried over anhydrous sodium sulfate, and separated by column chromatography to obtain Int 347-3 (0.97 g, 80%). Mass spectrometry: 180 (M+H + ). TIFF0007579249000461.tif27170 TIFF0007579249000462.tif39153 Intermediate Int 1-15 (30 mg, 0.09 mmol) was dissolved in DMF (1 mL), DIEA (35 mg, 0.027 mmol) and HATU (41 mg, 0.011 mmol) were added, and then Int 347-3 (24 mg, 0.135 mmol) was added and stirred at room temperature for 16 hours. Water (10 mL) was added to the reaction solution, and the mixture was extracted twice with ethyl acetate. The organic phase was washed with saturated saline and concentrated to obtain the crude product, which was subjected to column chromatography to obtain the nearly white solid product 347 (32 mg) in 72% yield. Mass spectrometry: 495 (M+H + ).
[0136] Composite of TIFF0007579249000463.tif18170 and TIFF0007579249000464.tif8170(348) TIFF0007579249000465.tif82156 Synthesis of intermediate (5-(4-fluorophenyl)-5-oxopentan-2-yl) t-butylcarbamate (348) TIFF0007579249000466.tif40100 Add dry THF (30 mL) to the reaction flask, then add SM 10 (2.22 g, 10 mmol), add 1N isopropyl magnesium bromide (10 mL, 1M in THF) under nitrogen gas protection in ice-water bath conditions, then react at room temperature for 7 hours, and finally add 2-methyl-5-oxopyrrolidine-1-carboxylate-t-butyl (1.99 g, 10 mmol), then react at room temperature for 12 hours. The reaction solution was poured into saturated aqueous ammonium chloride solution, extracted with 30 mL of ethyl acetate (10 mL x 3), the organic phase was combined, dried over anhydrous sodium sulfate, and purified by column chromatography to obtain Int 348-1 (1.5 g, 5 mmol) in 50% yield. Mass spectrometry: 296 (M+H + ). Synthesis of intermediate 5-(4-fluorophenyl)-2-methyl-3,4-dihydro-2H-pyrrole (Int 348-2) TIFF0007579249000467.tif4677 DCM (20 mL) was added to a reaction flask, followed by Int 348-1 (1.5 g, 5 mmol), followed by TFA (2 mL), and then reacted at room temperature for 7 hours. The reaction was poured into saturated aqueous sodium bicarbonate solution, extracted with 30 mL of DCM (10 mL x 3), the organic phases were combined, dried over anhydrous sodium sulfate, and purified by column chromatography to give Int 348-2 (0.8 g, 4.5 mmol) in 90% yield. Mass spectrometry: 178 (M+H + ). Synthesis of intermediate 2-(4-fluorophenyl)-5-methylpyrrolidine (Int 348-3) TIFF0007579249000468.tif4554Methanol (15 mL) was added to the reaction flask, followed by Int 348-2 (0.8 g, 4.5 mmol), followed by sodium borohydride (0.76 g, 20 mmol) in batchwise fashion, and then reacted at room temperature for 1 h. The reaction solution was poured into water and extracted with EA 30 mL (10 mL x 3), the organic phases were combined, dried over anhydrous sodium sulfate, and concentrated to give Int 348-3 (0.8 g, 4.4 mol) in 98% yield. Mass spectrometry: 180 (M+H) + ). TIFF0007579249000469.tif26170 TIFF0007579249000470.tif43154Int 1-15 (33 mg, 0.1 mmol) was dissolved in DMF (1 mL), DIEA (39 mg, 0.3 mmol) and HATU (38 mg, 0.1 mmol) were added, and then Int 348-3 (24 mg, 0.1 mmol) was added and stirred at room temperature for 16 hours. Water (10 mL) was added to the reaction solution, and the mixture was extracted twice with ethyl acetate. The organic phase was washed with saturated saline and concentrated to obtain the crude product, which was subjected to column chromatography to obtain the nearly white solid product 348 (25 mg) in 50% yield. Mass spectrometry: 495 (M+H + ). 1H NMR(400MHz,CDCl3):δ 7.59-7.41(m,1H),7.37-7.27(m,2H),7.21-6.88(m,4H),4.97(m,1H),4.49-4.35(m,1H),4.17-4.08(m,1H), 3.73(m,1H),3.08-2.95(m,1H),2.78-2.64(m,3H),2.59-2.36(m,2H),2.08-1.92(m,2H),1.49-1.16(m,6H).
[0137] TIFF0007579249000471.tif26170Synthesis of ethyl urea (349) TIFF0007579249000472.tif74154 Synthesis of intermediates 2,2-bis(4-methoxyphenyl)-5-methylpyrrolidine (Int 349-1) and 5-(4-methoxyphenyl)-2-methyl-3,4-dihydro-2H-pyrrole (Int 350-1) TIFF0007579249000473.tif48149SM 71 (1.9 g, 10 mmol) was dissolved in dry tetrahydrofuran (50 mL), substituted with nitrogen gas, and slowly dropped n-butyl lithium (10 mL, 1 M in hexane) at -78°C, stirred for 30 minutes, and slowly dropped 2-methyl-5-oxopyrrolidine-1-carboxylate-t-butyl (2 g, 10 mmol) and stirred for 30 minutes. Saturated aqueous ammonium chloride solution was added, extracted with ethyl acetate, dried over anhydrous sodium sulfate, and concentrated. The obtained crude product was dissolved in dichloromethane (20 mL), trifluoroacetic acid (2 mL) was added, stirred overnight, concentrated, and subjected to column chromatography to obtain intermediate Int 349-1 (500 mg). Mass spectrometry: 298 (M+H + ). Intermediate Int 350-1 (300 mg) was obtained. Mass spectrometry: 190 (M+H + ). Composition of TIFF0007579249000474.tif271709) TIFF0007579249000475.tif38154 Intermediate Int 1-15 (33 mg, 0.1 mmol), intermediate Int 349-1 (30 mg, 0.11 mmol), HATU) (50 mg, 0.13 mmol) and DIEA (20 mg, 0.15 mmol) were dissolved in DMF (5 mL), stirred overnight, added with water, extracted with EA, concentrated and subjected to column chromatography to give pale yellow solid 349 (38 mg) in 62% yield. Mass spectrometry: 613 (M+H) + ). 1 H NMR(400MHz,DMSO):δ 8.79(s,1H),8.25(s,1H),7.57(d,J=5.4Hz,1H),7.34(t,J=8.9Hz,1H),7.24(d,J=8.3Hz,1H),7.1 2-7.01(m,4H),7.00-6.91(m,2H),6.81(d,J=8.8Hz,1H),6.74(d,J=8.8Hz,1H),6.13(d,J=4.6Hz,1 H),5.91(s,1H),4.22-4.06(m,2H),3.93(td,J=13.1,6.2Hz,1H),3.78(t,J=5.9Hz,3H),3.72-3.6 7(m,3H),3.16-2.95(m,2H),2.69-2.44(m,5H),2.21(t,J=5.9Hz,2H),1.05(dd,J=6.6,2.4Hz,3H).
[0138] Composite of TIFF0007579249000476.tif26170(350) TIFF0007579249000477.tif83154 Synthesis of intermediate 2-(4-methoxyphenyl)-5-methylpyrrolidine (Int 350-2) TIFF0007579249000478.tif4862 Intermediate Int 350-1 (190 mg, 1 mmol) was dissolved in dichloromethane (10 mL), diisobutylaluminum hydride (4 mL, 1 M in DCM) was added in an ice bath, and the mixture was stirred for 4 hours. Diatomaceous earth and water (10 mL) were added, filtered, extracted with ethyl acetate, dried over anhydrous sodium sulfate, concentrated, and subjected to column chromatography to obtain a pale yellow liquid Int 350-2 (100 mg) in a yield of 53%. TIFF0007579249000479.tif26170 TIFF0007579249000480.tif44154 Int 1-15 (33 mg, 0.1 mmol), intermediate Int 350-2 (20 mg, 0.11 mmol), HATU (50 mg, 0.13 mmol) and DIEA (20 mg, 0.15 mmol) were dissolved in DMF (5 mL), stirred overnight, added with water, extracted with EA, concentrated and subjected to column chromatography to give pale yellow solid 350 (37 mg) in 73% yield. Mass spectrometry: 507 (M+H + ). 1 H NMR(400MHz,DMSO):δ 8.71(s,1H),7.53(d,J=4.8Hz,1H),7.28(d,J=8.6Hz,2H),7.23-7.08(m,2H),6. 98(dd,J=8.6,1.9Hz,2H),6.09(d,J=4.5Hz,1H),4.37(dd,J=20.2,12.2Hz,1H), 3.78(d,J=16.7Hz,2H),3.74-3.71(m,1H),3.34(s,3H),3.14-2.91(m,2H),2.70 -2.47(m,5H),2.45-2.28(m,2H),2.06-1.82(m,2H),1.36(dd,J=6.7,3.1Hz,3H).
[0139] TIFF0007579249000481.tif26170Synthesis of methylurea (351) TIFF0007579249000482.tif83154 Synthesis of intermediate 5-(4-chloro-2-methylphenyl)-2-methyl-3,4-dihydro-2H-pyrrole (Int 351-1) TIFF0007579249000483.tif47103SM 72 (2.1 g, 10 mmol) was dissolved in dry tetrahydrofuran (50 mL), substituted with nitrogen gas, and slowly dropped n-butyl lithium (10 mL, 1 M in hexane) at -78 ° C., stirred for 30 minutes, and slowly dropped 2-methyl-5-oxopyrrolidine-1-carboxylate-t-butyl (2 g, 10 mmol) and stirred for 30 minutes. Saturated aqueous ammonium chloride solution was added, extracted with ethyl acetate, dried over anhydrous sodium sulfate, and concentrated. The obtained crude product was dissolved in dichloromethane (20 mL), trifluoroacetic acid (2 mL) was added, stirred overnight, concentrated, and subjected to column chromatography to obtain intermediate Int 351-1 (600 mg), and the two-stage yield was 29%. Mass spectrometry: 208 (M + H + ). Synthesis of intermediate 2-(4-chloro-2-methylphenyl)-5-methylpyrrolidine (Int 352-2) TIFF0007579249000484.tif4761 Intermediate Int 351-1 (207 mg, 1 mmol) was dissolved in dichloromethane (10 mL), and diisobutylaluminum hydride (4 mL, 1 M in DCM) was added in an ice bath. The mixture was stirred for 4 hours, and then diatomaceous earth and water (10 mL) were added. The mixture was filtered and extracted with ethyl acetate. The mixture was dried over anhydrous sodium sulfate, concentrated, and subjected to column chromatography to obtain a pale yellow liquid Int 351-2 (153 mg) in a yield of 73%. Mass spectrometry: 210 (M+H + ). Composition of TIFF0007579249000485.tif2617051) TIFF0007579249000486.tif44154 Int 1-15 (33 mg, 0.1 mmol), intermediate Int 351-2 (21 mg, 0.11 mmol), HATU (50 mg, 0.13 mmol) and DIEA (20 mg, 0.15 mmol) were dissolved in DMF (5 mL), stirred overnight, added with water, extracted with EA, concentrated and subjected to column chromatography to give pale yellow solid 351 (38 mg) in 72% yield. Mass spectrometry: 525 (M+H + ). 1H NMR(400MHz,DMSO):δ 8.71(s,1H),7.53(s,1H),7.36-7.01(m,5H),6.08(d,J=4.5Hz,1H),5.39-5.31(m,1H),4.52-4.34(m,2H),4.22(dd,J=12. 5,6.3Hz,1H),3.06(dd,J=27.3,20.0Hz,2H),2.69-2.52(m,5H),2.46-2.29(m,5H),1.79-1.47(m,2H),1.44-1.37(m,3H).
[0140] TIFF0007579249000487.tif8169-Methyl-4-(trifluoromethyl)phenyl)pyrrolidin-1-yl)-2-oxo TIFF0007579249000488.tif9170Synthesis of [lysine]-5-yl)urea (352) TIFF0007579249000489.tif83156 Synthesis of intermediate (5-(2-methyl-4-(trifluoromethyl)phenyl)-5-oxopentan-2-yl) t-butylcarbamate (Int 352-1) TIFF0007579249000490.tif4395 Dry THF (30 mL) was added to the reaction flask, then SM 73 (2.86 g, 10 mmol) was added, and 1N isopropyl magnesium bromide (10 mL, 1M in THF) was added under nitrogen gas protection under ice-water bath conditions, then the reaction was allowed to proceed at room temperature for 7 hours, and finally t-butyl 2-methyl-5-oxopyrrolidine-1-carboxylate (1.99 g, 10 mmol) was added, and then the reaction was allowed to proceed at room temperature for 12 hours. The reaction solution was poured into a saturated aqueous ammonium chloride solution, extracted with 30 mL of ethyl acetate (10 mL x 3), and the organic phases were combined, dried over anhydrous sodium sulfate, and purified by column chromatography to obtain Int 352-1 (1.8 g, 5 mmol) in 50% yield. Mass spectrometry: 360 (M+H + ). Synthesis of intermediate 5-(2-methyl-4-(trifluoromethyl)phenyl)-2-methyl-3,4-dihydro-2H-pyrrole (Int 352-2) TIFF0007579249000491.tif4675 DCM (20 mL) was added to a reaction flask, followed by Int 352-1 (1.8 g, 5 mmol), followed by TFA (2 mL), and then reacted at room temperature for 7 hours. The reaction was poured into saturated aqueous sodium bicarbonate, extracted with 30 mL of DCM (10 mL x 3), the organic phases were combined, dried over anhydrous sodium sulfate, and purified by column chromatography to give Int 352-2 (1.08 g, 4.5 mmol) in 90% yield. Mass spectrometry: 242 (M+H + ). Synthesis of intermediate 2-(2-methyl-4-(trifluoromethyl)phenyl)-5-methylpyrrolidine (Int 352-3) TIFF0007579249000492.tif4662Methanol (15 mL) was added to the reaction flask, followed by Int 352-2 (1.08 g, 4.5 mmol), followed by sodium borohydride (0.76 g, 20 mmol) in batchwise fashion, and then reacted at room temperature for 1 h. The reaction solution was poured into water and extracted with EA 30 mL (10 mL x 3), the organic phases were combined, dried over anhydrous sodium sulfate, and concentrated to give Int 352-3 (1.07 g, 4.4 mmol) in 98% yield. Mass spectrometry: 244 (M+H) + ). TIFF0007579249000493.tif8168-(Trifluoromethyl)phenyl)pyrrolidin-1-yl)-2-oxoethyl)-2 TIFF0007579249000494.tif8170-Synthesis of (yl)urea (352) TIFF0007579249000495.tif43156 Int 1-15 (33 mg, 0.1 mmol) was dissolved in DMF (1 mL), DIEA (39 mg, 0.3 mmol) and HATU (38 mg, 0.1 mmol) were added, and then Int 352-3 (26 mg, 0.1 mmol) was added and stirred at room temperature for 16 hours. Water (10 mL) was added to the reaction solution, and the mixture was extracted twice with ethyl acetate. The organic phase was washed with saturated saline and concentrated to obtain the crude product, which was subjected to column chromatography to obtain the nearly white solid product 352 (28 mg) in 50% yield. Mass spectrometry: 559 (M+H+ ).
[0141] TIFF0007579249000496.tif26170-Synthesis of methylurea (353) TIFF0007579249000497.tif79156 Synthesis of intermediate (5-(4-fluoro-2-methylphenyl)-2-methyl-5-oxobutyl) t-butylcarbamate (Int 353-1) TIFF0007579249000498.tif4496SM 5 (2.36 g, 10 mmol) was added to a reaction flask with dry THF (20 mL), and isopropyl magnesium bromide (10 mL, 1M in THF) was added to the flask under nitrogen gas protection and ice-water bath conditions, then the ice-water bath was removed and the mixture was stirred at room temperature for 7 hours, and finally 2-methyl-5-oxopyrrolidine-1-carboxylate-t-butyl (1.99 g, 10 mmol) was added and reacted at room temperature for 12 hours. The reaction solution was poured into a saturated aqueous ammonium chloride solution, extracted with 30 mL of ethyl acetate (10 mL x 3), the organic phase was combined, dried over anhydrous sodium sulfate, and purified by column chromatography to obtain Int353-1 (2.63 g, 8.5 mmol) in 85% yield. Mass spectrometry: 310 (M+H + ). Synthesis of intermediate 5-(4-fluoro-2-methylphenyl)-2-methyl-3,4-dihydro-2H-pyrrole (Int 353-2) TIFF0007579249000499.tif4776 Int 353-1 (2.63 g, 8.5 mmol) was dissolved in DCM (23 mL), TFA (2.3 mL) was added, and the mixture was stirred at room temperature. TLC detection was performed. After the reaction was completed, the pH was adjusted to neutral with saturated aqueous sodium bicarbonate solution, extracted with DCM (10 mL x 3), dried with anhydrous sodium sulfate, and the solvent was removed by rotary evaporation to obtain Int 353-2 (1.41 g) in 87% yield. Mass spectrometry: 192 (M+H + ). Synthesis of intermediate 2-(4-fluoro-2-methylphenyl)-5-methylpyrrole (Int 353-3) TIFF0007579249000500.tif4662Int 353-2 (1.41 g, 7.4 mmol) was added to a reaction flask containing methanol (12 mL), and sodium borohydride (1.09 g, 29.58 mmol) was added batchwise while stirring at room temperature. After the addition was completed, the mixture was further stirred at room temperature and TLC detection was performed. After the reaction was completed, the reaction solution was poured into water and extracted with EA 30 mL (10 mL x 3). The organic phases were combined, dried over anhydrous sodium sulfate, and separated by column chromatography to obtain Int 353-3 (1.17 g) in 82% yield. Mass spectrometry: 194 (M+H + ). Composition of TIFF0007579249000501.tif2817053) TIFF0007579249000502.tif43155 Intermediate Int 1-15 (30 mg, 0.09 mmol) was dissolved in DMF (1 mL), DIEA (35 mg, 0.027 mmol) and HATU (41 mg, 0.011 mmol) were added, and then the raw material Int 353-3 (26 mg, 0.135 mmol) was added and stirred at room temperature for 16 hours. Water (10 mL) was added to the reaction solution, and the mixture was extracted twice with ethyl acetate. The organic phase was washed with saturated saline and concentrated to obtain the crude product, which was subjected to column chromatography to obtain the nearly white solid product 353 (37 mg) in 81% yield. Mass spectrometry: 509 (M+H + ).
[0142] TIFF0007579249000503.tif18170TIFF0007579249000504.tif11170-Synthesis of methylurea (354) TIFF0007579249000505.tif80155 Synthesis of intermediate (5-(2-bromo-4-fluorophenyl)-5-oxopentan-2-yl) t-butylcarbamate (Int 351-1) TIFF0007579249000506.tif4296 Dry THF (30 mL) was added to the reaction flask, then SM 74 (3 g, 10 mmol) was added, and 1N isopropyl magnesium bromide (10 mL, 1M in THF) was added under nitrogen gas protection under ice-water bath conditions, then the reaction was allowed to proceed at room temperature for 7 hours, and finally t-butyl 2-methyl-5-oxopyrrolidine-1-carboxylate (1.99 g, 10 mmol) was added, and then the reaction was allowed to proceed at room temperature for 12 hours. The reaction solution was poured into a saturated aqueous ammonium chloride solution, extracted with 30 mL of ethyl acetate (10 mL x 3), and the organic phases were combined, dried over anhydrous sodium sulfate, and purified by column chromatography to obtain Int 354-1 (1.87 g, 5 mmol) in 50% yield. Mass spectrometry: 374,376 (M+H + ). Synthesis of intermediate 5-(2-bromo-4-fluorophenyl)-2-methyl-3,4-dihydro-2H-pyrrole (Int 354-2) TIFF0007579249000507.tif4880 DCM (20 mL) was added to a reaction flask, followed by Int 354-1 (1.87 g, 5 mmol), followed by TFA (2 mL), and then reacted at room temperature for 7 hours. The reaction was poured into saturated aqueous sodium bicarbonate solution, extracted with 30 mL of DCM (10 mL x 3), the organic phases were combined, dried over anhydrous sodium sulfate, and purified by column chromatography to give Int 354-2 (1.15 g, 4.5 mmol) in 90% yield. Mass spectrometry: 256,258 (M+H + ). Synthesis of intermediate 2-(2-bromo-4-fluorophenyl)-5-methylpyrrolidine (Int 354-3) TIFF0007579249000508.tif4665Methanol (15 mL) was added to the reaction flask, followed by Int 354-2 (1.15 g, 4.5 mmol), followed by sodium borohydride (0.76 g, 20 mmol) in batchwise fashion, and then reacted at room temperature for 1 h. The reaction solution was poured into water and extracted with EA 30 mL (10 mL x 3), the organic phases were combined, dried over anhydrous sodium sulfate, and concentrated to give Int 354-3 (1.14 g, 4.4 mmol) in 98% yield. Mass spectrometry: 258,260 (M+H + ). Composition of TIFF0007579249000509.tif2717054) TIFF0007579249000510.tif44153 Intermediate Int 1-15 (33 mg, 0.1 mmol) was dissolved in DMF (1 mL), DIEA (39 mg, 0.3 mmol) and HATU (38 mg, 0.1 mmol) were added, and then the raw material Int 354-3 (27 mg, 0.1 mmol) was added and stirred at room temperature for 16 hours. Water (10 mL) was added to the reaction solution, and the mixture was extracted twice with ethyl acetate. The organic phase was washed with saturated saline and concentrated to obtain the crude product, which was subjected to column chromatography to obtain the nearly white solid product 354 (29 mg) in 50% yield. Mass spectrometry: 573,575 (M+H + ). 1 H NMR(400MHz,CDCl3):δ 7.64-7.26(m,3H),7.28-6.82(m,3H),5.27(m,1H),4.77-4.05(m,2H),3.82-3.36( m, 1H), 3.18-2.89 (m, 1H), 2.84-2.40 (m, 4H), 2.30-1.85 (m, 3H), 1.86-1.15 (m, 6H).
[0143] Composition of TIFF0007579249000511.tif26170 TIFF0007579249000512.tif39157 Intermediate Int 1-15 (33 mg, 0.1 mmol) was dissolved in DMF (1 mL), DIEA (39 mg, 0.3 mmol) and HATU (38 mg, 0.1 mmol) were added, and then SM 75 (24 mg, 0.1 mmol) was added and stirred at room temperature for 16 hours. Water (10 mL) was added to the reaction solution, and the mixture was extracted twice with ethyl acetate. The organic phase was washed with saturated saline and concentrated to obtain the crude product, which was subjected to column chromatography to obtain the nearly white solid product 355 (26 mg) in 50% yield. Mass spectrometry: 512 (M+H + ). 1 H NHR(400MHz,DMSO):δ 8.77(s,1H),7.55(m,1H),7.36-7.16(m,2H),6.13(d,J=4.5Hz,1H),4.43(m,2H),3.70-3.55(m,1H),3.47(m,3H),3.34 -3.27(m,1H),3.23-2.96(m,3H),2.82(m,1H),2.73-2.56(m,5H),2.00(m,3H),1.69(m,6H),1.41(m,2H),1.23(s,1H).
[0144] TIFF0007579249000513.tif9170Fluoromethyl)phenyl)-5-methylpyrrolidin-1-yl)-2-oxoethyl) TIFF0007579249000514.tif10170-5-yl)-3-methylurea (356) Synthesis TIFF0007579249000515.tif79157 Synthesis of intermediate (5-(2-trifluoromethyl-4-fluorophenyl)-5-oxopentan-2-yl) t-butylcarbamate (Int 356-1) TIFF0007579249000516.tif42100 Dry THF (30 mL) was added to the reaction flask, then SM 12 (2.9 g, 10 mmol) was added, and 1N isopropyl magnesium bromide (10 mL, 1M in THF) was added under nitrogen gas protection under ice-water bath conditions, then the reaction was allowed to proceed at room temperature for 7 hours, and finally t-butyl 2-methyl-5-oxopyrrolidine-1-carboxylate (1.99 g, 10 mmol) was added, and then the reaction was allowed to proceed at room temperature for 12 hours. The reaction solution was poured into a saturated aqueous ammonium chloride solution, extracted with 30 mL of ethyl acetate (10 mL x 3), and the organic phases were combined, dried over anhydrous sodium sulfate, and purified by column chromatography to obtain Int 356-1 (1.82 g, 5 mmol) in 50% yield. Mass spectrometry: 364 (M+H + ). Synthesis of intermediate 5-(2-trifluoromethyl-4-fluorophenyl)-2-methyl-3,4-dihydro-2H-pyrrole (Int 356-2) TIFF0007579249000517.tif4680 DCM (20 mL) was added to a reaction flask, followed by Int 356-1 (1.82 g, 5 mmol), followed by TFA (2 mL), and then reacted at room temperature for 7 hours. The reaction was poured into saturated aqueous sodium bicarbonate solution, extracted with 30 mL of DCM (10 mL x 3), the organic phases were combined, dried over anhydrous sodium sulfate, and purified by column chromatography to give Int 356-2 (1.1 g, 4.5 mmol) in 90% yield. Mass spectrometry: 246 (M+H + ). Synthesis of intermediate 2-(2-trifluoromethyl-4-fluorophenyl)-5-methylpyrrolidine (Int 356-3) TIFF0007579249000518.tif4668Methanol (15 mL) was added to the reaction flask, followed by Int 356-2 (1.1 g, 4.5 mmol), followed by sodium borohydride (0.76 g, 20 mmol) in batchwise fashion, and then reacted at room temperature for 1 h. The reaction solution was poured into water and extracted with EA 30 mL (10 mL x 3), the organic phases were combined, dried over anhydrous sodium sulfate, and concentrated to give Int 356-3 (1.1 g, 4.4 mmol) in 98% yield. Mass spectrometry: 248 (M+H) + ). TIFF0007579249000519.tif26170-Synthesis of methylurea (356) TIFF0007579249000520.tif40153 Intermediate Int 1-15 (33 mg, 0.1 mmol) was dissolved in DMF (1 mL), DIEA (39 mg, 0.3 mmol) and HATU (38 mg, 0.1 mmol) were added, and then Int 356-3 (24 mg, 0.1 mmol) was added and stirred at room temperature for 16 hours. Water (10 mL) was added to the reaction solution, and the mixture was extracted twice with ethyl acetate. The organic phase was washed with saturated saline and concentrated to obtain the crude product, which was subjected to column chromatography to obtain the nearly white solid product 356 (28 mg) in 50% yield. Mass spectrometry: 563 (M+H + ). 1 H NMR(400MHz,DMSO):δ 8.92-8.56(s,1H),7.78-7.39(m,4H),7.32-7.01(m,2H),6.17-6.01(m,1H),5.47-4.99(m,1H),4.77-4.47(m,1H),4.45-4 .17(m,2H),3.30(m,1H),3.18-2.87(m,2H),2.71-2.59(m,3H),2.39(m,2H),2.14(m,1H),1.89-1.55(m,2H),1.45(m,3H).
[0145] TIFF0007579249000521.tif27170 Synthesis of element (357)
[0146] TIFF0007579249000522.tif28170-Synthesis of methylurea (359) TIFF0007579249000523.tif77153 Synthesis of intermediate (5-(3-chloro-4-fluorophenyl)-5-oxopentan-2-yl) t-butylcarbamate (Int 359-1) TIFF0007579249000524.tif4195 Add dry THF (30mL) to the reaction flask, then add SM 76 (2.58g, 10mmol), add 1N isopropylmagnesium bromide (10mL, 1M in THF) under nitrogen gas protection in ice-water bath condition, then react at room temperature for 7 hours, finally add t-butyl 2-methyl-5-oxopyrrolidine-1-carboxylate (1.99g, 10mmol), then react at room temperature for 12 hours. The reaction liquid was poured into saturated aqueous ammonium chloride solution, extracted with ethyl acetate 30mL (10mL x 3), the organic phase was combined, dried over anhydrous sodium sulfate, and purified by column chromatography to obtain Int 359-1 (1.66g, 5mmol) in 50% yield. Mass spectrometry: 330, 331 (M+H + ). Synthesis of intermediate 5-(3-chloro-4-fluorophenyl)-2-methyl-3,4-dihydro-2H-pyrrole (Int 359-2) TIFF0007579249000525.tif4778 DCM (20 mL) was added to a reaction flask, followed by Int 359-1 (1.66 g, 5 mmol), followed by TFA (2 mL), and then reacted at room temperature for 7 hours. The reaction was poured into saturated aqueous sodium bicarbonate solution, extracted with 30 mL of DCM (10 mL x 3), the organic phases were combined, dried over anhydrous sodium sulfate, and purified by column chromatography to give Int 359-2 (0.95 g, 4.5 mmol) in 90% yield. Mass spectrometry: 212, 213 (M+H + ). Synthesis of intermediate 2-(3-chloro-4-fluorophenyl)-5-methylpyrrolidine (Int 359-3) TIFF0007579249000526.tif4765Methanol (15 mL) was added to the reaction flask, followed by Int 359-2 (0.95 g, 4.5 mmol), followed by sodium borohydride (0.76 g, 20 mmol) in batchwise fashion, and then reacted at room temperature for 1 h. The reaction solution was poured into water and extracted with EA 30 mL (10 mL x 3), the organic phases were combined, dried over anhydrous sodium sulfate, and concentrated to give Int 359-3 (0.95 g, 4.4 mmol) in 98% yield. Mass spectrometry: 214, 215 (M+H) + ). Composition of TIFF0007579249000527.tif2717059) TIFF0007579249000528.tif41153Int 1-15 (33 mg, 0.1 mmol) was dissolved in DMF (1 mL), DIEA (39 mg, 0.3 mmol) and HATU (38 mg, 0.1 mmol) were added, and then Int 359-3 (24 mg, 0.1 mmol) was added and stirred at room temperature for 16 hours. Water (10 mL) was added to the reaction solution, and the mixture was extracted twice with ethyl acetate. The organic phase was washed with saturated saline and concentrated to obtain the crude product, which was subjected to column chromatography to obtain the nearly white solid product 359 (26 mg) in 50% yield. Mass spectrometry: 529,530 (M+H + ). 1 H NMR(400MHz,CDCl3):δ 7.61-7.45(m,1H),7.44-7.25(m,2H),7.16-6.77(m,3H),5.42-5.22(m,1H),4.96-4.78(m,1H),4.54-4.20(m,1H),3.67(m,1H),3.10- 2.94(m,1H),2.92-2.84(m,1H),2.62(s,3H),2.37(m,2H),2.05-1.74(m,2H),1.62-1.48(m,1H),1.45-1.30(m,3H),1.23-1.13(m,1H).
[0147] TIFF0007579249000529.tif27170 Synthesis of (3-methyl)-3-methylurea (360) TIFF0007579249000530.tif36154 Synthesis of intermediate (R)-ethyl 5-(4-fluorophenyl)pyrrolidine-2-carboxylate (Int 360-1) TIFF0007579249000531.tif5566Int 51-2 (1.06 g, 4.5 mmol) was added to a reaction flask containing methanol (10 mL), and sodium borohydride (0.68 g, 18 mmol) was added batchwise while stirring at room temperature. After the addition was completed, the mixture was further stirred at room temperature and TLC detection was performed. After the reaction was completed, the reaction solution was poured into water and extracted with EA 30 mL (10 mL x 3). The organic phases were combined, dried over anhydrous sodium sulfate, and separated by column chromatography to obtain Int 360-1 (0.91 g) in 85% yield. Mass spectrometry: 238 (M+H + ). Synthesis of intermediate (R)-(5-(4-fluorophenyl)pyrrolidin-2-yl)methanol (Int 360-2) TIFF0007579249000532.tif5367Int 360-1 (0.91 g, 3.8 mmol) was added to a reaction flask containing tetrahydrofuran (10 mL), and lithium aluminum hydride (0.58 g, 15.3 mmol) was added batchwise while stirring at room temperature. After the addition was completed, the mixture was further stirred at room temperature and TLC detection was performed. After the reaction was completed, sodium sulfate decahydrate was added to the reaction solution, which was stirred, filtered, dried over anhydrous sodium sulfate, and distilled under reduced pressure to obtain Int 360-2 (0.44 g) in 60% yield. Mass spectrometry: 196 (M+H + ). TIFF0007579249000533.tif26170Synthesis of urea (360) TIFF0007579249000534.tif43154 Intermediate Int 1-15 (30 mg, 0.09 mmol) was dissolved in DMF (1 mL), DIEA (35 mg, 0.027 mmol) and HATU (41 mg, 0.011 mmol) were added, and then the raw material Int 347-3 (26 mg, 0.135 mmol) was added and stirred at room temperature for 16 hours. Water (10 mL) was added to the reaction solution, and the mixture was extracted twice with ethyl acetate. The organic phase was washed with saturated saline and concentrated to obtain the crude product, which was subjected to column chromatography to obtain the nearly white solid product 360 (36 mg) in 78% yield. Mass spectrometry: 511 (M+H + ). 1 H NMR(400MHz,CDCl3):δ 7.55-7.45(m,2H),7.30(dd,J=11.2,6.8Hz,2H),7.09(dd,J=15.5,7.0Hz,2H),6.96-6.90(m,1H),5. 33(d,J=4.5Hz,1H),5.03(d,J=6.3Hz,1H),4.33(dd,J=12.4,6.8Hz,1H),4.25(d,J=16.5Hz,1H),3.8 6-3.71(m,3H),3.17-3.07(m,1H),2.99(dd,J=13.4,5.4Hz,2H),2.81(s,2H),2.74(d,J=4.2Hz,3H), 2.43(d,J=7.3Hz,1H),2.00(d,J=12.9Hz,1H),1.83(d,J=6.5Hz,1H),1.76-1.67(m,1H),1.25(s,1H).
[0148] TIFF0007579249000535.tif26170Synthesis of (3-methyl)-3-methylurea (361) TIFF0007579249000536.tif47155 Intermediate Int 1-15 (30 mg, 0.09 mmol) was dissolved in DMF (1 mL), DIEA (35 mg, 0.027 mmol) and HATU (41 mg, 0.011 mmol) were added, and then the raw material Int 361-1 (26 mg, 0.135 mmol) was added and stirred at room temperature for 16 hours. Water (10 mL) was added to the reaction solution, and the mixture was extracted twice with ethyl acetate. The organic phase was washed with saturated saline and concentrated to obtain the crude product, which was subjected to column chromatography to obtain the nearly white solid product 361 (33 mg) in 71% yield. Mass spectrometry: 511 (M+H + ). 1 H NMR(400MHz,CDCl3):δ 7.55-7.45(m,2H),7.30(dd,J=11.2,6.8Hz,2H),7.09(dd,J=15.5,7.0Hz,2H),6.96-6.90(m,1H),5. 33(d,J=4.5Hz,1H),5.03(d,J=6.3Hz,1H),4.33(dd,J=12.4,6.8Hz,1H),4.25(d,J=16.5Hz,1H),3.8 6-3.71(m,3H),3.17-3.07(m,1H),2.99(dd,J=13.4,5.4Hz,2H),2.81(s,2H),2.74(d,J=4.2Hz,3H), 2.43(d,J=7.3Hz,1H),2.00(d,J=12.9Hz,1H),1.83(d,J=6.5Hz,1H),1.76-1.67(m,1H),1.25(s,1H).
[0149] TIFF0007579249000537.tif26170-Synthesis of 3-methylurea (362) TIFF0007579249000538.tif70170 Synthesis of element (362) TIFF0007579249000539.tif49155 Intermediate Int 1-15 (30 mg, 0.09 mmol) was dissolved in DMF (1 mL), DIEA (35 mg, 0.027 mmol) and HATU (41 mg, 0.011 mmol) were added, and then Int 362-1 (27 mg, 0.135 mmol) was added and stirred at room temperature for 16 hours. Water (10 mL) was added to the reaction solution, and the mixture was extracted twice with ethyl acetate. The organic phase was washed with saturated saline and concentrated to obtain the crude product, which was subjected to column chromatography to obtain the nearly white solid product 362 (36 mg) in 76% yield. Mass spectrometry: 525 (M+H + ). 1 H NMR(400MHz,CDCl3):δ 7.55-7.45(m,2H),7.30(dd,J=11.2,6.8Hz,2H),7.09(dd,J=15.5,7.0Hz,2H),6.96-6.90(m,1H),5.33( d,J=4.5Hz,1H),5.03(d,J=6.3Hz,1H),4.33(dd,J=12.4,6.8Hz,1H),4.25(d,J=16.5Hz,1H),3.86-3.71 (m,2H),3.31(s,3H),3.17-3.07(m,1H),2.99(dd,J=13.4,5.4Hz,2H),2.81(s,2H),2.74(d,J=4.2Hz,3H ),2.43(d,J=7.3Hz,1H),2.00(d,J=12.9Hz,1H),1.83(d,J=6.5Hz,1H),1.76-1.67(m,1H),1.25(s,1H).
[0150] TIFF0007579249000540.tif8170phenyl)-5-(hydroxymethyl)pyrrolidin-1-yl)-2-oxoethyl)-2 TIFF0007579249000541.tif10170-Il)-3-methylurea (363) Synthesis TIFF0007579249000542.tif83157 Synthesis of intermediate (S)-methyl-2-((t-butoxycarbonyl)amino)-5-(4-fluorophenyl)-5-oxovalerate (Int 363-1) TIFF0007579249000543.tif4691 Dry THF (30 mL) was added to the reaction flask, then SM 10 (2.22 g, 10 mmol) was added, and 1N isopropyl magnesium bromide (10 mL, 1M in THF) was added under nitrogen gas protection in ice-water bath conditions, then reacted at room temperature for 7 hours, and finally (S)-1-t-butyl 2-methyl-5-oxopyrrolidine-1,2-dicarboxylate (2.43 g, 10 mmol) was added, and then reacted at room temperature for 12 hours. The reaction solution was poured into a saturated aqueous ammonium chloride solution, extracted with 30 mL of ethyl acetate (10 mL x 3), and the organic phases were combined, dried over anhydrous sodium sulfate, and purified by column chromatography to obtain Int 363-1 (1.7 g, 5 mmol) in 50% yield. Mass spectrometry: 340 (M+H + ). Synthesis of intermediate (S)-methyl-5-(4-fluorophenyl)-3,4-dihydro-2H-pyrrole-2-carboxylate (Int 363-2) TIFF0007579249000544.tif5373 DCM (20 mL) was added to a reaction flask, followed by Int 363-1 (1.7 g, 5 mmol), followed by TFA (2 mL), and then reacted at room temperature for 7 hours. The reaction was poured into saturated aqueous sodium bicarbonate solution, extracted with 30 mL of DCM (10 mL x 3), the organic phases were combined, dried over anhydrous sodium sulfate, and purified by column chromatography to give Int 363-2 (1 g, 4.5 mmol) in 90% yield. Mass spectrometry: 222 (M+H + ). Synthesis of intermediate ((2S)-5-(4-fluorophenyl)pyrrolidin-2-yl)methanol TIFF0007579249000545.tif5370 DCM (15 mL) was added to a reaction flask, followed by Int 363-2 (1 g, 4.5 mmol). The temperature was lowered to -78°C under nitrogen gas protection, DIBAH (36 mL, 1 M in DCM) was added, and the temperature was gradually returned to room temperature for 15 hours. The reaction solution was poured into ice-cooled 1N aqueous sodium hydroxide solution, extracted with DCM, and the organic phases were combined, dried over anhydrous sodium sulfate, and concentrated to give Int 363-3 (0.86 g, 4.4 mmol) in 98% yield. Mass spectrometry: 196 (M+H + ). TIFF0007579249000546.tif18170TIFF0007579249000547.tif8170Synthesis of methylurea (363) TIFF0007579249000548.tif45154Int 1-15 (33 mg, 0.1 mmol) was dissolved in DMF (1 mL), DIEA (39 mg, 0.3 mmol) and HATU (38 mg, 0.1 mmol) were added, and then Int 363-3 (24 mg, 0.1 mmol) was added and stirred at room temperature for 16 hours. Water (10 mL) was added to the reaction solution, and the mixture was extracted twice with ethyl acetate. The organic phase was washed with saturated saline and concentrated to obtain the crude product, which was then subjected to column chromatography to obtain product 363 (26 mg) in 50% yield. Mass spectrometry: 511 (M+H + ). 1 H NMR(400MHz,CDCl3):δ 7.54-7.29(m,3H),7.16-7.04(m,2H),6.91(m,1H),5.38(m 1H),5.10-4.96(m,1H),4.55-4.27(m,2H),3.86-3.76(m,2H),3.19-2.86(m,2H) ),2.81(s,3H),2.78-2.65(m,3H),2.52-2.32(m,2H),2.04(m,2H),1.26(m,1H).
[0151] TIFF0007579249000549.tif26170Synthesis of urea (365) TIFF0007579249000550.tif4615725mL reaction flask was added with DMF (3mL), then Int 1-15 (33.3mg, 0.1mmol), Int 365-1 (19.3mg, 0.1mmol), DIEA (38.7mg, 0.3mmol), and finally HATU (38.1mg, 0.1mmol) were added, and the system was reacted at 20°C for 1 hour. After the reaction was completed, the reaction solution was poured into water (20mL), extracted with ethyl acetate 30mL (10mL x 3), the organic phase was combined, dried over anhydrous sodium sulfate, and purified by column chromatography to obtain compound 365 (28mg) in 55% yield. Mass spectrometry: 509 (M+H + ).
[0152] TIFF0007579249000551.tif27170-Synthesis of methylurea (366) TIFF0007579249000552.tif83154 Synthesis of intermediate (5-(3,4-difluorophenyl)-2-methyl-5-oxopentan-2-yl) t-butylcarbamate (Int 366-1) TIFF0007579249000553.tif4293 Dry THF (30 mL) was added to the reaction flask, then SM 44 (2.4 g, 10 mmol) was added, and 1N isopropyl magnesium bromide (10 mL, 1M in THF) was added under nitrogen gas protection in ice-water bath conditions, then reacted at room temperature for 7 hours, and finally Int 39-3 (2.13 g, 10 mmol) was added, and then reacted at room temperature for 12 hours. The reaction solution was poured into saturated aqueous ammonium chloride solution, extracted with 30 mL of ethyl acetate (10 mL x 3), the organic phases were combined, dried over anhydrous sodium sulfate, and purified by column chromatography to obtain Int 366-1 (1.8 g, 5.5 mmol) in 55% yield. Mass spectrometry: 328 (M+H + ). Synthesis of intermediate 5-(3,4-difluorophenyl)-2,2-dimethyl-3,4-dihydro-2H-pyrrole (Int 366-2) TIFF0007579249000554.tif4772 DCM (20 mL) was added to a reaction flask, followed by Int 366-1 (1.64 g, 5 mmol), followed by TFA (2 mL), and then reacted at room temperature for 7 hours. The reaction was poured into saturated aqueous sodium bicarbonate, extracted with 30 mL of DCM (10 mL x 3), the organic phases were combined, dried over anhydrous sodium sulfate, and purified by column chromatography to give Int 366-2 (941 mg, 4.5 mmol) in 90% yield. Mass spectrometry: 210 (M+H + ). Synthesis of intermediate 5-(3,4-difluorophenyl)-2,2-dimethylpyrrolidine (Int 366-3) TIFF0007579249000555.tif4762 Methanol (15 mL) was added to the reaction flask, followed by Int 366-2 (836 mg, 4 mmol), followed by sodium borohydride (0.76 g, 20 mmol) in batchwise fashion, and then reacted at room temperature for 1 h. The reaction solution was poured into water and extracted with EA 30 mL (10 mL x 3), the organic phases were combined, dried over anhydrous sodium sulfate, and concentrated to give Int 366-3 (802 mg, 3.8 mmol) in 95% yield. Mass spectrometry: 212 (M+H + ). Composition of TIFF0007579249000556.tif2717066) TIFF0007579249000557.tif4415425mL reaction flask was added with DMF (3mL), then Int 1-15 (33.3mg, 0.1mmol), Int 366-3 (21.1mg, 0.1mmol), DIEA (38.7mg, 0.3mmol), and finally HATU (38.1mg, 0.1mmol) were added, and the system was reacted at 20°C for 1 hour. After the reaction was completed, the reaction solution was poured into water (20mL), extracted with ethyl acetate 30mL (10mL x 3), the organic phase was combined, dried over anhydrous sodium sulfate, and purified by column chromatography to obtain compound 366 (26.3mg) in 50% yield. Mass spectrometry: 527 (M+H + ). 1H NMR(400MHz,CDCl3):δ 7.51(s,1H),7.29(t,J=8.2Hz,1H),7.19-7.00(m,5H),6.90(s,1H),5.35(d,J=8.6Hz,1H),5.13(s,1H),4.35-3.66( m,2H),3.22-2.90(m,2H),2.77(d,J=8.9Hz,3H),2.50(m,2H),1.99-1.89(m,2H),1.79(m,1H),1.49(d,J=5.8Hz,6H).
[0153] TIFF0007579249000558.tif27170-Synthesis of methylurea (367) TIFF0007579249000559.tif86154 Synthesis of intermediate (2S,5R)-2-(4-fluorophenyl)-5-formylpyrrolidine-1-carboxylate-t-butyl (Int 367-1) TIFF0007579249000560.tif50722 Int 367-1 (400 mg, 1.4 mmol) and dichloromethane (5 mL) were added to a 5 mL reaction flask, and finally Dess-Martin reagent (579 mg, 1.4 mmol) was added batchwise, and the system was reacted at room temperature overnight. After the reaction was completed, it was filtered and washed with aqueous sodium bicarbonate, and the organic layer was dried over anhydrous sodium sulfate and purified by column chromatography to obtain compound Int 367-2 (375 mg) in a yield of 94%. Mass spectrometry: 294.2 (M+H + ). Synthesis of intermediate (2S,5R)-2-(4-fluorophenyl)-5-vinylpyrrolidine-1-carboxylate-t-butyl (Int 367-2) TIFF0007579249000561.tif48782 Methyltriphenylphosphonium bromide (146 mg, 0.41 mmol) and tetrahydrofuran (3 mL) were added to a 5 mL reaction flask, and sodium t-butoxide (44 mg, 0.45 mmol) was added in a batchwise manner under ice bath. After about 1 hour of reaction, Int 367-2 (100 mg, 0.34 mmol) was added to the reaction solution, and the reaction was carried out at room temperature overnight. Water (5 mL) was added to the reaction flask, and the mixture was extracted with ethyl acetate (5 mL x 3). The organic phase was combined, dried over anhydrous sodium sulfate, and purified by column chromatography to obtain compound Int 367-3 (33 mg) in a yield of 33%. Mass spectrometry: 292.2 (M+H + ). Synthesis of intermediate ((2S,5R)-2-(4-fluorophenyl)-5-vinylpyrrolidine (Int 367-4) TIFF0007579249000562.tif47602 Int 367-3 (33 mg, 0.12 mmol) and dichloromethane (0.5 mL) were added to a 5 mL reaction flask, and finally, trifluoroacetic acid (1 mL) was added and reacted for about 3 hours. After the reaction was completed, the solvent was removed by rotary evaporation in vacuum, dichloromethane (5 mL) was added and washed with aqueous sodium bicarbonate, the organic layer was dried over anhydrous sodium sulfate, and the solvent was removed by rotary evaporation in vacuum to obtain crude Int 367-4 (13 mg) in 59% yield. Mass spectrometry: 192.2 (M+H + ). Composition of TIFF0007579249000563.tif3017067) TIFF0007579249000564.tif4415525mL reaction flask was added with DMF (1mL), then Int 1-15 (23mg, 0.07mmol), Int 367-3 (13mg, 0.07mmol), DIEA (27mg, 0.21mmol), and finally HATU (42mg, 0.11mmol) were added, and the system was reacted at room temperature overnight. After the reaction was completed, water (5mL) was added to the reaction solution, extracted with ethyl acetate (5mL x 3), the organic phase was combined, dried over anhydrous sodium sulfate, and purified by column chromatography to obtain compound 367 (9mg) in 25% yield. Mass spectrometry: 507.2 (M+H + ).
[0154] TIFF0007579249000565.tif12170(2,2,6,6-Tetramethylpiperazin-1-yl)ethyl)-2,3-dihydrospiro TIFF0007579249000566.tif54170 Intermediate Int 1-15 (33 mg, 0.1 mmol), SM 77 (15 mg, 0.11 mmol), HATU (50 mg, 0.13 mmol) and DIEA (20 mg, 0.15 mmol) were dissolved in dichloromethane (5 mL), stirred overnight, concentrated and subjected to column chromatography to give pale yellow solid 368 (35 mg) in 77% yield. Mass spectrometry: 457 (M+H + ).
[0155] TIFF0007579249000567.tif131704-Fluorophenyl)-5-methylpyrrolidin-1-yl)-2-oxoethyl)-2 TIFF0007579249000568.tif12170 Synthesis of (3-methyl)-3-methylurea (369) TIFF0007579249000569.tif4015525mL reaction flask was added with DMF (3mL), then Int 1-15 (333mg, 1mmol), Int 213-4 (213mg, 1mmol), DIEA (387mg, 3mmol), and finally HATU (381mg, 1mmol) were added, and the system was reacted at 20°C for 1 hour. After the reaction was completed, the reaction solution was poured into water (20mL), extracted with 30mL of ethyl acetate (10mL x 3), the organic phase was combined, dried over anhydrous sodium sulfate, and purified by column chromatography to obtain compound 369 (270mg) in 59% yield. Mass spectrometry: 529 (M+H + ).
[0156] TIFF0007579249000570.tif29170-Synthesis of methylurea (370) TIFF0007579249000571.tif83156 Synthesis of intermediate (S)-(5-(2,4-difluorophenyl)-5-oxopentan-2-yl) t-butylcarbamate (Int 370-1) TIFF0007579249000572.tif4397 Dry THF (30 mL) was added to the reaction flask, then SM 78 (2.4 g, 10 mmol) was added, and 1N isopropyl magnesium bromide (10 mL, 1M in THF) was added under nitrogen gas protection in ice-water bath conditions, then the reaction was carried out at room temperature for 7 hours, and finally (S)- 2-methyl-5-oxopyrrolidine-1-carboxylate t-butyl (1.99 g, 10 mmol) was added, and then the reaction was carried out at room temperature for 12 hours. The reaction solution was poured into a saturated aqueous ammonium chloride solution, extracted with ethyl acetate 30 mL (10 mL x 3), the organic phase was combined, dried over anhydrous sodium sulfate, and purified by column chromatography to obtain Int 370-1 (1.5 g, 5 mmol) in 50% yield. Mass spectrometry: 314 (M+H + ). Synthesis of intermediate (S)-5-(2,4-difluorophenyl)-2-methyl-3,4-dihydro-2H-pyrrole (Int 370-2) TIFF0007579249000573.tif4877 DCM (20 mL) was added to a reaction flask, followed by Int 370-1 (1.5 g, 5 mmol), followed by TFA (2 mL), and then reacted at room temperature for 7 hours. The reaction was poured into saturated aqueous sodium bicarbonate solution, extracted with 30 mL of DCM (10 mL x 3), the organic phases were combined, dried over anhydrous sodium sulfate, and purified by column chromatography to give Int 370-2 (0.8 g, 4.5 mmol) in 90% yield. Mass spectrometry: 196 (M+H + ). Synthesis of intermediate (5S)-2-(2,4-difluorophenyl)-5-methylpyrrolidine (Int370-3) TIFF0007579249000574.tif4864Methanol (15 mL) was added to the reaction flask, followed by Int 370-2 (0.8 g, 4.5 mmol), followed by sodium borohydride (0.76 g, 20 mmol) in batchwise, and then reacted at room temperature for 1 h. The reaction solution was poured into water, extracted with EA 30 mL (10 mL x 3), the organic phases were combined, dried over anhydrous sodium sulfate, and concentrated to obtain the crude racemate, which was purified to give Int 370-3 (0.8 g, 4.4 mmol) in 800% yield. Mass spectrometry: 198 (M+H) + ). TIFF0007579249000575.tif30170 Synthesis of element (370) TIFF0007579249000576.tif44156 Int1-15 (33 mg, 0.1 mmol) was dissolved in DMF (1 mL), DIEA (39 mg, 0.3 mmol) and HATU (38 mg, 0.1 mmol) were added, and then Int370-3 (24 mg, 0.1 mmol) was added and stirred at room temperature for 16 hours. Water (10 mL) was added to the reaction solution, and the mixture was extracted twice with ethyl acetate. The organic phase was washed with saturated saline and concentrated to obtain the crude product, which was subjected to column chromatography to obtain the nearly white solid product 370 (26 mg) in 50% yield. Mass spectrometry: 513 (M+H + ). 1H NMR(400MHz,CDCl3):δ 7.47(m,2H),7.25-7.05(m,1H),6.99-6.51(m,3H),5.47-5.11(m,1H),4.57-4.37(m,1H),4.30(m,1H),3. 81(m,1H),3.13-2.90(m,2H),2.76-2.65(m,3H),2.64-2.40(m,2H),2.24-1.51(m,4H),1.34-1.22(m,3H).
[0157] TIFF0007579249000577.tif27170Synthesis of cyclopropyl urea (371) TIFF0007579249000578.tif38152Triphosgene (35 mg, 0.12 mmol) was added to dichloromethane (5 mL), and a mixture of compound Int 114-4 (62 mg, 0.2 mmol), triethylamine (200 mg, 2 mmol) and dichloromethane (5 mL) was slowly added dropwise to the reaction flask under ice bath. After the dropwise addition, the mixture was stirred for 1 hour, and cyclopropylamine (33 mg, 0.5 mmol) was added and stirred for 4 hours. Water (10 mL) was added, and the organic layer was separated and extracted with dichloromethane. The organic phases were combined, dried over anhydrous sodium sulfate, concentrated, and subjected to column chromatography to obtain a yellow solid 371 (30 mg) in a yield of 45%. Mass spectrometry: 521 (M+H + ).
[0158] TIFF0007579249000579.tif77170 Intermediate Int 97-12 (36 mg, 0.1 mmol), intermediate Int 14-3 (18 mg, 0.11 mmol), HATU (50 mg, 0.13 mmol) and DIEA (20 mg, 0.15 mmol) were dissolved in dichloromethane (5 mL), stirred overnight, concentrated and subjected to column chromatography to give pale yellow solid 373 (37 mg) in 71% yield. Mass spectrometry: 521 (M+H + ).
[0159] TIFF0007579249000580.tif29170-Synthesis of methylurea (374) TIFF0007579249000581.tif80157 Synthesis of intermediate (5S)-2-(3,4-difluorophenyl)-5-methylpyrrolidine (Int374-1) TIFF0007579249000582.tif4663 DCM (15 mL) was added to a reaction flask, followed by Int 201-2 (195 mg, 1 mmol), followed by sodium borohydride (152 mg, 4 mmol) in batchwise fashion, and then reacted at room temperature for 1 h. The reaction solution was poured into water and extracted with EA 30 mL (10 mL x 3), the organic phases were combined, dried over anhydrous sodium sulfate, and concentrated to give Int 374-1 (187 mg, 0.95 mmol) in 95% yield. Mass spectrometry: 198 (M+H + ). TIFF0007579249000583.tif28170 Synthesis of element (374) TIFF0007579249000584.tif4215325mL reaction flask was added with DMF (3mL), then Int 1-15 (33.3mg, 0.1mmol), Int 374-1 (19.7mg, 0.1mmol), DIEA (38.7mg, 0.3mmol), and finally HATU (38.1mg, 0.1mmol) were added, and the system was reacted at 20°C for 1 hour. After the reaction was completed, the reaction solution was poured into water (20mL), extracted with ethyl acetate 30mL (10mL x 3), the organic phase was combined, dried over anhydrous sodium sulfate, and purified by column chromatography to obtain compound 374 (28.2mg) in 55% yield. Mass spectrometry: 513 (M+H + ).
[0160] Composition of TIFF0007579249000585.tif2717075) TIFF0007579249000586.tif77157 Synthesis of intermediate (S)-(5-oxo-5-(pyridin-4-yl)pent-2-yl) t-butylcarbamate (Int 375-1) TIFF0007579249000587.tif3890 Dry THF (30 mL) was added to the reaction flask, then SM 79 (2.05 g, 10 mmol) was added, and 1N isopropyl magnesium bromide (10 mL, 1M in THF) was added under nitrogen gas protection in ice-water bath conditions, then the reaction was carried out at room temperature for 7 hours, and finally (S)- 2-methyl-5-oxopyrrolidine-1-carboxylate t-butyl (2.13 g, 10 mmol) was added, and then the reaction was carried out at room temperature for 12 hours. The reaction solution was poured into a saturated aqueous ammonium chloride solution, extracted with ethyl acetate 30 mL (10 mL x 3), the organic phase was combined, dried over anhydrous sodium sulfate, and purified by column chromatography to obtain Int 375-1 (1.53 g, 5.5 mmol) in 55% yield. Mass spectrometry: 279 (M+H + ). Synthesis of intermediate (S)-4-(2-methyl-3,4-dihydro-2H-pyrrol-5-yl)pyridine (Int 375-2) TIFF0007579249000588.tif4367 DCM (20 mL) was added to a reaction flask, followed by Int 375-1 (1.39 g, 5 mmol), followed by TFA (2 mL), and then reacted at room temperature for 7 hours. The reaction was poured into saturated aqueous sodium bicarbonate solution, extracted with 30 mL of DCM (10 mL x 3), the organic phases were combined, dried over anhydrous sodium sulfate, and purified by column chromatography to give Int 375-2 (640 mg, 4 mmol) in 80% yield. Mass spectrometry: 161 (M+H + ). Synthesis of intermediate 4-((5S)-5-methylpyrrolidin-2-yl)pyridine (Int 375-3) TIFF0007579249000589.tif4257 DCM (15 mL) was added to a reaction flask, followed by Int 375-2 (483 mg, 3 mmol), followed by sodium borohydride (0.57 g, 15 mmol) in a batchwise manner, and then reacted at room temperature for 1 h. The reaction solution was poured into water and extracted with EA 30 mL (10 mL x 3), the organic phases were combined, dried over anhydrous sodium sulfate, and concentrated to give Int 375-3 (462 mg, 2.85 mmol) in 95% yield. Mass spectrometry: 163 (M+H + ). TIFF0007579249000590.tif7017025mL reaction flask was added with DMF (3mL), then Int 1-15 (33.3mg, 0.1mmol), Int 375-3 (16.2mg, 0.1mmol), DIEA (38.7mg, 0.3mmol), and finally HATU (38.1mg, 0.1mmol) were added, and the system was reacted at 20°C for 1 hour. After the reaction was completed, the reaction solution was poured into water (20mL), extracted with ethyl acetate 30mL (10mL x 3), the organic phase was combined, dried over anhydrous sodium sulfate, and purified by column chromatography to obtain compound 375 (24.8mg) in 52% yield. Mass spectrometry: 478 (M+H + ). 1 H NMR(400MHz,CDCl3):δ 8.63(dd,J=10.7,6.0Hz,1H),8.40(dd,J=38.2,6.0Hz,1H),7.65-7.41(m,2H),7.18(m ,1H),7.06(m,1H),6.96-6.55(m,1H),5.51-5.29(m,1H),5.05m,1H),4.61-4.39(m,1H) ),4.35-4.13(m,1H),3.80-3.44(m,1H),3.07m,1H),2.98-2.91(m,1H),2.68m,3H),2. 48-2.42(m,1H),2.27-2.18(m,2H),2.01-1.76(m,1H),1.49(m,2H),1.26-1.22(m,4H).
[0161] TIFF0007579249000591.tif9167-2-(4-fluorophenyl)-5-methylpyrrolidin-1-yl)-2-oxoethyl Synthesis of 170-5-phenylacetamide (376) TIFF0007579249000593.tif401512,2-Difluoroacetic acid (100 mg, 1 mmol) was dissolved in dichloromethane (5 mL), oxalyl chloride (127 mg, 1 mmol) was added dropwise, and the mixture was stirred at room temperature for 1 hour and concentrated. The obtained crude product was added to dichloromethane (5 mL), and triethylamine (101 mg, 1 mmol) and Int 114-4 (44 mg, 0.1 mmol) were added, and the mixture was stirred at room temperature overnight. The mixture was concentrated and subjected to column chromatography to obtain a yellow solid 376 (33 mg) in a yield of 64%. Mass spectrometry: 516 (M+H + ).
[0162] Synthesis of 2-methoxypropionamide (377) TIFF0007579249000595.tif38155(S)-2-Methoxypropionic acid (104 mg, 1 mmol) was dissolved in dichloromethane (5 mL), oxalyl chloride (127 mg, 1 mmol) was added dropwise, and the mixture was stirred at room temperature for 1 hour and concentrated. The obtained crude product was added to dichloromethane (5 mL), and triethylamine (101 mg, 1 mmol) and Int 114-4 (44 mg, 0.1 mmol) were added, and the mixture was stirred at room temperature overnight. The mixture was concentrated and subjected to column chromatography to obtain a yellow solid 377 (35 mg) in a yield of 67%. Mass spectrometry: 524 (M+H + ).
[0163] TIFF0007579249000596.tif11170O-6-aza-spiro[2.5]oct-6-yl)methyl)-5-methylpyrrolidine TIFF0007579249000597.tif81170 Synthesis of intermediate (S)-(5-oxopyrrolidin-2-yl)methyl-4-benzenesulfonate methyl ester (Int 378-1) TIFF0007579249000598.tif2985 DCM (30 mL) was added to the reaction flask, followed by TsCl (1.9 g, 10 mmol), SM 80 (4.6 g, 40 mmol), triethylamine (2 g, 20 mmol), and then reacted at room temperature for 5 hours. The reaction solution was poured into the aqueous solution and extracted with 30 mL of DCM (10 mL x 3), the organic phases were combined, dried over anhydrous sodium sulfate, and purified by column chromatography to give Int 378-1 (2.55 g, 9.5 mmol) in 95% yield. Mass spectrometry: 270 (M+H + ). Synthesis of intermediate ((S)-(1-t-butoxycarbonyl-5-oxopyrrolidin-2-yl)-methyl-4-benzenesulfonate (Int 378-2) TIFF0007579249000599.tif3099Add DCM (30mL) to a reaction flask, then add Int 378-1 (2.55g, 9.5mmol), di-t-butyl carbonate (2.18g, 10mmol), DMAP (122mg, 1mmol), and then react at room temperature for 15 hours. The reaction solution was poured into an aqueous solution and extracted with 30mL DCM (10mL x 3), the organic phases were combined, dried over anhydrous sodium sulfate, and purified by column chromatography to give Int 378-2 (1.85g, 5mmol) in 50% yield. Mass spectrometry: 370 (M+H + ). Synthesis of intermediate (S)-2-((1,1-difluoro-6-azaspiro[2.5]oct-6-yl)methyl)-5-oxopyrrolidine-1-carboxylate-t-butyl (Int 378-3) TIFF0007579249000600.tif33126 NMP (20 mL) was added to a reaction flask, followed by Int 378-2 (1.85 g, 5 mmol), potassium carbonate (1.38 g, 10 mmol), 1,1-difluoro-6-azaspiro[2.5]octane hydrochloride (905 mg, 5 mmol), then heated to 80 °C and reacted at room temperature for 5 h. The reaction solution was poured into an aqueous solution and extracted with 30 mL of DCM (10 mL x 3), the organic phases were combined, dried over anhydrous sodium sulfate, and purified by column chromatography to give Int 378-3 (1.04 g, 3 mmol) in 60% yield. Mass spectrometry: 345 (M+H + ). Synthesis of intermediate (S)-(1-(1,1-difluoro-6-azaspiro[2.5]oct-6-yl)-5-oxohexan-2-yl) t-butylcarbamate (Int 378-4) TIFF0007579249000601.tif37111 Anhydrous THF (15 mL) was added to the reaction flask, followed by Int 378-3 (1.04 g, 3 mmol), which was then cooled in an ice-water bath under nitrogen gas protection, followed by methylmagnesium bromide solution (3 mL, 1 M in hexane), followed by reaction at room temperature for 1 hour. The reaction solution was poured into saturated aqueous ammonium chloride solution, extracted with EA 30 mL (10 mL x 3), the organic phases were combined, dried over anhydrous sodium sulfate, and purified by column chromatography to obtain Int 378-4 (0.72 g, 2 mmol) in 67% yield. Mass spectrometry: 361 (M+H + ). Synthesis of intermediate (S)-1,1-difluoro-6-((5-methyl-3,4-dihydro-2H-pyrrol-2-yl)methyl)-6-aza-spiro[2.5]octane (Int 378-5) TIFF0007579249000602.tif36103 DCM (10 mL) was added to a reaction flask, followed by Int 378-4 (0.72 g, 2 mmol), TFA (1 mL), and then reacted at room temperature for 5 hours. The reaction solution was decomposed of the solvent by rotary evaporation, neutralized with saturated aqueous sodium bicarbonate, extracted with 30 mL of DCM (10 mL x 3), the organic phases were combined, dried over anhydrous sodium sulfate, and purified by column chromatography to give Int 378-5 (0.44 g, 1.8 mmol) in 90% yield. Mass spectrometry: 243 (M+H + ). Synthesis of intermediate 1,1-difluoro-6-(((2S)-5-methylpyrrolidin-2-yl)methyl)-6-aza-spiro[2.5]octane (Int 378-6) TIFF0007579249000603.tif32105Methanol (10 mL) was added to the reaction flask, followed by Int 378-5 (0.44 g, 1.8 mmol), sodium borohydride (0.38 g, 10 mmol) was added batchwise, and then reacted at room temperature for 1 h. The reaction solution was poured into the aqueous solution and extracted with 30 mL of DCM (10 mL x 3), the organic phases were combined, dried over anhydrous sodium sulfate, and concentrated to give Int 378-6 (0.44 g, 1.75 mmol) in 98% yield. Mass spectrometry: 245 (M+H) + ). TIFF0007579249000604.tif12170-Spiro[2.5]oct-6-yl)methyl)-5-methylpyrrolidin-1-yl)- TIFF0007579249000605.tif13170-Oxazolidine-5-yl)-3-methylurea (378) Synthesis TIFF0007579249000606.tif32154Int 1-15 (33 mg, 0.1 mmol) was dissolved in DMF (1 mL), DIEA (39 mg, 0.3 mmol) and HATU (38 mg, 0.1 mmol) were added, and then Int 378-6 (24 mg, 0.1 mmol) was added and stirred at room temperature for 16 hours. Water (10 mL) was added to the reaction solution, and the mixture was extracted twice with ethyl acetate. The organic phase was washed with saturated saline and concentrated to obtain the crude product, which was subjected to column chromatography to obtain the nearly white solid product 378 (28 mg) in 50% yield. Mass spectrometry: 560 (M+H + ).
[0164] TIFF0007579249000607.tif11170Fluoro-6-aza-spiro[2.5]oct-6-yl)methyl-5-methylpyrrolidine TIFF0007579249000608.tif73170 Synthesis of intermediate 1,1-difluoro-6-(((2S,5S)-5-methylpyrrolidin-2-yl)methyl)-6-aza-spiro[2.5]octane (Int 379-1) TIFF0007579249000609.tif31104Add DCM (10mL) to the reaction flask, then add Int 378-5 (0.44g, 1.8mmol), cool in ice-water bath under nitrogen gas protection, add DIBAL-H (10mL, 1M in DCM) batchwise, then react at room temperature for 16 hours. The reaction solution was poured into cold 0.5N aqueous sodium hydroxide solution, extracted with 30mL DCM (10mL x 3), the organic phase was combined, dried over anhydrous sodium sulfate, and concentrated to give Int 379-1 (0.44g, 1.75mmol) in 98% yield. Mass spectrometry: 245 (M+H + ). TIFF0007579249000610.tif11170The-spiro[2.5]oct-6-yl)methyl)-5-methylpyrrolidin-1-yl) TIFF0007579249000611.tif48170 Int 1-15 (33 mg, 0.1 mmol) was dissolved in DMF (1 mL), DIEA (39 mg, 0.3 mmol) and HATU (38 mg, 0.1 mmol) were added, and then Int 379-1 (24 mg, 0.1 mmol) was added and stirred at room temperature for 16 hours. Water (10 mL) was added to the reaction solution, and the mixture was extracted twice with ethyl acetate. The organic phase was washed with saturated saline and concentrated to obtain the crude product, which was subjected to column chromatography to obtain the nearly white solid product 379 (28 mg) in 50% yield. Mass spectrometry: 560 (M+H + ).
[0165] TIFF0007579249000612.tif29170Synthesis of (3-methyl)-3-methylurea (380) TIFF0007579249000613.tif162154 Synthesis of intermediate 4-(4-fluorophenyl)-4-oxobutyric acid (Int 74-1) TIFF0007579249000614.tif291082 Fluorobenzene (10 g, 0.1 mol), succinic anhydride (9.4 g 0.09 mmol), and dichloromethane (100 mL) were added to a 50 mL reaction flask. Aluminum trichloride (13.9 g, 0.1 mol) was added batchwise to the reaction flask under ice bath and reacted overnight. The reaction solution was poured into 2N aqueous hydrochloric acid solution, separated, the organic layer was dried over anhydrous sodium sulfate, and the solvent was removed by rotary evaporation in vacuum to obtain crude Int 74-1 (10 g) in 57% yield. Mass spectrometry: 197.1 (M+H + ). Synthesis of intermediate (3R,7aR)-7a-(4-fluorophenyl)-3-phenyltetrahydropyrrolidine[2,1-b]oxazol-5(6H)-one (Int 74-2) TIFF0007579249000615.tif40127 Intermediate Int 73-1 (6.1 g, 31 mmol) and (R)-2-amino-1-phenylethan-1-ol (4.3 g, 31 mmol) were added to 50 mL of toluene, separated using a water separator, and reacted at 148 °C for 20 hours. Concentration and column chromatography were performed to obtain 6 g of white solid Int 74-2 in 66% yield. Mass spectrometry: 298 (M + H + ). Synthesis of intermediate (S)-5-(4-fluorophenyl)-1-((R)-2-hydroxy-1-phenylethyl)pyrrolidin-2-one (Int 74-3) TIFF0007579249000616.tif37129 Intermediate Int 74-2 (6 g, 20 mmol) and triethylsilane (7.5 g, 65 mmol) were added to 100 mL of dichloromethane, and titanium tetrachloride solution (20 mL, 1 M in hexane) was added dropwise at -78°C. After the addition was completed, the mixture was slowly returned to room temperature and stirred for 4 hours. A saturated aqueous solution of ammonium chloride was added, and the mixture was extracted with ethyl acetate, dried and concentrated with anhydrous sodium sulfate, and the crude product was used as it was in the next step of the reaction. Synthesis of intermediate (S)-5-(4-fluorophenyl)-1-((R)-2-chloro-1-phenylethyl)pyrrolidin-2-one (Int 74-4) TIFF0007579249000617.tif361182 In a 50 mL reaction flask, Int 74-3 (10 g, 33 mmol) and tetrahydrofuran (100 mL) were added, and thionyl chloride (8 g, 67 mmol) was slowly added under ice bath, and the reaction was allowed to naturally warm to room temperature, and further reacted at room temperature for 2 hours. After the reaction was completed, the solvent was removed by rotary evaporation in vacuum to obtain crude compound Int 74-4 (13 g, 122% yield). Mass spectrometry: 318.1 (M+H + ). Synthesis of intermediate (S)-5-(4-fluorophenyl)-1-(1-phenylvinyl)pyrrolidin-2-one (Int 74-5) TIFF0007579249000618.tif381062 Add crude Int 74-4 (13 g, 41 mmol) and t-butanol (130 mL) to a 50 mL reaction flask, then add sodium t-butoxide (7.9 g, 82 mmol), heat the reaction to 40 °C, react for 2-3 hours, after the reaction is complete, remove the solvent by rotary evaporation, add water (50 mL), extract with ethyl acetate (5 mL × 3), combine the organic phase, dry with anhydrous sodium sulfate, remove the solvent by rotary evaporation, and obtain crude compound Int 74-5 (11 g, 96% yield). Mass spectrometry: 282.1 (M+H + ). Synthesis of intermediate (R)-5-(4-fluorophenyl)pyrrolidin-2-one (Int 74-6) TIFF0007579249000619.tif38982 Crude Int 74-5 (11 g, 39 mmol), 2N hydrochloric acid aqueous solution (50 mL), and tetrahydrofuran (60 mL) were added to a 50 mL reaction flask, heated to 80 °C and reacted for 2-3 hours. After the reaction was completed, the mixture was adjusted to pH ~7 with saturated sodium bicarbonate aqueous solution, extracted with ethyl acetate (50 mL × 3), the organic phases were combined, dried over anhydrous sodium sulfate, and the solvent was removed by rotary evaporation in vacuum. The obtained solid was beaten with ethyl acetate (20 mL) for 1 hour and filtered to obtain compound Int 74-6 (5 g, 74% yield). Mass spectrometry: 180.1 (M+H + ). Synthesis of intermediate (S)-2-(4-fluorophenyl)-5-oxopyrrolidine-1-carboxylate-t-butyl (Int 74-7) TIFF0007579249000620.tif4088 Crude Int 74-6 (5 g, 28 mmol), di-t-butyl dicarbonate (7.4 g, 34 mmol), and dichloromethane (50 mL) were added to a 100 mL reaction flask, and finally, 4-dimethylaminopyridine (3.4 g, 28 mmol) was added in batches and stirred at room temperature overnight. After the reaction was completed, 0.5 N aqueous hydrochloric acid (20 mL) was added and separated, the organic phase was dried over anhydrous sodium sulfate, the solvent was removed by rotary evaporation in vacuum, and the compound Int 74-7 (7.5 g, 96% yield) was obtained by purification by column chromatography. Mass spectrometry: 280.1 (M+H + ). Synthesis of intermediate (S)-4-cyclopropyl-1-(4-fluorophenyl)-4-oxobutyl t-butylcarbamate (Int 380-1) TIFF0007579249000621.tif4185 Crude Int 74-7 (500 mg, 1.8 mmol) and tetrahydrofuran (5 mL) were added to a 50 mL reaction flask, and cyclopropyl magnesium bromide (1.8 mL, 1 M in THF) was added under ice bath and reacted for about 2 to 3 hours. After the reaction was completed, a saturated aqueous ammonium chloride solution (5 mL) was added, and the mixture was extracted with ethyl acetate (50 mL x 3). The organic phase was combined, dried over anhydrous sodium sulfate, and purified by column chromatography to obtain compound Int 380-1 (310 mg) in a yield of 54%. Mass spectrometry: 322.1 (M+H + ). Synthesis of intermediate (S)-5-cyclopropyl-2-(4-fluorophenyl)-3,4-dihydro-2H-pyrrole (Int 380-2) TIFF0007579249000622.tif5271 Crude Int 380-1 (310 mg, 1 mmol) and dichloromethane (3 mL) were added to a 25 mL reaction flask, and trifluoroacetic acid (0.3 mL) was added. The reaction was carried out at room temperature overnight. After the reaction was completed, the solvent was removed by rotary evaporation in vacuum, and an aqueous sodium bicarbonate solution was added to adjust the pH to 7, and the mixture was extracted with ethyl acetate (5 mL x 3). The organic phases were combined and dried over anhydrous sodium sulfate, and the solvent was removed by rotary evaporation in vacuum to obtain crude compound Int 380-2 (125 mg) in 70% yield. Mass spectrometry: 204.1 (M+H + ). Synthesis of intermediate (2R,5S)-2-cyclopropyl-5-(4-fluorophenyl)pyrrolidine (Int 380-3) TIFF0007579249000623.tif536025mL reaction flask was added with crude Int 380-2 (125mg, 0.68mmol) and dichloromethane (3mL), and diisobutylaluminum hydride (2.7mL, 1M in hexane) was added dropwise under ice bath, and the reaction was carried out at room temperature overnight. After the reaction was completed, 15% aqueous sodium hydroxide solution (0.2mL) was added, water (0.2mL) was added, and the mixture was filtered through diatomaceous earth. The filtrate was dried over anhydrous sodium sulfate, and the solvent was removed by rotary evaporation in vacuum to obtain crude compound Int 380-3 (103mg) in 82% yield. Mass spectrometry: 206.1 (M+H + ). TIFF0007579249000624.tif30170Synthesis of urea (380) TIFF0007579249000625.tif46158 Compound Int 1-15 (33 mg, 0.1 mmol), Int 380-3 (31 mg, 0.15 mmol), DIEA (39 mg, 0.3 mmol), and DMF (1 mL) were added to a 25 mL reaction flask. HATU (57 mg, 0.15 mmol) was added while stirring. After stirring overnight at room temperature, the reaction was completed. Water (5 mL) was added to the reaction solution, and the solution was extracted with ethyl acetate (5 mL x 3). The organic phases were combined, dried over anhydrous sodium sulfate, and purified by column chromatography to obtain compound 380 (26 mg) in a yield of 50%. Mass spectrometry: 521.2 (M+H+ ). 1 H NMR(400MHz,DMSO)δ 8.71(s,1H),7.58-7.11(m,7H),6.14-6.03(m,1H),5.11(dt,J=53.2,7.3Hz,1H ),4.59(dd,J=99.5,16.9Hz,1H),4.39-3.75(m,2H),3.51(d,J=16.8Hz,1H),3.0 7(dd,J=15.8,7.8Hz,1H),3.03-2.89(m,1H),2.70-2.55(m,4H),2.47-2.03(m, 2H),1.85(ddd,J=53.6,33.0,9.3Hz,3H),1.19-1.03(m,1H),0.80-0.44(m,3H).
[0166] TIFF0007579249000626.tif12170Fluorophenyl-5-methylpyrrolidin-1-yl-2-oxoethyl-4-fluorophenyl Synthesis of 1-(2-methyl-5-yl)-3-methylurea (381) TIFF0007579249000628.tif137151 Synthesis of intermediate 5-bromo-4-fluoro-1-((trimethylsilyl)oxy)-2,3-dihydro-1H-indene-1-nitrile (Int 381-1) TIFF0007579249000629.tif3499Aluminum trichloride (1.26 g, 9.4 mmol), 5-bromo-4-fluoroindanone (10.7 g, 47 mmol), and dry dichloromethane (100 mL) were added to a 100 mL reaction flask, and trimethylsilyl cyanide (9.4 g, 94 mmol) was slowly added dropwise under ice bath. After the addition was completed, the mixture was stirred at room temperature for 5 hours. The reaction solution was poured into a saturated aqueous potassium bicarbonate solution (200 mL), extracted three times with dichloromethane, and the organic phases were combined, dried and concentrated with anhydrous sodium sulfate. Column chromatography was performed to obtain a white intermediate Int 381-1 (10 g) in 65% yield. Mass spectrometry: 328,330 (M+H + ). Synthesis of intermediate 5-bromo-4-fluoro-1-hydroxy-2,3-dihydro-1H-indene-1-carboximidic acid ethyl ester (Int 381-2) TIFF0007579249000630.tif3892 Intermediate Int 381-1 (10 g, 32 mmol) was dissolved in dry ethanol (60 mL), and dried HCl gas was introduced and stirred overnight. After detection by TLC, the crude pale yellow solid Int 381-2 (9.5 g) was obtained and used directly in the next step reaction. TIFF0007579249000631.tif591709.5g Intermediate Int 381-2 was suspended in dry THF (120 mL), triethylamine (20 mL, 5 e.q.) was added under ice bath, and triphosgene (3.8 g, 0.4 eq) was added batchwise. After the addition was completed, the mixture was stirred for 2 hours, and HCl (2N) was slowly added under ice bath until pH < 5, and the mixture was stirred for 1 hour, extracted with EA, dried over anhydrous sodium sulfate, and concentrated. Recrystallized with EA / PE, stirred and filtered to obtain white intermediate Int 381-3 (5 g), the two-stage yield was 53%. Mass spectrometry: 300, 302 (M+H + ). TIFF0007579249000632.tif18170 TIFF0007579249000633.tif45134Int 381-3 (10 g, 34 mmol), t-butyl bromoacetate (7.5 g, 38.4 mmol) and potassium carbonate (7.3 g, 52.9 mmol) were dissolved in DMF (100 mL) and stirred at room temperature for 4 h. Water (200 mL) was added and extracted three times with ethyl acetate. The organic phases were combined, dried over anhydrous sodium sulfate, concentrated, triturated with petroleum ether and filtered to give a white solid Int 381-4 (12 g) in 84% yield. Mass spectrometry: 414,416 (M+H) + ). TIFF0007579249000634.tif17170Synthesis of t-butyl ester (Int 381-5) TIFF0007579249000635.tif49153 Intermediate Int 381-4 (12 g, 28 mmol), Benzophenone imine (7 g, 3 TIFF0007579249000636.tif17170 and cesium carbonate (13.2 g, 40 mmol) were dissolved in toluene (50 mL), purged with nitrogen gas, heated to 100° C., and stirred for 4 hours. The mixture was concentrated and subjected to column chromatography to obtain a gray solid Int 381-5 (12 g) in 82.1% yield. Mass spectrometry: 515 (M+H + ). TIFF0007579249000637.tif1717081-6) synthesis TIFF0007579249000638.tif41119Int 381-5 (12 g, 24 mmol) was dissolved in tetrahydrofuran (20 mL), and hydrochloric acid (2N, 10 mL) was added at room temperature and stirred for 30 min. Extracted three times with ethyl acetate, the organic phases were combined, dried over anhydrous sodium sulfate, concentrated, and subjected to column chromatography to obtain a yellow solid Int 381-6 (6.8 g) in 85% yield. Mass spectrometry: 307 (M-43). TIFF0007579249000639.tif19170Synthesis of Butyl (Int 381-7) TIFF0007579249000640.tif37153Triphosgene (3.5g, 12mmol) was added to dichloromethane (25mL), and a mixture of Int 381-6 (6.8g, 20mmol), triethylamine (20g, 200mmol) and dichloromethane (25mL) was slowly added dropwise to the reaction flask under ice bath. After the addition, the mixture was stirred for 1 hour, and methylamine hydrochloride (7g, 104mmol) was added and stirred for 4 hours. Water (100mL) was added, and the organic layer was separated and extracted with dichloromethane. The organic phases were combined, dried over anhydrous sodium sulfate, concentrated, and subjected to column chromatography to obtain a yellow solid Int 381-7 (5.1g) in 61% yield. Mass spectrometry: 425 (M+18). TIFF0007579249000641.tif17170t-Butyl (Int 381-8) and (R)-2-(4-fluoro-5-(3-methyl TIFF0007579249000642.tif18170TIFF0007579249000643.tif35153Chiral separation conditions: Instrument: SFC-80 (Thar, Waters); Chiral separation column: CHIRALCEL OD (4.6x100mm 3μm); Column temperature: 35℃; Mobile phase: A=CO2, B= MEOH; Peak appearance time: t1=1.61min, t2=1.98min. Chiral separation of Int 381-7 (5g) gave Int 381-8 (t1, 2.3g), ee=99%, Int 383-1 (t2, 2.3g), ee=99%, Synthesis of TIFF0007579249000644.tif17170nt 381-9) TIFF0007579249000645.tif41122 Intermediate Int 381-8 (2.3 g, 5 mmol) was dissolved in dichloromethane (20 mL), trifluoroacetic acid (2 mL) was added, stirred at room temperature overnight, and concentrated to give pale yellow solid Int 381-9 (1.6 g) in 91% yield. Mass spectrometry: 350 (MH - ). [α] 20 D =-54.5°(c 1.0,MeOH) TIFF0007579249000646.tif28170-3-Synthesis of methylurea (381) TIFF0007579249000647.tif45153 Int 381-9 (33 mg, 0.1 mmol), Int 201-3 (20 mg, 0.11 mmol), HATU (50 mg, 0.13 mmol) and DIEA (20 mg, 0.15 mmol) were dissolved in dichloromethane (5 mL), stirred overnight, concentrated and subjected to column chromatography to give pale yellow solid 381 (35 mg) in 69% yield. Mass spectrometry: 531 (M+H + ).
[0167] TIFF0007579249000648.tif10170Methyl-5-(3,4,5-trifluorophenyl)pyrrolidin-1-yl)-2-oxo TIFF0007579249000649.tif9170Synthesis of [lysine]-5-yl)-3-methylurea (382) TIFF0007579249000650.tif43154 Int 381-9 (33 mg, 0.1 mmol), intermediate Int 205-3 (20 mg, 0.11 mmol), HATU (50 mg, 0.13 mmol) and DIEA (20 mg, 0.15 mmol) were dissolved in dichloromethane (5 mL), stirred overnight, concentrated and subjected to column chromatography to give pale yellow solid 382 (35 mg) in 69% yield. Mass spectrometry: 549 (M+H + ). 1 H NMR (400MHz, CDCl3) δ 8.02-7.91(m,1H),7.21(dd,J=33.7,8.6Hz,1H),7.04-6.96(m,1H),6.85(d ,J=7.1Hz,1H),4.97(d,J=35.7Hz,1H),4.44(dt,J=69.8,34.9Hz,2H),3.99( dd,J=148.8,16.4Hz,2H),3.27-3.11(m,2H),2.93-2.75(m,4H),2.61(s,1H) ,2.52-2.39(m,1H),2.32-1.89(m,3H),1.73(d,J=65.5Hz,1H),1.28(s,1H).
[0168] TIFF0007579249000651.tif10170)-5-methylpyrrolidin-1-yl)-2-oxoethyl)-4-fluorophenyl Synthesis of 1-(5-methyl-3-phenyl)urea (383) Synthesis of TIFF0007579249000653.tif97170nt 383-2) TIFF0007579249000654.tif43121 Int 383-1 (2.3 g, 5 mmol) was dissolved in dichloromethane (20 mL), trifluoroacetic acid (2 mL) was added, stirred at room temperature overnight, and concentrated to give a pale yellow solid Int 383-2 (1.6 g) in 91% yield. Mass spectrometry: 350 (MH - ). [α] 20 D=+53.8°(c 1.0,MeOH) TIFF0007579249000655.tif28170-3-Synthesis of methylurea (383) TIFF0007579249000656.tif45154 Int 383-1 (33 mg, 0.1 mmol), Int 201-3 (20 mg, 0.11 mmol), HATU (50 mg, 0.13 mmol) and DIEA (20 mg, 0.15 mmol) were dissolved in dichloromethane (5 mL), stirred overnight, concentrated and subjected to column chromatography to give pale yellow solid 381 (35 mg) in 69% yield. Mass spectrometry: 531 (M+H + ). 1H NMR(400MHz,DMSO)δ 8.71(s,1H),7.53(d,J=6.4Hz,1H),7.36-7.31(m,1H),7.23(ddd,J=29.6,16.1,9.6Hz,3H),6 .08(d,J=4.5Hz,1H),5.38-4.97(m,1H),4.54-4.30(m,2H),4.27-4.17(m,1H),3.44(t,J=17.0 Hz,1H),3.14-3.03(m,1H),2.98(s,1H),2.69-2.56(m,4H),2.46-2.41(m,1H),2.04(dd,J=13 .1,6.1Hz,1H),1.73(dd,J=12.6,6.0Hz,1H),1.65-1.46(m,2H),1.29(dd,J=40.9,5.9Hz,2H).
[0169] TIFF0007579249000657.tif9170Methyl-5-(3,4,5-trifluorophenyl)pyrrolidin-1-yl)-2-oxo TIFF0007579249000658.tif9170Synthesis of [lysine]-5-yl)-3-methylurea (384) TIFF0007579249000659.tif43155 Int 383-2 (33 mg, 0.1 mmol), intermediate Int 205-3 (20 mg, 0.11 mmol), HATU (50 mg, 0.13 mmol) and DIEA (20 mg, 0.15 mmol) were dissolved in dichloromethane (5 mL), stirred overnight, concentrated and subjected to column chromatography to give pale yellow solid 382 (35 mg) in 69% yield. Mass spectrometry: 549 (M+H + ). 1 H NMR(400MHz,CDCl3)δ 8.02-7.86(m,1H),7.14(dd,J=47.6,7.9Hz,1H),7.04-6.96(m,1H),6.87 -6.78(m,1H),4.96(d,J=31.1Hz,1H),4.59-3.73(m,4H),3.18(d,J=10.1H z,2H),2.84(s,4H),2.59(d,J=8.2Hz,1H),2.44(s,1H),2.23(s,1H),2.07 (dd,J=21.2,13.1Hz,2H),1.75(d,J=80.1Hz,1H),1.30(d,J=13.0Hz,1H).
[0170] TIFF0007579249000660.tif10170)-5-methylpyrrolidin-1-yl)-2-oxoethyl)-7-fluorophenyl Synthesis of 1-(5-methyl-3-phenyl)urea (385) TIFF0007579249000662.tif130161 Synthesis of intermediate 5-bromo-7-fluoro-1-((trimethylsilyl)oxy)-2,3-dihydro-1H-indene-1-nitrile (Int 385-1) TIFF0007579249000663.tif2999Aluminum trichloride (1.17 g, 8.8 mmol), 5-bromo-7-fluoroindanone (10 g, 44 mmol), and dry dichloromethane (100 mL) were added to a 100 mL reaction flask, and trimethylsilyl cyanide (8.7 g, 88 mmol) was slowly added dropwise under ice bath. After the addition was completed, the mixture was stirred at room temperature for 5 hours. The reaction solution was poured into a saturated aqueous potassium bicarbonate solution (200 mL), extracted three times with dichloromethane, and the organic phases were combined, dried over anhydrous sodium sulfate, and concentrated. Column chromatography was performed to obtain a white intermediate Int 385-1 (9 g) in 63% yield. Mass spectrometry: 328,330 (M+H + ). Synthesis of intermediate 5-bromo-7-fluoro-1-hydroxy-2,3-dihydro-1H-indene-1-carboximidic acid ethyl ester hydrochloride (Int 385-2) TIFF0007579249000664.tif3395 Intermediate Int 385-1 (9 g, 27 mmol) was dissolved in dry ethanol (60 mL), and dry HCl gas was introduced and stirred overnight. After detection by TLC, the crude pale yellow solid Int 385-1 (8.5 g) was obtained and used directly in the next step reaction. TIFF0007579249000665.tif52170 Intermediate Int 385-2 (8.5 g, 25 mmol) was suspended in dry THF (120 mL), triethylamine (17.7 g, 175 mmol) was added under ice bath, and triphosgene (3 g, 10 mmol) was added in batches. After the addition was completed, the mixture was stirred for 2 hours, adjusted to pH < 5 with hydrochloric acid solution (2N) under ice bath, stirred for 1 hour, extracted with EA, dried and concentrated with anhydrous sodium sulfate. Recrystallized with EA and PE, filtered to obtain white intermediate Int 385-3 (4 g), the two-stage yield was 50%. Mass spectrometry: 300, 302 (M+H + ). Composition of TIFF0007579249000666.tif1717085-4) TIFF0007579249000667.tif37130 Intermediate Int 385-3 (4 g, 13 mmol), t-butyl bromoacetate (2.6 g, 13 mmol) and potassium carbonate (2.8 g, 20 mmol) were dissolved in DMF (100 mL) and stirred at room temperature for 4 h. Water (200 mL) was added and extracted three times with ethyl acetate. The organic phases were combined, dried over anhydrous sodium sulfate, concentrated, triturated with petroleum ether and filtered to give white solid Int 385-4 (4.7 g) in 85% yield. Mass spectrometry: 414,416 (M+H) + ). TIFF0007579249000668.tif18170Synthesis of t-butyl ester (Int 385-5) TIFF0007579249000669.tif45156 Intermediate Int 385-4 (4.7 g, 11 mmol), benzophenone imine (2.67 g, 15 mmol), palladium acetate (250 mg, 1.10 mmol), (±)-2,2 TIFF0007579249000670.tif10170 and cesium carbonate (5.54 g, 17 mmol) were dissolved in toluene (50 mL), purged with nitrogen gas, heated to 100° C., and stirred for 4 hours. Concentration and column chromatography were performed to obtain a gray solid Int 385-5 (4.3 g) in 76% yield. Mass spectrometry: 515 (M+H + ). Composition of TIFF0007579249000671.tif1917085-6) TIFF0007579249000672.tif39120 Intermediate Int 385-5 (4.3 g, 8.4 mmol) was dissolved in tetrahydrofuran (20 mL), and hydrochloric acid (10 mL, 2N) was added at room temperature and stirred for 30 min. Extracted three times with ethyl acetate, the organic phases were combined, dried over anhydrous sodium sulfate, concentrated, and subjected to column chromatography to obtain a yellow solid Int 385-6 (2.8 g) in 96% yield. Mass spectrometry: 307 (M-43). TIFF0007579249000673.tif18170Synthesis of Butyl (Int 385-7) TIFF0007579249000674.tif36154 Triphosgene (1.2g, 4mmol) was added to dichloromethane (25mL), and a mixture of intermediate Int 385-6 (2.8g, 8mmol), triethylamine (6.5g, 64mmol) and dichloromethane (25mL) was slowly added dropwise to the reaction flask under ice bath. After the addition, the mixture was stirred for 1 hour, and methylamine hydrochloride (1.6g, 24mmol) was added and stirred for 4 hours. Water (100mL) was added, and the organic layer was separated and extracted with dichloromethane. The organic phases were combined, dried over anhydrous sodium sulfate, concentrated, and subjected to column chromatography to obtain a yellow solid Int 385-7 (2.5g) in a yield of 77%. Mass spectrometry: 408 (M+H + ). TIFF0007579249000675.tif17170t-Butyl (Int 385-8) and (R)-2-(7-fluoro-5-(3-methyl) TIFF0007579249000676.tif50170Chiral separation conditions: Instrument: SFC-80 (Thar, Waters); Chiral separation column: CHIRALCEL OD (4.6x100mm 3μm); Column temperature: 35℃; Mobile phase: A=CO2, B= MEOH; Peak appearance time: t1=1.61min, t2=1.98min. Chiral separation of Int 385-7 (5g) gave Int 385-8 (t1, 1.2g), ee=99%, Int 387-1 (t2, 1.2g), ee=99%, Synthesis of TIFF0007579249000677.tif17170nt 385-9) TIFF0007579249000678.tif43120 Intermediate Int 385-8 (1.2 g, 3 mmol) was dissolved in dichloromethane (20 mL), trifluoroacetic acid (2 mL) was added, stirred at room temperature overnight, and concentrated to give pale yellow solid Int 385-9 (0.9 g) in 86% yield. Mass spectrometry: 350 (MH - ). [α] 20 D =-68°(c 1.0,MeOH) TIFF0007579249000679.tif9167TIFF0007579249000680.tif17170-Synthesis of 3-methylurea (385) TIFF0007579249000681.tif45153 Intermediate Int 385-9 (33 mg, 0.1 mmol), Int 201-3 (20 mg, 0.11 mmol), HATU (50 mg, 0.13 mmol) and DIEA (20 mg, 0.15 mmol) were dissolved in dichloromethane (5 mL), stirred overnight, concentrated and subjected to column chromatography to give pale yellow solid 385 (35 mg) in 69% yield. Mass spectrometry: 531 (M+H + ). 1 H NMR(400MHz,DMSO):δ 8.96(d,J=4.4Hz,1H),7.51(d,J=10.5Hz,1H),7.42-7.12(m,4H),6.22-6.16(m,1H),4.97(m,1H),4.53-4.36(m,2) H),3.85(m,1H),3.09(m,2H),2.62-2.51(m,5H),2.45-2.32(m,1H),2.00(m,2H),1.70(m,1H),1.39-1.33(m,3H).
[0171] TIFF0007579249000682.tif8170Methyl-5-(3,4,5-trifluorophenyl)pyrrolidin-1-yl)-2-oxo TIFF0007579249000683.tif8170Synthesis of lysine-5-yl)-3-methylurea (386) TIFF0007579249000684.tif42152 Intermediate Int 385-9 (33 mg, 0.1 mmol), Int 205-3 (20 mg, 0.11 mmol), HATU (50 mg, 0.13 mmol) and DIEA (20 mg, 0.15 mmol) were dissolved in dichloromethane (5 mL), stirred overnight, concentrated and subjected to column chromatography to give pale yellow solid 386 (35 mg) in 69% yield. Mass spectrometry: 549 (M+H + ). 1H NMR(400MHz,DMSO):δ 8.97(s,1H),7.36-7.24(m,3H),7.15(s,1H),7.11-7.05(m,1H),6.20 (s,1H),4.88-4.76(m,1H),4.47(m,2H),4.18-3.54(m,1H),3.14(m,1H) ),3.05(m,1H),2.71-2.57(m,4H),2.41-2.32(m,1H),2.14-2.05(m,1H ),2.02-1.91(m,1H),1.81(m,1H),1.47(m,1H),1.36(t,J=5.9Hz,3H).
[0172] TIFF0007579249000685.tif10167)-5-methylpyrrolidin-1-yl)-2-oxoethyl)-7-fluorophenyl Synthesis of 1-(5-methyl-3-phenyl)urea (387) Synthesis of TIFF0007579249000687.tif52170nt 387-2) TIFF0007579249000688.tif43120 Intermediate Int 387-1 (1.2 g, 3 mmol) was dissolved in dichloromethane (20 mL), trifluoroacetic acid (2 mL) was added, stirred at room temperature overnight, and concentrated to give pale yellow solid Int 387-2 (0.9 g) in 86% yield. [α] 20 D =+67°(c 1.0,MeOH) TIFF0007579249000689.tif27170-3-Synthesis of methylurea (387) TIFF0007579249000690.tif45153 Intermediate Int 387-2 (33 mg, 0.1 mmol), Int 201-3 (20 mg, 0.11 mmol), HATU (50 mg, 0.13 mmol) and DIEA (20 mg, 0.15 mmol) were dissolved in dichloromethane (5 mL), stirred overnight, concentrated and subjected to column chromatography to give pale yellow solid 387 (35 mg) in 69% yield. Mass spectrometry: 531 (M+H + ). 1H NMR(400MHz,DMSO):δ 8.97(s,1H),7.52(dd,J=18.9,8.4Hz,1H),7.42-7.29(m,2H),7.23-7.12( m,2H),6.20(d,J=4.5Hz,1H),5.06(m,1H),4.74-4.34(m,2H),3.98(m,1H) ,3.15(m,1H),3.03(m,1H),2.71-2.57(m,4H),2.42-2.33(m,1H),2.14-1. 98(m,1H),1.92(m,1H),1.87-1.64(m,1H),1.49(m,1H),1.40-1.31(m,3H).
[0173] TIFF0007579249000691.tif8169Methyl-5-(3,4,5-trifluorophenyl)pyrrolidin-1-yl)-2-oxo TIFF0007579249000692.tif9170Synthesis of lysine-5-yl)-3-methylurea (388) TIFF0007579249000693.tif42152 Int 387-2 (33 mg, 0.1 mmol), Int 205-3 (20 mg, 0.11 mmol), HATU (50 mg, 0.13 mmol) and DIEA (20 mg, 0.15 mmol) were dissolved in dichloromethane (5 mL), stirred overnight, concentrated and subjected to column chromatography to give pale yellow solid 387 (35 mg) in 69% yield. Mass spectrometry: 549 (M+H + ). 1H NMR(400MHz,DMSO):δ 8.97(s,1H),7.35-7.29(m,1H),7.26(dd,J=13.4,4.9Hz,1H),7.15(s,1H),7.10(dd,J=9 .0,6.9Hz,1H),6.20(d,J=4.8Hz,1H),5.27-4.85(m,1H),4.76-4.37(m,2H),4.20-3.57( m,1H),3.15(m,1H),3.08-3.00(m,1H),2.67-2.55(m,4H),2.42-2.31(m,1H),2.17-2.05 (m,1H),2.02-1.91(m,1H),1.88-1.74(m,1H),1.48(d,J=6.8Hz,1H),1.39-1.31(m,3H).
[0174] TIFF0007579249000694.tif9168)-5-methylpyrrolidin-1-yl)-2-oxoethyl)-6-fluorophenyl Synthesis of 1-methyl-5-phenyl-3-methylurea (389) TIFF0007579249000696.tif119167Synthesis of 3-(4-fluoro-3-nitrophenyl)acrylic acid (Int 389-1) TIFF0007579249000697.tif29114 4-Fluoro-3-nitrobenzaldehyde (50 g, 295.7 mmol), malonic acid (30.75 g, 295.7 mmol), glacial acetic acid (200 mL) were added to a reaction flask, and sodium acetate (7.27 g, 88.7 mmol) was further added, and the mixture was heated to 100 ° C. and reacted for 16 hours. The reaction solution was poured into a hydrochloric acid solution (800 mL, 0.1 N), filtered, and the filter cake was washed with water (100 mL), followed by washing with MTBE (50 mL), and finally with ethanol (20 mL), and pumped to dryness, and the filter cake was dried to obtain intermediate Int 389-1 (40 g) in 63% yield. Mass spectrometry: 210 (MH - ). Synthesis of 3-(3-amino-4-fluorophenyl)propionic acid (Int 389-2) TIFF0007579249000698.tif28102 Intermediate Int 389-1 (40 g, 189.4 mmol) was dissolved in ethanol (600 mL), palladium on carbon (2 g) was added, and the mixture was purged with hydrogen gas three times and reacted for 18 hours. After filtration, the filtrate was concentrated to give intermediate Int 389-2 (33 g) in 95% yield. Mass spectrometry: 184 (M+H + ). Synthesis of 3-(3-acetylamino-4-fluorophenyl)propionic acid (Int 389-3) TIFF0007579249000699.tif29105 Intermediate Int 389-2 (18.3 g, 100 mmol) was dissolved in DCM (200 mL), acetic anhydride (10.2 g, 100 mmol) was added, and the mixture was reacted at room temperature for 2 h. Water (50 mL) was added, stirred for 5 min, concentrated to remove dichloromethane, and more water (100 mL) was added, stirred, filtered, the filter cake was washed with water, pumped to dryness, and the solvent was removed by rotary evaporation to give intermediate Int 389-3 (20.2 g) in 90% yield. Mass spectrometry: 226 (M+H + ). Synthesis of N-(6-fluoro-1-oxo-2,3-dihydro-1H-inden-5-yl)acetamide (Int 389-4) TIFF0007579249000700.tif32112 Intermediate Int 389-3 (22.5 g, 100 mmol) was dissolved in DCM (200 mL), thionyl chloride (24 g, 200 mmol) was added, and the mixture was reacted at room temperature for 1 hour. The solvent was removed by rotary evaporation, and the residue was dissolved in DCM (200 mL), anhydrous aluminum chloride (26.6 g, 200 mmol) was added, and the mixture was heated to 40 °C and reacted for 16 hours. The reaction solution was poured into ice water (400 mL), extracted, and the organic phase was washed with saturated saline, dried and concentrated with anhydrous sodium sulfate, and then recrystallized to obtain intermediate Int 389-4 (14.5 g) in a yield of 70%. Mass spectrometry: 208 (M + H + ). Synthesis of N-(-cyano-6-fluoro-1-((trimethylsilyl)oxy)-2,3-dihydro-1H-inden-5-yl)acetamide (Int 389-5) TIFF0007579249000701.tif36111 Intermediate Int 389-4 (2.07 g, 10 mmol) was dissolved in DCM (20 mL), NMO (468 mg, 4 mmol) was added, and finally TMSCN (2 g, 20 mmol) was added and reacted at room temperature for 18 hours. DCM was removed by rotary evaporation, and intermediate Int 389-5 (2.14 g) was obtained after column chromatography in 70% yield. Mass spectrometry: 324 (M+18). Synthesis of 5-acetylamino-6-fluoro-1-hydroxy-2,3-dihydro-1H-indene-1-carboximidic acid ethyl ester (Int 389-6) TIFF0007579249000702.tif37121 Intermediate Int 389-5 (3.06 g, 10 mmol) was dissolved in ethanol (40 mL), and dried HCl gas was continuously introduced and stirred overnight. After detection by TLC and concentration, intermediate Int 389-6 crude (3 g) was obtained, which was used directly in the next step reaction. TIFF0007579249000703.tif53170 Intermediate Int 389-6 (3.16 g, 10 mmol) was suspended in THF (30 mL), and DIEA (20 mL; 50 mmol) was added under ice bath, and triphosgene (1.5 g, 5 mmol) was added batchwise. After the addition was completed, the mixture was stirred for 2 hours, and HCl (2N) was slowly added under ice bath until pH < 5, and the mixture was stirred for 1 hour, extracted with EA, dried over anhydrous sodium sulfate, and concentrated. Recrystallization from ethyl acetate and petroleum ether gave white intermediate Int 389-7 (1.75 g) in 60% yield. Mass spectrometry: 279 (M+H + ). Composition of TIFF0007579249000704.tif1717089-8) TIFF0007579249000705.tif38143Int 389-7 (2.78 g, 10 mmol), t-butyl bromoacetate (1.95 g, 10 mmol) and potassium carbonate (2.76 g, 20 mmol) were dissolved in DMF (15 mL) and stirred at room temperature for 2 h. Poured into water (30 mL) and extracted three times with ethyl acetate. The organic phases were combined, dried over anhydrous sodium sulfate, concentrated, triturated with petroleum ether and filtered to give intermediate Int 389-8 (3.2 g) in 80% yield. Mass spectrometry: 410 (M+18). TIFF0007579249000706.tif18170 synthesis TIFF0007579249000707.tif37118Int 389-8 (3.92 g, 10 mmol) was dissolved in methanol (20 mL), concentrated hydrochloric acid (20 mL) was added, and the mixture was heated to 65° C. and reacted for 18 hours. The solvent was removed by rotary evaporation, and the mixture was subjected to column chromatography to obtain intermediate Int 389-9 (2.46 g) in 80% yield. Mass spectrometry: 265 (M-43). TIFF0007579249000708.tif18170nt 389-10) and (S)-2-(6-fluoro-5-(3-methylurea)-2 TIFF0007579249000709.tif45170 Intermediate Int 389-9 (12.3 g, 40 mmol) was dissolved in DCM (150 mL), cooled in an ice-water bath, triphosgene (7.1 g, 24 mmol) was added, and the mixture was reacted for 10 minutes. DIEA (36.1 g, 280 mmol) was added, and finally, methylamine hydrochloride (4.1 g, 60 mmol) was added, and the mixture was reacted for half an hour. Water (100 mL) was added, and the organic layer was separated, extracted with dichloromethane, and the organic phases were combined, dried over anhydrous sodium sulfate, concentrated, and subjected to column chromatography to obtain a yellow solid (10.2 g) in a 70% yield. 5 g was subjected to chiral separation to obtain Int 389-10 (t2, 2.3 g). ee=99%, mass spectrometry: 366 (M+H + ). Int 389-11 (t1, 2.3 g) was obtained. ee=99%, mass spectrometry: 366 (M+H + ). Chiral separation conditions: Instrument: SFC-80 (Thar, Waters); Chiral separation column: CHIRALCEL OD (4.6×100 mm 3 μm); Column temperature: 35° C.; Mobile phase: A=CO2, B=MEOH; Peak appearance time: t1=1.848 min, t2=2.228 min. Composition of TIFF0007579249000710.tif1717089-12) TIFF0007579249000711.tif40140 Int 389-10 (3.65 g, 10 mmol) was dissolved in concentrated hydrochloric acid (30 mL), heated to 65 °C and reacted for 3 h, and concentrated to dryness to give solid Int 389-12 (3.4 g) in 96% yield. Mass spectrometry: 352 (M+H + ). [α] 20 D =+39.3°(c 1.0,MeOH) TIFF0007579249000712.tif27170-3-Synthesis of methylurea (389) TIFF0007579249000713.tif44154 Int 389-12 (35 mg, 0.1 mmol), Int 201-3 (20 mg, 0.11 mmol), HATU (50 mg, 0.13 mmol) and DIEA (20 mg, 0.15 mmol) were dissolved in DMF (3 mL), stirred for 2 h, poured into water, extracted, washed with saturated aqueous sodium chloride, dried over anhydrous sodium sulfate and subjected to column chromatography to give white solid 389 (40 mg) in 80% yield. Mass spectrometry: 531 (M+H + ). 1 H NMR(400MHz,CDCl3):δ 8.10(m,1H),7.28-6.82(m,5H),4.98(m,1H),4.49-3.67(m,3H),3.08(m,2H), 2.76(m,3H),2.56-2.39(m,2H),2.03(m,3H),1.71-1.58(m,1H),1.48(m,3H). TIFF0007579249000714.tif79152 Synthesis of intermediate (S)-(5-cyclohexyl-5-oxopentan-2-yl) t-butylcarbamate (Int 357-1) TIFF0007579249000715.tif3572 Dry THF (30 mL) was added to a reaction flask, followed by SM 76 (10 mL, 10 mmol), followed by (S)-2-methyl-5-oxopyrrolidine-1-carboxylate-t-butyl (2 g, 10 mmol) under nitrogen gas protection in an ice-water bath, followed by reaction at room temperature for 12 hours. The reaction solution was poured into a saturated aqueous ammonium chloride solution, extracted with 30 mL of ethyl acetate (10 mL x 3), the organic phases were combined, dried over anhydrous sodium sulfate, and purified by column chromatography to obtain Int 357-1 (1.7 g, 6 mmol) in 60% yield. Mass spectrometry: 284 (M+H + ). Synthesis of intermediate (S)-5-cyclohexyl-2-methyl-3,4-dihydro-2H-pyrrole (Int 357-2) TIFF0007579249000716.tif4063 DCM (20 mL) was added to a reaction flask, followed by Int 357-1 (1.42 g, 5 mmol), followed by TFA (2 mL), and then reacted at room temperature for 7 hours. The reaction was poured into saturated aqueous sodium bicarbonate solution, extracted with 30 mL of DCM (10 mL x 3), the organic phases were combined, dried over anhydrous sodium sulfate, and purified by column chromatography to give Int 357-2 (701 mg, 4.25 mmol) in 85% yield. Mass spectrometry: 166 (M+H + ). Synthesis of intermediate (2S,5S)-2-cyclohexyl-5-methylpyrrolidine (Int 357-3) TIFF0007579249000717.tif4159Add DCM (15 mL) to a reaction flask, then add Int 357-2 (660 mg, 4 mmol), add DIBAL-H (16 mL, 1 M in DCM) under ice-water bath conditions, and react at room temperature for 1 h. The reaction was quenched by adding water, filtered, washed with 30 mL of DCM (10 mL x 3), and the organic phases were combined, dried over anhydrous sodium sulfate, and concentrated to give Int 357-3 (618 mg, 3.7 mmol) in 94% yield. Mass spectrometry: 168 (M+H + ). TIFF0007579249000718.tif28170 synthesis TIFF0007579249000719.tif4215325mL reaction flask was added with DMF (3mL), then Int 1-15 (33.3mg, 0.1mmol), Int 357-3 (16.7mg, 0.1mmol), DIEA (38.7mg, 0.3mmol), and finally HATU (38.1mg, 0.1mmol) were added, and the system was reacted at 20°C for 1 hour. After the reaction was completed, the reaction solution was poured into water (20mL), extracted with ethyl acetate 30mL (10mL x 3), the organic phase was combined, dried over anhydrous sodium sulfate, and purified by column chromatography to obtain compound 357 (26.5mg) in 55% yield. Mass spectrometry: 483 (M+H + ).
[0175] TIFF0007579249000720.tif11170Methyl-5-(3,4,5-trifluorophenyl)pyrrolidin-1-yl)-2-oxo TIFF0007579249000721.tif11170Synthesis of lysine-5-yl)-3-methylurea (390) TIFF0007579249000722.tif43154 Int 389-12 (35 mg, 0.1 mmol), Int 205-3 (20 mg, 0.11 mmol), HATU (50 mg, 0.13 mmol) and DIEA (20 mg, 0.15 mmol) were dissolved in DMF (3 mL), stirred for 2 h, poured into water, extracted, washed with saturated aqueous sodium chloride, dried over anhydrous sodium sulfate and subjected to column chromatography to give white solid 390 (40 mg) in 80% yield. Mass spectrometry: 549 (M+H) + ). 1 H NMR(400MHz,CDCl3):δ 8.12(m,1H),7.07(m,3H),6.86-6.74(m,1H),5.02-4.85(m,1H),4.50-3.74(m,3H), 3.21-2.95(m,2H),2.79(s,3H),2.59-2.32(m,2H),2.28-1.65(m,4H),1.49(m,3H).
[0176] Example 391 Compound Synthesis of TIFF0007579249000723.tif44170nt 389-13) TIFF0007579249000724.tif43127Int 389-11 (3.65 g, 10 mmol) was dissolved in concentrated hydrochloric acid (30 mL), heated to 65 °C and reacted for 3 h, then concentrated to dryness to give solid Int 389-12 (3.4 g) in 96% yield. Mass spectrometry: 352 (M+H + ). [α] 20 D =-34.9°(c 1.0,MeOH) TIFF0007579249000725.tif29170-Synthesis of 3-methylurea (391). TIFF0007579249000726.tif43153 Int 389-13 (35 mg, 0.1 mmol), Int 201-3 (20 mg, 0.11 mmol), HATU (50 mg, 0.13 mmol) and DIEA (20 mg, 0.15 mmol) were dissolved in DMF (3 mL), stirred for 2 h, poured into water, extracted, washed with saturated aqueous sodium chloride, dried over anhydrous sodium sulfate and subjected to column chromatography to give white solid 391 (40 mg) in 80% yield. Mass spectrometry: 531 (M+H + ). 1 H NMR(400MHz,CDCl3):δ 8.10(m,1H),7.28-6.82(m,5H),4.98(m,1H),4.49-3.67(m,3H),3.08(m,2H), 2.76(m,3H),2.56-2.39(m,2H),2.03(m,3H),1.71-1.58(m,1H),1.48(m,3H).
[0177] TIFF0007579249000727.tif12170Methyl-5-(3,4,5-trifluorophenyl)pyrrolidin-1-yl)-2-oxo TIFF0007579249000728.tif12170Synthesis of [lysine]-5-yl)-3-methylurea (392) TIFF0007579249000729.tif42152 Int 389-13 (35 mg, 0.1 mmol), Int 205-3 (20 mg, 0.11 mmol), HATU (50 mg, 0.13 mmol) and DIEA (20 mg, 0.15 mmol) were dissolved in DMF (3 mL), stirred for 2 h, poured into water, extracted, washed with saturated aqueous sodium chloride, dried over anhydrous sodium sulfate and subjected to column chromatography to give white solid 392 (40 mg) in 80% yield. Mass spectrometry: 549 (M+H + ). 1 H NMR(400MHz,CDCl3):δ 8.12(m,1H),7.07(m,3H),6.86-6.74(m,1H),5.02-4.85(m,1H),4.50-3.74(m,3H), 3.21-2.95(m,2H),2.79(s,3H),2.59-2.32(m,2H),2.28-1.65(m,4H),1.49(m,3H).
[0178] The beneficial effects of the present invention will be demonstrated through the following experimental examples.
[0179] Experimental Example 1: Detection of the inhibitory activity of compounds against histone acetylase p300 1. Experimental Method Half-inhibitory concentration IC of the compounds of the present invention against histone acetylase p300 (purchased from BPS) 50was detected using radioisotope FlashPlate technology. The test compound was diluted to 10 concentration gradient points and detected (single well), and C646 (CAS: 328968-36-1, purchased from Calbiochem), known as a histone acetylase p300 inhibitor, was used as a positive control. Through the catalytic action of histone acetylase p300, the [3H]-Ac group on the isotope-labeled [3H]-Ac-CoA was transferred to a biotinylated histone polypeptide substrate (purchased from Calbiochem), and the biotinylated histone polypeptide substrate was bound to streptavidin on the FlashPlate plate, and when the isotope was placed at a sufficiently close distance from the FlashPlate plate, the isotope radiation energy was converted into photons by the scintillation liquid coated on the FlashPlate plate and could be detected. The specific steps are as follows: (1) Preparation of solutions 1. Preparation of reaction buffer and reaction stop solution 1x reaction buffer: 50mM Tris-HCl, pH 7.5; 0.01%Tween-20 Stop solution: 750 μM Ac-CoA solution 2. Preparation of Compounds Each compound to be measured was dissolved in 100% DMSO to 10 mM. The compound was diluted to the desired concentration on an Echo 384-well plate. Using an Echo 550 instrument, 200 nl of the compound was transferred from the diluted Echo 384-well plate to a 384-well reaction plate, with compound C646 as the positive control. The negative control was transferred to 200 nl of 100% DMSO. ▲3▼Preparation of 2x enzyme solution p300 was added to the 1x reaction buffer to form a 2x enzyme solution (final enzyme concentration 0.2 nM). ▲4▼Preparation of 2x substrate solution Polypeptide substrate and [3H]-Ac-CoA were added to the 1x reaction buffer to form a 2x substrate solution (final substrate concentrations of 600 nM and 250 nM). (2) Experimental steps 1. The enzyme solution was added to a 384-well plate. 10 μl of 2x enzyme solution was added to a 384-well reaction plate. For control wells without enzyme activity, 10 μl of 1x reaction buffer was used instead of enzyme solution. Centrifuge at 1000 rpm for 1 minute and incubate at room temperature for 15 minutes. 2) The substrate solution was added to a 384-well plate to initiate the enzyme reaction. 10 μl of 2x substrate solution was added per well to a 384-well reaction plate. The plate was centrifuged at 1000 rpm for 1 minute. The reaction was allowed to proceed at 25° C. for 60 minutes. 3. Stopping the enzyme reaction The reaction was stopped by adding 10 μl of reaction stop solution per well to the 384-well reaction plate. 25 uL per well was transferred from the test plate to a Flashplate and left at room temperature for 1 hour. The Flashplate was then washed three times with 0.1% Tween-20 solution. ▲4▼The data was read using MicroBeta 2. ▲5▼Inhibition rate calculation Data was copied from Microbeta 2. Inhibition rate was calculated by the formula: Inhibition rate (%) = (maximum value - sample value) / (maximum value - minimum value) x 100%. The maximum value is the conversion rate of the DMSO control, and the minimum value is the conversion rate of the control without enzyme activity. The data was imported into GraphPad Prism5 and curve-fitted using the equation "log(inhibitor) vs. response--Variable slope" to obtain the median inhibitory concentration, IC 50 obtained. 2. Experimental Results [Table 1] The compounds prepared according to the present invention effectively inhibit histone acetylase p300, and the IC 50was mostly below 0.01 μM, which was much lower than that of the positive control compound C646 (0.96 μM). Therefore, the compounds of the present invention can be used to prepare histone acetylase p300 inhibitors, and their inhibitory effect is significantly superior to that of compound C646, a known inhibitor of histone acetylase p300.
[0180] Experimental Example 2 Biological measurement of the inhibitory effect of the compounds of the present invention on CWR22RV1 cell proliferation 1. Experimental steps: (1) CWR22RV1 cells were subcultured in cell culture medium, and cells in a good growth state were seeded into a 96-well plate at 80 μL per well and 1,500 cells per well, and cultured overnight in a 37°C, 5% CO2 cell incubator. ▲2▼ Pharmaceutical grade dimethyl sulfoxide (DMSO) was prepared to a stock solution of 30 mM. Just before use, it was diluted 3-fold with DMSO, and then further diluted 3-fold to obtain 9 concentration gradients. Each concentration of compound was diluted 200-fold with culture medium (this resulted in a DMSO concentration of 0.1% in the culture system), and two wells were repeated for each concentration. 20 μL of diluted compound was added to the cell culture wells (final concentrations 10 μM, 3.3 μM, 1.1 μM, etc.) and gently shaken to mix evenly. In addition, three negative control wells containing only cells and three blank control wells containing only culture medium were set up (for each of the six wells, 200-fold diluted DMSO was added with 20 μL of culture medium). 2. Finding Results (1) After 6 days of culture, 10 μL of CCK-8 was added per well, and the culture was continued for 2.5 hours in a cell incubator at 37°C and 5% CO2. (2) The absorbance (OD value) was measured at 450 nm using a multifunction microplate reader. (3) The data were analyzed using the dose-response-inhibition equation in the software GraphPad Prism 6 to obtain the IC 50 Got the value. Inhibitory activity of compounds of the present invention against CWR22RV1 cells IC 50 The results (nM) are shown in Table 2. A is IC 50 A indicates that the IC is less than 500 nM. B indicates that the IC 50 indicates an IC50 of greater than 500 nM and less than or equal to 2000 nM, and C indicates an IC50 of greater than 2000 nM. [Table 2] TIFF0007579249000733.tif39170The compounds prepared according to the present invention have obvious inhibitory effects on human prostate cancer cells CWR22RV1. In particular, compounds 14, 15, 18, 21, 43, 201, 205, 209, 212, 213, 217, 308, 348, 351, 353, 357, 359, 362, 380, 389, and 390 have IC 50 was found to be less than 500 nM.
[0181] Experimental Example 3 Biological measurement of the inhibitory effect of the compounds of the present invention on the proliferation of other tumor cells 1. Experimental Method The inhibitory IC value of the compound of the present invention against the activity of these tumor cells was determined by the same method as in Experimental Example 2, except that the CWR22RV1 cells were replaced with the tumor cells shown in Table 3. 50 (nM) was tested and calculated, and the results are shown in Table 3. 2. Experimental Results A is IC 50 indicates that IC is 500 nM or less, and B indicates that IC 50 is greater than 500 nM and less than 2000 nM. [Table 3] TIFF0007579249000735.tif203170The compound prepared by the present invention has been found to have effective inhibitory effects on the proliferation of prostate cancer cells, leukemia cells, lymphoma cells, breast cancer cells, and multiple myeloma cells.The compound of the present invention has been shown to have inhibitory effects on multiple tumors simultaneously.
[0182] Experimental Example 4 Biological measurement of the inhibitory effect of the combination of the compound of the present invention and the CDK4 / 6 inhibitor palbociclib on CWR22RV1 cell proliferation 1. Experimental Steps IC of inhibition of CWR22RV1 cell proliferation by compounds of the present invention, palbociclib, and combinations of compounds of the present invention with palbociclib 50 (nM) was tested and calculated as follows: 1) CWR22RV1 cells were subcultured in cell culture medium, and cells in good growth condition were seeded into a 96-well plate at 60 μL per well and 2,000 cells per well, and cultured overnight at 37°C in a 5% CO2 cell incubator. 2) Pharmaceutical grade dimethyl sulfoxide (DMSO) was prepared to a stock solution of 10 mM. Just before use, it was diluted 3-fold with DMSO, and then further diluted 3-fold to obtain 9 concentration gradients. Each concentration of compound was diluted 200-fold with culture medium (this resulted in a DMSO concentration of 0.1% in the culture system), with two wells repeated for each concentration. 20 μL of diluted compound was added to cell culture wells (final concentrations of 10 μM, 3.3 μM, 1.1 μM…), palbociclib was diluted to 500 nM, 150 nM, 50 nM, 5 nM with culture medium, and 20 μL of diluted compound was added to the corresponding cell culture wells (final concentrations of 100 nM, 30 nM, 10 nM, 1 nM) and mixed evenly by shaking gently. In addition, three negative control wells to which only cells were added and three blank control wells to which only culture medium was added (DMSO diluted 200-fold with 20 μL of culture medium was added to each of the six wells) were set up. 2. Finding Results 1) After 6 days of culture, 10 μL of CCK-8 was added per well, and the cells were cultured for 2.5 hours in a cell incubator at 37°C and 5% CO2. 2) The absorbance (OD value) was measured at 450 nm using a multi-function microplate reader. 3) The data were analyzed using the dose-response-inhibition equation in the software GraphPad Prism6 to obtain IC 50 Got the value. Inhibitory activity of the compounds of the present invention in combination with palbociclib against CWR22RV1 cells IC 50 The results (nM) are shown in Table 4. [Table 4] It was found that compound 205 of the present invention, when used in combination with CDK4 / 6 inhibitor palbociclib, exhibits much higher inhibitory activity against CWR22RV1 cells than compound 205 alone or palbociclib alone. It was shown that the combination of the compound of the present invention and palbociclib exerts a synergistic effect in inhibiting prostate cancer.
[0183] Experimental Example 5 Biological measurement of the inhibitory effect of the combination of the compound of the present invention and the CDK4 / 6 inhibitor palbociclib on MCF-7 cell proliferation 1. Experimental Method The IC50 inhibitory effect of the compound of the present invention, palbociclib, and the combination of the compound of the present invention and palbociclib on MCF-7 cell proliferation was measured in the same manner as in Experimental Example 4, except that CWR22RV1 cells were replaced with MCF-7 cells. 50 (nM) was tested and calculated, and the results are shown in Table 5. 2. Experimental Results [Table 5] It was found that compound 205 of the present invention, when used in combination with CDK4 / 6 inhibitor palbociclib, exhibits much higher inhibitory activity against MCF-7 cells than compound 205 alone or palbociclib alone. It was shown that the combination of the compound of the present invention and palbociclib exerts a synergistic effect in inhibiting breast cancer.
[0184] As mentioned above, the present invention provides a compound represented by formula I, which can effectively inhibit histone acetylase p300 and effectively inhibit the proliferation activity of multiple types of tumor cells, including prostate cancer cells, leukemia cells, lymphoma cells, breast cancer cells, multiple myeloma cells, etc. In addition, when the compound of the present invention is combined with a CDK4 / 6 inhibitor, it has a synergistic effect in inhibiting the proliferation of tumor cells, including prostate cancer cells and breast cancer cells. Therefore, the compound of the present invention is promising in the manufacture of histone acetylase inhibitors, medicines for preventing and / or treating cancer, metabolic diseases, neurological diseases or inflammation, and the manufacture of combination medicines.
Claims
1. A compound of formula I, or a stereochemical isomer, solvate, or pharma- ceutically acceptable salt thereof, or an isotopic variant thereof. (In the formula, A is selected from O, N, and S; R is selected from absence, H, an alkyl group, a substituted alkyl group, and an alkenyl group; Rv and Rw are each independently selected from hydrogen, halogen, an alkyl group, and a substituted alkyl group; R x is a group represented by formula V and R b Ha-YR a and R a is selected from a methyl group or a cyclopropyl group, Y is NH; R 1 is H, F, and CH 3 Selected from R 2 is H, F, or CH 3 Or R 1 , R 2 All are CH 2 are linked together to form a three-membered ring; R 3 is H, or R 2 is CH 2 and R 3 is H and combines to form a three-membered ring; R 4 is H, R 5 is a group of formula VI and R 6 , R 7 are linked to form a heterocycle or a substituted heterocycle, The R 6 , R 7 The heterocyclic ring or substituted heterocyclic ring formed by linking the heterocyclic rings is a group represented by formula VII or a group represented by formula VIII and Here, X is C, N, O, S, SO 2 and R 8 , R 9are each independently selected from hydrogen, an alkyl group, a substituted alkyl group, an alkoxy group, an alkenyl group, an alkynyl group, a cycloalkyl group, a substituted cycloalkyl group, a heterocyclic group, a substituted heterocyclic group, an aryl group, a substituted aryl group, an aromatic heterocyclic group, and a substituted aromatic heterocyclic group; R 0 is absent, H or an alkoxy group, or R 8 , R 9 are linked together to form a bridged ring, R 10 , R 11 , R 12 , R 13 , R 14 are each independently selected from hydrogen, halogen, a cyano group, a carboxy group, a nitro group, an alkyl group, a substituted alkyl group, a cycloalkyl group, a substituted cycloalkyl group, a heterocyclic group, a substituted heterocyclic group, an aryl group, a substituted aryl group, an aromatic heterocyclic group, and a substituted aromatic heterocyclic group, or R 10 , R 11 are linked together to form a ring, or R 10 , R 13 are linked to form a ring, The R 8 , R 9 , R 10 , R 11 , R 12 , R 13 , R 14 The above substituents are each independently halogen, C 1~6 Alkyl group, haloC 1~6 Alkyl group, C 1~6 Alkoxy group, haloC 1~6 is selected from an alkoxy group and a hydroxy group.
2. 2. The compound of claim 1, wherein A is O, or a stereochemical isomer, solvate, or pharma- ceutically acceptable salt, or an isotopic variant thereof.
3. 2. The compound of claim 1, wherein the compound is one of the compounds of the following structural formulas: 1-9, 11, 13-64, 73-97, 101-104, 107, 111, 112, 201-220, 225, 303, 306, 307, 309, 310, 313-315, 318, 319, 322-325, 328, 330-341, 343, 347-354, 356-363, 365, 366, 369-371, 373-375, and 378-392.
4. 13. Use of the compound according to claim 1 or a stereochemical isomer, solvate or pharma- ceutically acceptable salt thereof, or an isotopic derivative thereof, in the manufacture of a histone acetylase inhibitor.
5. The use according to claim 4, characterized in that the histone acetylase is p300.
6. The use according to claim 4 or 5, characterized in that the histone acetylase inhibitor is a pharmaceutical agent for treating cancer, metabolic disease, neurological disease and / or inflammation, and the cancer is prostate cancer, leukemia, lymphoma, breast cancer or multiple myeloma.
7. A pharmaceutical composition comprising the compound according to any one of claims 1 to 3, or a stereoisomer, solvate or pharma- ceutically acceptable salt thereof, or an isotope substitute thereof, as an active ingredient, and a pharma- ceutically acceptable auxiliary material.
8. A combination drug comprising a compound according to any one of claims 1 to 3 and an anticancer drug for simultaneous or separate administration in unit dosage forms of the same or different specifications, and a pharma- ceutical acceptable carrier.
9. The combination drug of claim 8, wherein the anticancer drug is a CDK4 / 6 inhibitor.
Citation Information
Patent Citations
isoxazolyl-substituted imidazopyridines
JP2018517672A
Use of histone acetyltransferase inhibitors as novel Anti-cancer therapies
WO2011085039A2
Spirocyclic hat inhibitors and methods for their use
WO2016044770A1
Hat inhibitors and methods for their use
WO2016044771A1
Crebbp related cancer therapy
WO2018022637A1
